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Abstract
The lens is the primary medium by which light is transmitted onto the retina.
The transparency of the lens to light in the visible region and its flexibility to focus this
light are crucial in maintaining vision. Ageing of the h u m a n lens is characterised by the
slow onset of a variety of physical changes that affect the w a y w e visualise the world.
A s w e age, the integrity of the lens deteriorates in several quantifiable ways. The protein
in the lens becomes progressively more yellow, the effect of this filter being that the
colours transmitted to the retina are diminished, especially the blue-green colours. In
addition the lens proteins become more fluorescent and the crystallin protein, which
makes up most of the dry weight of the lens, slowly becomes more insoluble. It is a
widely held view that these physical manifestations of ageing in the lens are attributed
to post-translational modification of the crystallin protein. Over time these
modifications alter the integrity of the protein. Individual units aggregate and eventually
cease to remain soluble. Increased insolubility of the protein is associated with the
elderly suffering glare from bright lighting and the eventual loss of vision through
cataract formation.
The h u m a n lens contains a number of low molecular weight fluorescent
compounds derived from the metabolism of tryptophan, termed U V filter compounds.
They absorb most of the U V light transmitted by the cornea between 295 and 400 n m . It
has been speculated that the function of these compounds within the lens m a y be to
protect the lens and the retina from harmful U V radiation and to increase visual acuity.
In this study tryptophan metabolites were examined for their ability to
covalently modify crystallin protein of the lens. The primary objective was to find
evidence for this modification on the protein. Secondary objectives of this study were to
discover what physical effects these modifications had on parameters normally
associated with the ageing lens, namely increases in protein 'colouration', fluorescence,
aggregation and precipitation.
A n important finding from research undertaken in our laboratory w a s that
metabolites of tryptophan that contain the kynurenine side-chain, can spontaneously
deaminate to form an a, P-unsaturated carbonyl compound. Model incubation studies
were conducted with an analogue of this reactive intermediate in aqueous buffered
solutions to determine if the intermediate can further react to form adducts with various
nucleophilic amino acids. Evidence is given that not only shows that the intermediate is
stable in aqueous buffered solution but that adducts are formed with thiol and s-amino
groups of cysteine and lysine, respectively, in high yield.
Having established the feasibility of forming kynurenine-derived adducts with
crystallin, w e then established a test to quantify the amount of 3-hydroxykynurenine-O(3-D-glucoside ( 3 0 H K G - the most abundant kynurenine-derived U V filter) bound to
protein from h u m a n lenses. B y treating protein material with alcoholic hydroxide for 48
hours, a fluorescent compound was released that was identified as the cleavage product
of 3 0 H K G (2-amino-3-hydroxyacetophenone-0-P-D-glucoside, A H A G ) . A H A G w a s
quantified from the protein extracts of over 100 individual h u m a n lenses spanning over
eight decades of life. Quantification showed that there were negligible quantities of the
bound fluorophore prior to approximately 40 years of age, whereafter an exponential
increase could be observed. The amount of 3 0 H K G bound to the crystallin protein also
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showed a good correlation to the observed 360 n m absorption and non-tryptophan
fluorescence of the h u m a n lens protein.
The U V filter compounds were incubated with crystallin protein derived from
young bovine lenses for up to five days with the aim of examining the parameters
associated with the ageing lens. The crystallins obtained from the bovine lens have a
close sequence homology to that of the analogous h u m a n lens proteins but the bovine
species lack the U V filter metabolic pathway, hence the protein had not previously been
in contact with these small molecules. The incubated protein material exhibited similar
physical characteristics as protein from aged h u m a n lenses, namely increases were
observed in 360 n m absorption, non-tryptophan fluorescence, protein aggregation and
protein precipitation as incubation time and U V filter concentration were increased. The
inclusion of glutathione, an anti-oxidant compound normally found in healthy h u m a n
lens homogenates, delayed crystallin modification as measured by these parameters.
Finally, mass spectral evidence is provided for crystallin sequences that had
been modified by the most abundant U V filter, 3 0 H K G . B y incubating separate
crystallin families with 3 0 H K G for up to five weeks followed by digestion with trypsin,
w e found that cysteine residues from bovine ocA and P B 2 crystallin sequences were
initial and major sites of covalent modification by this U V filter compound. Since
3 0 H K G (and the other kynurenine-derived U V filters) are continually synthesised in
the h u m a n lens over the lifetime of the individual, these findings m a y provide a
biochemical link to the physical parameters associated with the ageing lens and cataract
formation.
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Chapter I
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CHAPTER ONE
Introduction

1.1 Relevance of Cataract to the Community

Eye diseases preferentially affect the elderly, it has been estimated that nearly 7

of people in the 75+-age category suffer from some form of eye disease that may lea

blindness . Of these eye diseases, cataract is the major cause of blindness worldwi

the United States of America, 1.3 million cataract operations occur each year, cost

approximately 3.4 billion U.S.dollars . India has nearly four million patients dia
as legally blind, mainly due to cataract, each year . At present there is no known
for this debilitating disease, which is forecast to increase along with the ageing
population, making research into this phenomenon vitally important. Cataract is an
opacification of the eye's primary focussing medium, the lens, impeding light from

reaching the retina at the back of the eye. It has been estimated that if the onset
cataract could be delayed by ten years then the economic saving to the community
would be hundreds of millions of dollars .
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1.1.1

Introduction

C a s e Study o n M o n e t : T h e Artist's V i e w with Cataract

Claude Monet (1840-1926) painted for more than 60 years. His works remain

some of the most highly regarded of all the 19th and 20th century painters. The pain

created during his long career span the period from early Impressionism to the vagu

scenes from his old age. The cataracts that blinded Monet in later life were an im
influence on the way he saw the world and on the way he painted it. What is of

particular interest in Monet's work is that he intentionally painted a series of p

of the same motif. It was thought that they were an attempt to capture exact moment

light. In this way paintings of the same object are available from times when, acco

to Monet's letters, his vision was, and was not, affected by cataract5. Since his s

painting was deliberately based on a certain imprecision of detail, his visual dif

later in life did not become apparent until, when he was in his 60's, a further blu

occurred in his paintings. As Monet's cataracts progressed further, he found it ne

to alter his method of painting. Bright sunlight caused him difficulty, so he chan

hours he painted, as his ability to distinguish colours diminished he was forced to

the labels on the tubes of paint and maintain a regular order of colours on his pal

avoid mistakes in his selection6. Despite Monet's methods of adapting to the disea

difficulty in distinguishing colours persisted. By 1922, his paintings had become m

more 'muddied', essentially devoid of the blue and green colours, characteristic of

early works, to replaced by mainly red and yellow colours. Monet described the loss

vision that he had been noticing during the proceeding four or five years:'.. .forc

myself to resume my interrupted task and recapture the freshness that has disappear
from my palette! Wasted efforts. What I painted was more and more like an "old
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picture", and w h e n the attempt was over and I compared it to m y former works, I would

be seized by a frantic rage and slash all my canvases with my penknife.' Later t

when he was pronounced blind, Monet decided to undergo cataract surgery to the r

eye. The science of surgery to the eye was, however, imprecise at best. The lens

was totally removed and Monet had to adjust to using aphakic spectacles, about w

he complained bitterly. Objects appeared curved, he was unsteady on his feet and
colours appeared strange and new. He found it necessary to cover one eye when

painting, depending on whether he preferred a 'blue-green' picture (using his re
operated eye) or a 'red-yellow' picture (using the remaining cataractous eye)5.

Examples of these can be seen in figure 1.1 A and B, 'The House seen from the Ro
Garden.'

3
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Figure 1.1:

'The House seen from the Rose Garden' by Claude Monet. Both

paintings were painted around August 1923 from the same position in
Monet's garden. After cataract surgery to his right eye in December 1922
and the prescription of aphakic spectacles, Monet found colours 'strange
and new'. This problem led him to cover one eye at a time when he
painted, depending on whether he wanted a blue-green picture (using his
right eye) or a red-yellow picture (left, cataractous eye).

1.1.2 Diagnosis and Treatment of Cataract

Age-related nuclear cataract is a disease that develops over decades, with the

majority of cases reported to health professionals in the seventh or eighth decade

Most individuals are unaware of the progressive loss of visual acuity and colour v

because of the very slow onset and the lack of an external control. The physical c

to the lens during cataract formation include increases in light scattering, absor

4
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fluorescence. A s cataract progresses, opacification of the centre of the lens becomes
more obvious, figure 1.2 shows the simple in vivo classification system developed,

which places lenses into four major classes, depending on the severity of the condi

Type I

Type II

Type III

Type IV

Figure 1.2: The development of age-related cataract as viewed by Scheimpflug slitimage photography. Classification of the cataract is based on the severity
of the condition. Type I cataract patients experience increases in glare
and the loss of visual acuity, while those suffering from type IV cataract
will be totally blind. Reproduced from Brown et al1.

In western countries current treatment for cataract involves intracapsular extractio
of the lens contents by phacoemulsification, followed by insertion of a plastic

replacement lens inside the lens capsule. In developing countries such as India, th

number of operations requires that a proportion of the population undergo the simple

procedure of whole lens removal (extracapsular) and optical correction achieved with

aphakic spectacles. As with any surgical procedure, however, risks are involved such

the possibility of infection and secondary opacification of the lens capsule that r
further surgery to correct7.

5
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Anatomy of the Lens

The function of the human lens is to filter and focus light passing through from the

cornea onto the retina. The normal lens is transparent to all frequencies of light be
450 and 900nm, allowing for perception of colour and good visual acuity8. The lens is
able to obtain this transparency by being essentially devoid of internal structures
(organelles) normally associated with cellular function. The lens, itself, grows

throughout life like an onion and is therefore unlike any other organ. Lens cells are
discarded; older cells are surrounded by new cuboidal epithelial cells, which

differentiate and elongate into fibre cells at the equator of the lens. As the lens f
cells elongate further they begin to manufacture one major class of protein, the

crystallins, and finally to lose internal organelles such as mitochondria and nuclei.
the lens becomes an almost uniform composition of crystallin protein throughout,

allowing the passage of light through the lens with as little light scattering as pos
The lens crystallin proteins constitute some 30% of the lens by weight with the
remainder of the cell made up mostly of water. At birth the equatorial lens is about

mm in diameter with a sagittal width of approximately 3 mm, by the ninth decade of li
these dimensions change to about 10 mm and 5-6 mm respectively8. Anatomically, the

lens is made up of the pre-natal lens at the centre, or nucleus, surrounded by the ou
layers of fibre cells, referred to as the cortex (Fig. 1.3). On the outer rim of the

cortex is a single layer of cuboidal epithelial cells. The capsule surrounds the lens;
to this are attached the ciliary muscles and suspensory ligaments that control lens

curvature by either contracting or relaxing, hence changing the focal length. The len
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suspended near thefrontof the eye just behind the iris, forming a boundary between the
aqueous and vitreous humors on the anterior and posterior sides respectively.

sclera

choroid

d.*Yt

conjunctiva

cornea

1C P i

sir

tear film — - f fi

.

vitreous
humour

rilvl
Leas Nucleus ,

>

CioSr

optic nerve

ciliary
body

Figure 1.3:

fovea

^•I*M

\\l

iris

^ neural retina

Hfea

—•—f- { »

humour

retinal pigment
epithelium

^
^L,^"5$»»"r,'"^Cv

't^-if^^^

Cross-section of the h u m a n eye with the lens shown in yellow. The lens

is divided into the inner region, referred to as the nucleus and the outer,
metaboHcally more active, cortex region.

D u e to the fact that the lens has no direct vascular or nervous supply, it is primarily

the aqueous humor that supplies the nutrients required for lens epithelial cell gr
well as functioning to remove metaboHc waste9.
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Protein Composition

Over 90% of the protein in the lens is made up of a family of proteins called the
crystallins. The high refractive index of the lens is largely due to the very high
concentration (>300 mgmL"1) and short-range, highly ordered packing of this family of
proteins. The crystallin proteins are broadly segregated into three families: alpha,
and gamma (a, P and y) based on the molecular size of the aggregates they form, but
can be classified into individual polypeptides.
The alpha fraction consists of two related protein units designated aA (for
acidic) and aB (for basic) on the basis of their pi values10. These subunits of acrystallin have a molecular mass of approximately 20 kDa each and form highly
aggregated complexes of approximately 40 subunits11. The role of a-crystallin is

twofold: it has structural and refractive properties, along with the other lens prote

its chaperone activity is believed to help stabilise the other proteins in the lens t

maintain transparency . The secondary structure of the a-crystallins are quite simila
that they contain approximately 10% a-helix and 50% P-sheet as determined by circular
dichroism experiments . NMR spectroscopy has shown that the C-terminus of both
proteins contain highly flexible extensions, which are exposed in solution, of
approximately 8 amino acids in the case of ccA-crystallin and 10 amino acids for aBcrystallin. These hydrophilic amino acid extensions may facilitate the chaperoning
ability of this class of proteins14.
In addition to a-crystallin, the mammalian lens also contain P- and y-crystallins.
The p- and y-crystallins have approximately 30% sequence homology and have a

similar evolutionary history15. This family of proteins can be divided into pH-crysta
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("heavy"), pL-crystallin ("light"), yS-crystallin and yT-crystallin based on the order in

which these proteins elute from size-exclusion chromatography. The pH-crystallins tend

to form octomers of heterogeneous subunits whereas the PL-crystallin fraction consists

of a mixture of trimers and dimers. The P-crystallin family consists of 6 closely rela
monomer units, which are divided into two groups, acidic (A) and basic (B). The y-

crystallin family has 7 proteins, yS-crystallin and yA to yF (collectively referred t
crystallin in this thesis).
Structural analysis of the P- and y-crystallins reveals that they mostly consist of
P-sheet and have a supersecondary structure of the "Greek key" domain15. Proteins in
these families possess a high degree of similarity between the N- and C- terminal
regions within the primary sequences, separated in the middle by a "linking"
polypeptide section. Shown in figure 1.4 is the ribbon structure for the tetramer of
human pB2-crystallin, as determined from the crystal structure15.

9
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Figure 1.4:

Ribbon structure of the tetramer of pB2-crystaUin as determined by

crystaUography16. The "Greek key" supersecondary structure, which
mostly consists of P-sheet is highlighted in the figure by a box.

The proportion of the crystaUin families changes as we age: at birth the lens
contains approximately 20% a-crystaUin, 42% P-crystaUin and 38% y-crystaUin; by
adolescence these proportions have changed to approximately 42%, 35% and 13%
respectively, indicating that production of y-crystallin ceases at birth, thus being

localised largely in the nuclear portion of older lenses8. Other proteins to be assoc
with the lens include: metabolite transport and ceUular communication proteins such

gap junction (i.e. connexins), ion-channel and transporter proteins; enzymes associat

with metaboHsm (mainly in the cortical epithelial cells); enzymes associated with ant
oxidant production, as weU as lens membranes which are rich in cholesterol and
phosphoHpids.

10
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a-Crystallin as a Molecular C h a p e r o n e

The crystallins within the lens display an overall repulsive interaction,

dominated by those of a-crystallin. Lens transparency is attributed to these repulsive

interactions that lead to an even packing of the proteins17. The function of a-crystall

in the lens appears to be twofold: to help maintain these repulsive interactions, as w

as to help stabilise other proteins in the lens that may have become denatured in some
way. Proteins that are undergoing unfolding processes can adopt intermediatelystructured, molten globule states and it is these states which interact and bind with
1 o

chaperone proteins . The molten globule state is characterised by having only part of

the native structure of the protein, there is a loss of tertiary structure but retent
most of the native secondary structure elements (Fig. 1.5). Molten globule states may
induced in proteins via changes in pH, temperature, salt concentration or posttranslational modification14.

11
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Native State
Figure 1.5:

Molten Globule

Schematic representation of the structural changes that occur in the

molten globule state compared to the native protein. Secondary structure
within the protein is depicted by cylindrical a-helices. These a-helices
are mostly maintained in the molten globule state. Interior hydrophobic
residues are exposed in the molten globule, resulting in an overall change
in the tertiary structure. Exposed hydrophobic regions tend to aggregate
with other nearby proteins that are also undergoing unfolding. Left
unchecked, these aggregates will eventually precipitate. The role of acrystallin in the lens (and elsewhere in the body) is to stabilise these
disordered proteins to prevent precipitation 7.

The molten globule state has increased exposure of regions of hydrophobicity.
This exposure of the hydrophobic regions tends proteins to aggregate and thus making

them more likely to precipitate from solution18. The chaperone action of a-crystallin is

exerted by stabilising proteins in the disordered molten globule that are aggregating a
are about to precipitate from solution19, a-crystallin and other proteins in this class
not refold proteins back into their native state, but maintain solubility of the high
molecular weight (HMW) complex.
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Biochemistry of the L e n s

Lens metabolism is generally considered to occur primarily in the superficial
layer of cuboidal epithelial cells and cortical cells of the anterior cortex. These
provide the metabolic energy, in the form of ATP, required by ion-channel and

transporter proteins to nourish the underlying avascular fibre cells with the requi
for cellular function.
The absence of organelles, active enzymes and low protein turnover in the
innermost tissue makes it vulnerable to the cumulative effects of oxidative and non-

oxidative stresses. As the lens continues to grow throughout the life of an individu
nucleus of the lens become increasingly remote from the epithelial cells supplying
nutrient and anti-oxidants .

1.2.4 UV Filter Pathway

Aside from the metabolic activity required to produce energy, the epithelial cells
of the lens also metabolise tryptophan along the kynurenine pathway. The metabolism
of tryptophan, an essential amino acid, has long been known to be critical for many

biological functions. Tryptophan is metabolised in nerve tissues to produce the vital
neurotransmitter, serotonin. The enzyme co-factors NAD and NADP are produced from
-» I

tryptophan along with the co-enzyme acetyl-CoA . This oxidative pathway is shown in
figure 1.6. Many disease states have been linked to abnormalities in the kynurenine
pathway, in particular elevated levels of the key intermediate, 3-hydroxykynurenine
(30HK) has been found in patients suffering from the neurodegenerative disorders -
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Huntington's and Parkinson's disease22, as well as elevated levels in AIDS-related
dementia-23 and hepatic encephalopathy24

COOH

,COOH
"NH,

O
HO
3-hydroxykynurenine
(30HK)

acetyl C o A

Figure 1.6:

N

COOH

O

2-acroleyl-3-aminofumarate

3-hydroxyanthranilic acid
(30HA)

XOOH

quinolinic acid

NAD+

The catabolic pathway for 3-hydroxykynurenine ( 3 0 H K ) . 3 0 H K is

predominantly metabolised by kynureninase to 3-hydroxyanthranilic acid
(30HA). A ferro-protein oxygenase, hydroxyanthranilate oxidase,
catalyses the ring opening to yield 2-acroleyl-3-aminofumarate. This
metabolite can undergo a non-enzymatic cyclisation to quinolinic acid (a
precursor for NAD+) or oxidise completely to acetyl-CoA.

The h u m a n lens contains a group of tryptophan derived, fluorescent compounds,
which absorb ultraviolet light in the 300-400 nm region of the spectrum25. The major
tryptophan derived metabolite found in the lens is 3-hydroxykynurenine-O-p-Dglucoside (3OHKG). The identification of 3OHKG in the lens signalled that a unique

pathway for tryptophan metabolism existed, which seems to only occur in the lenses o
humans and other higher primates26. Throughout the rest of the body, tryptophan is
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converted to 3-hydroxykynurenine ( 3 0 H K ) before being converted to 3-

hydroxyanthranilic acid. In the lens, 30HK is, instead, conjugated to glucose. Smal
amounts of kynurenine (Kyn) and 30HK have been detected in human lens extracts27,28

Importantly for projects associated with this thesis, the lenses of cattle (Bos Tau
not metabolise tryptophan to any significant extent down the kynurenine pathway,
therefore we could mimic the conditions inside the human lens by incubating protein
derived form bovine lenses with the UV filters found in human lenses.
The first, and rate-limiting step in tryptophan metabolism in the lens is the
heterocyclic indole ring opening by indoleamine-2,3-dioxygenase (IDO) [EC
1.13.11.17]29 to yield N'-formylkynurenine which is further, rapidly, hydrolysed by
non-specific formamidase to kynurenine (Kyn). Kynurenine is hydroxylated at the
meta-position by a mitochondrial NADPH-dependent flavoprotein, kynurenine
monooxygenase [EC 1.14.13.9], to yield 3-hydroxykynurenine (30HKyn). 3Hydroxykynurenine is then conjugated to D-glucose by an as yet unidentified enzyme
to yield 3-hydroxykynurenine-O-P-D-glucoside (30HKG), the tryptophan metabolite

found only in the lens of the higher primates. It is the most abundant UV filter. Th
second most abundant UV filter compound found in the lens is 4-(2-amino-3hydroxyphenyl)-4-oxobutanoic acid-O-P-D-glucoside (AHBG)30, a compound
structurally related to, and derived from, 3 OHKG via deamination and reduction of
•21

kynurenine side chain (Fig. 1.7) .
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Figure 1.7:

The tryptophan metabolic pathway inside the lens. The most abundant

UV filter is 3-hydroxykynurenine-O-p-D-glucoside (30HKG). Recent
findings suggest that the second most abundant U Vfilter,A H B G , forms
from 3 O H K G via initial deamination of the kynurenine side chain31 (see
section 1.3.2).
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The fact that these kynurenine moieties are found in the lenses of higher
primates would lead one to assume they play a role in the function of the lens.

Kynurenine and related structures have the ability to absorb long-wavelength UV light,
with peak absorption occurring at approximately 360nm. It has been postulated that
having small molecules of this type in the lens helps reduce the amount of damaging
UV light from reaching the sensitive retina at the back of the eye32. Kynurenine -like
molecules may also play a role in helping to prevent chromatic aberration26.

1.3 Age-Related Changes to the Lens

As we age, several factors can be quantified in relation to changes in the properties
o

of the lens and its function . Presbyopia is the age-related loss of the ability to focus on
near targets. Normally, accommodation of the lens is achieved by ciliary muscle
contraction, which allows the lens to become more globular in shape especially in its
anterior curvature. It is thought that one or other of four main factors may cause
presbyopia:
(1) The progressive transformation of the ciliary muscle into connective tissue,
thus weakening the ability of the muscle to contract maximally.
(2) Reduced responsiveness of the ciliary muscle to neural stimulation, again
reducing the ability of the muscle to contract fully.
(3) Age-related increase of the curvature of the anterior lens that reduces the
ability of the ciliary muscle to cause further change. The increase in curvature
primarily comes about with the increase in lens volume and sagittal thickness.
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Change in lenticular elastic properties, which affects the accommodation power

of the lens. There is an increase in stiffness of the nucleus, and to a lesser
extent the cortex, as we age. The change in stiffness has been attributed to
several factors including: increased compaction of the protein and loss of water
content at the centre of the lens; the loss of viscosity caused by the
transformation of the membrane cholesterol into cholesterol esters and an
Q

increased binding of lens proteins to lens membranes .

Other quantifiable age-related morphological changes to the lens include: a
progressive increase in yellow colouration and fluorescence leading to diminished
colour perception, particularly in blue end of the spectrum33"35. Increases in light

scattering, particularly forward scattering, which is associated with patients sufferin
from glare36. Intra-cellular membrane rupture37 and water vacuoles38 become evident
after the fourth decade of life and then become progressively larger and more frequent.

1.3.1 Age-Related Changes in Crystallin Proteins

Due to the fact that protein turnover in the lens occurs minimally, if at all in the

nucleus, one can conclude that some proteins at the centre of the lens are as old as the
individual8. Because of the exceptionally long lifetimes of these proteins, a variety of

post-translational modifications accumulate on the lenticular protein. It is these chan

that are of greatest interest to researchers looking for biochemical reasons behind agerelated changes to the properties of the lens. As we age there are dramatic changes in

crystallin solubility and aggregate size. There is a general increase in the formation o
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both water soluble high molecular weight ( H M W ) crystallin aggregates and insoluble
protein39. Concurrent with the increase in crystallin associated with HMW aggregates,

there is a progressive loss of soluble a-and y-crystallins, particularly from the nucle
At birth we have around 40% each of soluble a- and y-crystallin in the nucleus, this
decreases to less than 5% by age 4040.
Quantifiable post-translational modifications that occur with ageing include:
phosphorylation of serine residues41'42; carboxymethylation and/or glycosylation of the
e-amino group of lysine43; deamidation of asparagine44 and the addition of kynurenine
moieties to cysteine, lysine and histidine58. Glycosylation of the lysyl e-amino groups

has been postulated as the major cause of the lens colouration and protein cross-linking
observed in the ageing lens and in cataract, although the biochemical evidence is
lacking46. Aldehydes and ketones react non-enzymatically with amino acids to create
products known as advanced glycation end products (AGEs) via Schiff-base formation
followed by Amadori rearrangement. Once formed, this product can undergo further
non-enzymatic cross-linking and tanning via Maillard reactions to produce an
aggregated and coloured protein similar in appearance to that observed with cataract47.
A similar mechanism has also been used to show that ascorbate can react with lens
crystallins, the fact that the material produced shows similar spectroscopic and
fluorescent characteristics to those observed with cataract supports this hypothesis '
Many crystallin subunits were also found to be truncated at either the N-terminus ' or
C-terminus52"54 in older individuals.
Modifications of the amino acids in the crystallins has been postulated as a root
cause of the protein unfolding and aggregation observed with ageing, due to the

alteration of the charge distribution on the surface of the crystallin molecules . Due t
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the high protein concentration and highly ordered packing of the crystallins, it is
reasonable to assume that any modification to the amino acid composition would alter
the way the proteins interact with each other and the way they fold. Relating these

changes to the observed changes in the lens, however, is somewhat more difficult due t

the inherent difficulty of working with modified and insoluble protein material. Thus

there is a relatively poor biochemical understanding of age-related changes within th
lens.

1.3.2 Age-Related Changes in Lens UV Filter Composition and Antioxidant Defence

One theory to account for age-dependant human lens colouration is via the addition

of UV filters to crystallins55. A novel mechanism for the addition of these compounds
nucleophiles in the lens was recently discovered by the isolation and structural
elucidation of the glutathione adduct of 30HKG (GSH-30HKG)56. This mechanism
involves deamination of the a-amino group on the kynurenine side chain. Finding GSH3 OHKG in the lens demonstrated that even at neutral pH, the amino group of the

kynurenine side-chain of the UV filter was inherently unstable. This instability lead
slow deamination and formation of a reactive a, p-unsaturated carbonyl, which is

susceptible to nucleophilic attack (Fig. 1.7). Such a process has also been demonstra
to be responsible for the formation of the second most abundant UV filter compound
AHBG31 as well as 3 OHKG adducts to human lens crystallin proteins (see Chapter
three)57. Recent mass spectroscopic advances have shown that deaminated kynurenine

binds to specific amino acids of crystallin protein (see Chapter seven), namely cyste
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lysine and histidine residues. This was confirmed by acid-hydrolysis of crystallin

protein to yield kynurenine adducts of the above amino acid residues58. The importance

of finding these compounds in the lens demonstrates a key advance in the understanding

of the age-related changes occurring in the lens. With this discovery, our research gr

undertook a major study on the quantification of the UV filter components in the lens,
together with the amounts of reduced and oxidised glutathione in the nuclear and

cortical regions of the lens with respect to age of the individual. This study repres
larger sample population (n = 50) than those previously reported, with analysis
performed on dissected lens homogenates of the nuclear and cortical parts of the lens
and a more comprehensive age range covered by the analysis. Results from this study
indicate a linear loss of the major UV filter compounds: Kyn, 30HKyn, 3OHKG and
AHBG with age. With the exception of AHBG, the UV filters were shown to have
slightly lower levels in the nuclear regions as compared to the cortex. In agreement
previous studies59'60, reduced glutathione (GSH) was found in lower levels near the

centre of the lens compared to the cortex, with a general decline in both regions with

age. Oxidised glutathione, however, was found in increasing levels in the nucleus, whi
levels in the cortex remained constant .
The role of reduced glutathione in the lens as the primary antioxidant is well

established61. Glutathione is synthesised and regenerated primarily in the lens epithe
cells and outer cortex on the anterior surface of the lens and then is transported or

diffuses throughout the remainder of the lens62. There is a demonstrated loss of speci
activity by the enzymes associated with the maintenance of reduced glutathione in the

lens, leading to a small decrease in total (nuclear + cortical) reduced glutathione as

function of age63'64. Recent findings point to the fact that there is a major change in
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transport associated with the normal ageing lens. It has been proposed that a barrier to
permeability of reduced GSH and other small metabolites forms at the nucleus/cortex
interface in older individuals55. Two separate experiments lend weight to this
hypothesis:
(1) By incubating young (< 30 years) and older (> 50 years) lenses in artificial
aqueous humor (AAH) containing radioactive labelled [35S]cysteine and
measuring the metabolic incorporation into GSH and penetration into the
lens, Sweeney and Truscott found that in older lenses penetration of the
radiolabel into the lens occurred minimally past the cortical regions of the
lens65.
(2) Using magnetic resonance microscopy to measure the rate of replacement
of H2O with deuterium oxide (D20)-present in AAH. NMR signal
intensity decreased with time corresponding to a decrease in concentration
of H2O from within the lenses66. With age, however, the loss of water (i.e.
diffusion in of D2O) from the nuclear portion of the lenses occurred at a
much slower rate, leading one to assume that water-soluble low molecular
weight metabolites also diffused through the lens at a slower rate.

This barrier which inhibits antioxidants from reaching the innermost layers of lens
tissue could account for the otherwise paradoxical finding that some advanced nuclear

cataract patients had quite normal levels of reduced GSH in the cortical regions of the
lens59, but major oxidative damage to the crystallin protein in the nuclear portion of
lens.
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1.4 Characteristics of Age-Related Cataract

Normal, healthy aged lenses display most of the characteristics described above
but an important differentiation occurs between aged lens and those with some nuclear

cataract: the environment inside the aged lens is in a reduced state with oxygen tensio
being quite low, as evidenced by minimal quantities of oxidised methionine and few
protein-protein disulphide cross-linkages59'67, which are all hallmarks of nuclear
cataract. The very low to undetectable concentrations of GSH in the centre of the lens
the case of age-related cataract68"70 has two consequences: lower GSH concentrations

will allow for greater protein modification and low GSH will also allow for proteins to
be more easily damaged by oxygen species71"73.
A distinguishing feature of age-related cataract, as opposed to normal ageing, is
the large amount of crystallin oxidation, consistent with the generation of reactive
oxygen species (ROS), in particular, hydroxylation of protein-bound amino acids

evident in the crystallins at the centre of the lens. On the basis of these observatio

was postulated that the reaction of the crystallins with hydrogen peroxide derived from
superoxide may be responsible for the changes associated with nuclear cataract
formation '7 '75. Hydroxylation may arise from transition-metal catalysed Fenton
reactions for which a recent study showed elevated levels of iron, but not copper, in
type IV cataract as opposed to normal lenses7 . Some of the quantifiable oxidation
products of amino acids that occur in the cataractous lens include:
oxidation of tyrosine to ortho-tyrosine and dityrosine74; the formation of methionine

sulfoxide77 and lanthionine, a thioether derived from cysteine78; as well as the formati
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of both disulfide (with a concomitant loss of protein thiol groups) 59 and non-disulphide
protein cross-links79.

1.4.1 Proposed Models for Age-Related Nuclear Cataract

UV wavelengths below 290 nm (termed UV-C) are completely absorbed by the
cornea80. Roughly two percent of UV-B radiation (290-315 nm) does, however, reach
the lens and it is radiation of this higher energy which has been investigated as a

possible cause of cataract by either directly damaging the lens structural proteins (l
evidence supports this hypothesis) or acting on compounds termed photo-sensitisers species capable of generating reactive oxyradicals. Ruth van Heyningen's paper of 1973
showed that UV filter compounds accelerated the degradation of certain amino acids in
the crystallin protein when irradiated with sunlight, her conclusion was that they
Q 1

probably acted as photo-sensitisers . Finding evidence for oxidative damage to the

nuclear crystallins has led to many other studies on the effect of oxidising condition
the kynurenine -like UV filters. Kynurenic acid and N-formylkynurenine are
intermediates formed during tryptophan metabolism which are known to act as photoft")

sensitisers . 3-Hydroxykynurenine ( 3 0 H K ) is an inherently unstable compound that is
readily autoxidised to products including hydrogen peroxide, it may be involved in
cataract based on the observations above83. A wide variety of products are obtained
from the oxidation of 30HK (Fig. 5.1), which may have deleterious biological effects.
3-Hydroxyanthranilic acid, when incubated with oxygen, will readily undergo

autoxidation e.g. in the presence of calf lens protein, to produce coloured and oxidise
proteins

84

and this is accelerated by light85. A recent study has also shown that
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oxidation products of 3 0 H K m a y also covalently cross-link polypeptide chains, thus
giving further impetus to the theory of its involvement in cataractogenesis86.
Photolysis research has been conducted in various laboratories in an attempt to
explain the molecular basis for the observations described in Section 1.4. Dillon and
workers have extensively researched the effect of UV radiation on the proteins of the
lens. When irradiated with UV light with a maximum output at 365 nm and a plastic
filter which absorbs radiation below 290 nm (mimicking the effect of the cornea), in

vitro solutions of alpha-crystallin protein incubated with the major UV filter, 3OHKG,

resulted in conjugation87. The mechanism proposed by Dillon is oxidative, reliant on th
initial radiation-catalysed cleavage of the o-glucoside from 3 OHKG. The resultant
phenoxy radical can then autoxidise in the same way as 30HK. The question arises,
however, how much radiation is necessary to achieve this glucose cleavage and does

this much UV radiation, in fact, reach the nuclear parts of the lens where colouration
*7

and oxidation are occurring? The epidemiological evidence is far from conclusive . If
direct photo-oxidation were responsible for the o-glucoside cleavage from 3 OHKG,
then one would expect that there would be a decreasing concentration gradient of
30HK-modified protein from the cortex to the nucleus that paralleled the decrease in
UV light as it was adsorbed by the lens7 . This does not appear to be the case.
Proteins can undergo cross-linking between pentose, arginine and lysine to form a
fluorescent yellow compound, pentosidine. In the lens this compound was only found,
however, in significant quantities in patients suffering from the most severe Type V
QQ

(nigrescent) nuclear cataract so its relationship in cataractogenesis must be questioned .
Similarly a-dicarbonyl compounds such as methylglyoxal, glyoxal and ascorbate were
found to modify arginine residues within proteins to form argpyrimidine. Although
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these compounds were detected in larger quantities than those for pentosidine,
significant quantities were, again, only observed in advanced cataract lenses.

1.5 Introduction to present work

The aim of this study was to examine various physical parameters in relation to
the non-oxidative binding of kynurenine-derived UV filters to crystallin protein. As

mentioned in Section 1.2.4, UV filters that contain the kynurenine side chain, are able

deaminate at neutral pH to form reactive a, P-unsaturated carbonyl intermediates. These
intermediates were examined for reactivity toward protein in vivo by probing for
evidence of crystallin-30HKG adducts in the human lens and in vitro by assessing the
relevance of analogous reactions in the modification of bovine lens crystallins (Fig.
1.8).
The physical parameters used to assess this modification were measurements of

increases in absorption at 360 nm and so-called 'non-tryptophan' fluorescence by taking

three-dimensional fluorescence spectra in the regions of 250-450 nm (excitation) / 300600 nm (emission) and quantifying these peaks in relation to control experiments. Other
parameters to be measured were: the effect of incubating crystallins (bovine) with
human UV filters on protein aggregation (by size-exclusion chromatography); protein
precipitation and protein cross-linking (by SDS-PAGE). Finally mass spectrometry was
used to identify protein sequences to which 3 OHKG had bound.

26

Chapter 1

Figure 1.8:

Introduction

The proposed interaction of U Vfiltersinside the lens. The U Vfiltersare

all derived from L-tryptophan metabolism in the cortical region of the
lens . These metabolites, along with glutathione, diffuse into the centre
of the lens at progressively slower rates as we age 5. Kynurenine-type
moieties have been shown to spontaneously deaminate in aqueous buffer
solution31. This fact combined with a slower diffusion rate for these
metabolites and a concomitant decrease in GSH availability would
increase the likelihood of forming adducts with protein. It is the
consequences of this adduction that is the primary concern of this thesis.
This region of interest is highlighted above with a box. The protein
adducts with each of the kynurenine-type UV filters are examined in the
chapters of this thesis listed above. The figure is reproduced (with
modification) from Bova et al. .
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CHAPTER TWO
Preliminary Studies in Support of the Experimental

Hypothesis that

Tryptophan Metabolites can Form Covalent Adducts with Protein

2.1

Introduction

A n importantfindingis that the side-chain of kynurenine and other endogenous

metabolites of tryptophan can spontaneously deaminate to form an unsaturated carbo

compound, which can further react to form adducts with nucleophilic amino acids (F
2.1).
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Figure 2.1:
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Proposed reaction mechanism for the covalent attachment of kynurenine-

type molecules to nucleophilic amino acids (in this case cysteine).
Kynurenine (R = H), 3-hydroxykynurenine (R = OH) and 3hydroxykynurenine-O-P-D-glucoside (R = Oglu) are tryptophan
metabolites found in the homogenates of human and other higher order
primate lenses. "X" and "Y" represent amino acids in a polypeptide
(protein) chain.
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Based on this hypothesis, model incubation and reaction studies were carried out
using an analogue of the key intermediate shown above in figure 2.1:
3-benzoylacrylic acid (BAA) (Fig. 2.2). BAA was incubated for 48 hours at 37°C with

various nucleophilic amino acids to assess the likelihood of addition reactions occ
to an aromatic a, P-unsaturated carbonyl in aqueous buffer solution. Model studies
also carried out using synthetic 3-hydroxykynurenine-O-P-D-glucoside (3 OHKG),
using nucleophilic amino acids under similar conditions to those used for BAA.

3-Benzoylacrylic acid ( B A A )

Figure 2.2:

Structure of 3-benzoylacrylic acid ( B A A ) , purchased from Acros (Cat.

No. 40201-0250, CAS No. 583-06-2, MW =176.17 gmol"1, guaranteed
purity = 97%). Reactions between BAA and various amino acids were
undertaken in aqueous buffer solutions. Assessment of the outcome was
by HPLC and mass spectrometry.
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2.2 Materials and Methods

3-Benzoylacrylic acid (BAA) was purchased from Acros Fine Chemicals

(Australia); Triglycine, f-Boc-L-lysine, lysine, cysteine and glutathione from Sigm
Louis, MO, U.S.A.) and used without further purification. 3-Hydroxykynurenine-O-pD-glucoside was synthesised in our laboratory by the method of Manthey and co-

workers90. Milli-Q™ water, purified to 18 mega ohms cm"2, was used in the preparatio

of all solutions. Organic solvents were of HPLC grade purity and purchased from Aja

Unichrom, Auburn, N.S.W., Australia. All other chemicals used throughout this chapt
were of analytical quality and used without further purification.

2.2.1 Model Incubations of BAA and Various Amino Acid Derivatives

3-Benzoylacrylic acid (BAA) (2-3 mg) was incubated in either 2 mL of 25 mM

phosphate buffer, pH 8, or 2 mL of 25 mM carbonate buffer, pH 10, along with variou
amino acids or their protected derivatives (10-12 mg each), according to table 2.1.

solutions were made fresh and filtered through a 0.45 urn cut-off membrane prior to
incubation at 37°C for 48 hours in the dark.
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Incubation N u m b e r

Amino Acid Derivative

1

GlyGlyGly

25mM NaH2P04 / Na2HP04 (pH 8)

2

Glutathione

25mM NaH2P04 / Na2HP04 (pH 8)

3

L-Lysine

25mM Na2C03 / NaHC03 (pH 10)

4

f-Boc-L-Lysine

25mMNa2C03 /NaHC03 (pH 10)

Table 2.1:

Buffer Solution

Incubation conditions used to assess the reactivity of B A A towards

various amino acids and their derivatives. Incubations were allowed to
proceed for 48 hours prior to analysis by HPLC.

2.2.2 Model Incubations with 3 0 H K G and Amino Acids

3-Hydroxykynurenine-O-p-D-glucoside (30HKG) (5 mg) was incubated with

glutathione (GSH) and lysine (50 mg each) in 25 mM carbonate buffer, pH 9, to ass

whether adducts could be formed under these conditions. In these incubations, th
was increased from 48 hours to 7 days to allow for the low yield expected due to
deamination of the kynurenine side-chain (Fig. 2.1). Reactions were carried out
dark. Analysis of the reaction mixtures was by HPLC and mass spectrometry.
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2.2.3 HPLC of the Incubation Mixtures

High performance liquid chromatography (HPLC) was performed on aliquots of
the incubation mixtures as described below:
HPLC analysis was performed using a Varian Microsorb-MV C-18, 4.6 x 250 mm,

300A column with the following mobile phase conditions: 0.05% TFA for 5 mins the

linear gradient of 0-80% acetonitrile / 0.05% TFA over 15 mins with a flow rate

mLmin"1. Detection of the eluent was at 229 nm and 365 nm, achieved with a Water
440 UV detector with an extended wavelength module attached. All samples were

diluted with 0.05% TFA solution prior to injection. Initially, HPLC runs were ca
out in order to ascertain the retention times of the starting materials. Larger
the mixture were employed to collect suspected adducts for mass spectrometry.

2.2.4 Mass Spectrometry of the Collected Adducts from HPLC

Mass spectra of the adducts collected from HPLC were obtained on a VG

Quattro II triple quadrupole mass spectrometer (VG Biotech, Altincham, UK) equip
with an upgraded electrospray ionisation source. Samples were dissolved in 50%
aqueous acetonitrile, 0.1% formic acid, and delivered by a Harvard Apparatus 22

syringe pump at 5-20 uXmin"1, depending on sample concentration. Mass spectra we

obtained in positive ion mode with a scan rate of 100 mass-to-charge (m/z) unit
second with nitrogen bath gas flow of 350 Lh"1, and nebulising gas to the probe

Lh"1. Capillary probe tip potential was 3.2 kV, HV lens 0.2 kV and skimmer poten
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ranged from 25 to 35 V. The source temperature was maintained at 80°C for rout

sample analysis and 150°C for LC-MS, the instrument was calibrated with sodium
iodide.
Suspected adducts from the incubation of 3 OHKG and GSH were collected from

the Microsorb column above and further analysed by in-line HPLC mass spectrosc
(LC-ESIMS). The microbore HPLC system consisted of an Applied Biosystems 140B

solvent delivery system and a 785 A variable UV detector. Separation of the co
adducts was achieved via an Alltech Alltima 2.1 mm x 250 mm C-18, 300 A, 5 uM

column with a flow rate of 200 uLmin"1 using a 0-80% acetonitrile, 4 mM ammoni
acetate, gradient over 40 mins and a column oven temperature of 25°C. Spectra
obtained in centroid mode.

2.3 Results

3-Benzoylacrylic acid (BAA) and 3-hydroxykynurenine-O-P-D-glucoside

(3 OHKG) were incubated with various nucleophilic amino acids and the mixtures
examined for formation of covalent adducts by HPLC and mass spectroscopy.
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2.3.1 B A A Incubated with G l y G l y G l y in Phosphate Buffer, p H 8

COOH
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H.N
+

O

N
H

COOH

Triglycine ( M W = 189.2g/mol) \

Phosphate Buffer, p H 8
3 7 o C 4 8 hours inthe dark

O
O
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^

Suspected Adduct ( M W = 365.3g/mol)

Figure 2.3: Expected reaction of the tripeptide, triglycine with BAA, under the
reaction conditions described above.

B A A was incubated for 48 hours in phosphate buffer, p H 8, with the tripeptide
glyglygly (triglycine) and assessed for reaction via HPLC and mass spectrometry.

can be seen in figure 2.4, the HPLC profile of the reaction mixture indicates a l

peak eluting from the column at approximately 8 mins that did not correspond, from
spiking experiments, with either BAA or triglycine.
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Figure 2.4:

H P L C profile of the reaction mixture of B A A and triglycine after 48

hours of incubation at 37°C in the dark at pH 8. Detection of the eluting
compounds was with a 229 nm detector. Running times for the starting
materials was confirmed with spiking experiments: triglycine eluting at 3
mins and BAA at 13.5 mins.

T h e suspected adduct of the reaction between triglycine and B A A w a s collected
from the HPLC and lyophilised. The dried pellet was submitted for electrospray
ionisation mass spectrometry (ESI-MS). Mass spectrum of this is shown in figure 2.5.
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Figure 2.5:

Positive ion ESI-MS of the major reaction product collected from H P L C

of the incubation of BAA and triglycine. The most abundant ion in the
chromatogram above (m/z 366) is singly charged and corresponds to the
adduct between BAA and triglycine (M+H ion), m/z 246 could be due to
M1" - glycine - CO2 and m/z 189 is attributed to the (triglycine-H)+ ion.

2.3.2 B A A Incubated with G S H in Phosphate Buffer, p H 8

Following the success of the incubation with triglycine, B A A was incubated

with glutathione (GSH) under identical conditions as those used above. Shown below
figure 2.6 is the proposed reaction scheme for the addition of GSH to BAA.
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Figure 2.6:

Possible reaction schemes for reaction between B A A and G S H in

aqueous phosphate buffer, pH 8.

The incubation was allowed to proceed for 48 hours at 37°C in the dark before
an aliquot was taken and HPLC performed using the conditions described above in
methods section 2.2.3. A chromatogram appears in figure 2.7. The HPLC profile

indicates an adduct was again formed, this large peak at approximately 10 mins did

correspond to either of the starting materials. It also appears that this reaction
to completion as little or no peak was observed for BAA, which normally elutes at
approximately 13.5 mins.
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Figure 2.7:

H P L C chromatogram of the 48 hour incubation of B A A and G S H at p H

8. GSH eluted from the C-18 column under these solvent conditions at
approximately 6 mins. Little or no BAA was observed (elution time 13.5
mins).

ESI-MS was performed on the adduct collected from HPLC, the mass spectrum

is shown in figure 2.8. Shown in the figure are ions which correspond to the mole
ion with a m/z of 484.8, and a fragment of m/z 354.6, characteristic of the loss
glutamic acid from the adduct molecule.

38

Chapter 2
Preliminary Studies in Support of the Experimental Hypothesis that Tryptophan
Metabolites can Form Covalent Adducts with Protein

484.8
^

100

0s
0»

u
S3
rt
'V

60

a
s

40

Xi
<
>

20

"3

0

rt

483.3

80

354.6

X
51

100

145

184

231

X
274

1
320

-r—

358

399

451

XJ^

493

541

Mass to Charge Ratio (m/z)

Figure 2.8: ESI-MS of the collected adduct from the incubation of BAA and GSH
pH 8. The adduct was collected from the HPLC, lyophilised and
submitted for positive ion-mode ESI-MS analysis as described in
Methods section 2.2.4. The peak at m/z 484.8 corresponds to the (M+H)
molecular ion for the adduct formed between BAA and GSH with m/z
354.6 indicative of the loss of glutamic acid from the molecular ion (M glutamic acid + H).

2.3.3 B A A Incubated with Lysine in Carbonate Buffer, p H 10

BAA was incubated with lysine in carbonate buffer, pH 10, to assess whether

addition is possible at both the epsilon and alpha-amino groups of lysine. Sh

HPLC chromatogram of BAA incubated with L-lysine (Fig. 2.9). As indicated, t

fractions, which did not correspond to the stating materials used in the incu
collected and lyophilised.
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Figure 2.9:

H P L C chromatogram of B A A incubated with lysine in carbonate buffer,

pH 10. Incubation was allowed to proceed for 48 hours in the dark prior
to injecting a portion for HPLC analysis. Three suspected adducts of the
incubation mixture was collected as per the labels above. These fractions
were lyophilised and submitted for ESI-MS (see below).

Separate positive ion mass spectra where collected for each of the three fractions

shown above (Figs. 2.10 to 2.12). The major fraction collected from HPLC, fraction 1
showed a molecular ion of m/z 323.3, indicative of an adduct formed between lysine
and BAA with no other higher masses recorded in the scanning range. Fraction 2 also

contained this same molecular ion (m/z 323.3) as the base peak. This may be explaine
by BAA binding through the other amino group. Also shown in fraction 2 is a minor

peak of m/z 499.3, attributed to lysine bound to two BAA molecules. This is most lik
a contaminant from fraction 3 as these peaks elute close to each other. The mass
spectrum of fraction 3 contains this same mass peak in highest abundance. Other
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fragment peaks found in all three spectra at m/z 203.2, indicative of loss from the

molecular ion of acetophenone (from BAA); m/z 186.1 attributed to the

acetophenone and ammonia; m/z 147.1 corresponds to the mass expected f
positive ion of lysine and m/z 130.1 is the loss of BAA and ammonia.
2.13 is the proposed reaction scheme to explain these mass spectra.
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Figure 2.10: Mass spectrum of fraction 1 collected from HPLC of the r
BAA and lysine in aqueous carbonate buffer, pH 10. Fraction one was
the major adduct of the reaction and contains a singly charged ion of

323.3, attributed to the single addition of lysine to BAA at either th
alpha or epsilon-amino group.
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Figure 2.11: Mass spectrum of fraction 2 collected from HPLC of the incubation o
lysine and BAA. The predominant species is the ion corresponding to a
single addition of lysine to BAA (m/z 323.3), probably to the other
amino group to that modified in fraction 1.
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Figure 2.12: Mass spectrum of fraction 3 collected from HPLC of the incubation o
lysine and BAA. A major ion at m/z 499.3 is attributed to an adduct
formed between lysine and two BAA molecules, probably one bound to
each amino group.
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37°C, 48 hours in the dark
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Figure 2.13: Proposed reaction scheme for the addition of lysine to BAA. At pH 10
both the alpha and epsilon amino groups of lysine are deprotonated and
thus become good nucleophiles for addition to the a, p-unsaturated
carbonyl of BAA. A minor peak in the reaction mixture showed evidence
for addition of two BAA molecules per lysine residue.
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2.3.4 B A A Incubated with f-Boc-L-Lysine in Carbonate Buffer, p H 10

B A A was also incubated with f-Boclysine in carbonate buffer, p H 10, to assess
whether an addition to B A A was still possible once the a-amino group of the lysine was
blocked by a tertiary butyloxycarbonyl group. S h o w n below in figure 2.14 is the H P L C
chromatogram 48 hours after incubation began. A large peak was collected at 16 mins,
which did not correspond to the retention times of the starting materials.
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Figure 2.14: H P L C chromatogram of the incubation mixture B A A and J-Boclysine in
carbonate buffer, p H 10, after 48 hours. A large adduct peak was
collected at 16 mins. This peak did not correspond to either NBoclysine
or B A A . After collection, the fraction was lyophilised and submitted for
mass spectral analysis.
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ESI-MS was performed on the suspected adduct fraction collected from the
HPLC; this is shown in figure 2.15 below.
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Figure 2.15: Mass spectrum of the adduct (Fig. 2.14), collected from H P L C by
incubating BAA and ?-Boclysine for 48 hours in carbonate buffer, pH 10.
The molecular ion, m/z 423.4, corresponds to the expected mass of the
addition product.

Shown in thefigure2.15, above, and diagrammatically in figure 2.16 is the
fragmentation pattern observed when BAA is adducted to f-Boclysine. Fragmentation
assigned to the following m/z values:
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Mass to Charge Ratio (m/z)

Assignment

423.4

Molecular ( M + H ) ion

379.4

(M-C0 2 + H)

367.3

( M - ^-butane + H )

323.3

(M - ?-Boc + H )

203.2

( M - acetophenone + H )

147.1

(lysine + H )

84.1

(lysine immonium ion - N H 3 )

Table 2.2:

Fragmentation assignments for the mass spectrum of the adduct formed

between BAA and r-Boclysine.

H3C^^CH3

COOH
^

^

BAA-t-BOClysine Adduct ( M W = 422.5 g/mol)

Figure 2.16: Proposed structure and fragmentation pattern for the major product
reaction between BAA and r-Boclysine. Bracketing of the bonds
indicates proposed formation of some of the product ions.
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2.3.5 30HKG Incubated with Lysine in Carbonate Buffer, pH 9

Following the success of incubating BAA, a close analogue of the key reactive
UV filter intermediate with nucleophilic amino acids, it was decided to attempt the
same incubations with the major UV filter compound of the human lens, 3 OHKG.
Incubation time was increased, however, to account for the fact that 3 OHKG had to

deaminate to form the reactive intermediate in solution before an adduct could be m

Aliquots of the incubation mixture where taken at 1 and 5 days and HPLC performed to

assess the progress of reaction. As anticipated, only minor adduct peaks were obser

after this short time of incubation. Shown in figure 2.17 is a HPLC chromatogram of

reaction mixture after 12 days of incubation, possible adducts where collected from

eluent of the HPLC at 10.7, 11.8 and 13.2 minutes, respectively. These fractions wer
lyophilised and submitted for ESI-MS analysis.
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Figure 2.17: H P L C chromatogram of the incubation mixture with 3 0 H K G and lysine
in carbonate buffer, pH 9. Three possible adduct peaks, which did not
correspond to the starting materials, were collected from the eluent.

Electrospray ionisation mass spectrometry was employed to identify possible

structures for the three fractions collected from the HPLC; mass chromatograms are

shown for these fractions in figures 2.18 to 2.20. Inspection of these mass spectr
reveals that 3 OHKG appears to be adducted to lysine in a similar fashion to BAA.
Fraction 1 contains an ion of m/z 516.7, which corresponds to the molecular mass

expected for the adduct between lysine and 30HKG. Also shown in figure 2.18 are th
following fragment ions and their designation: m/z 472.5 (M - CO2 + H); m/z 387.2
(30HKG + H); m/z 354.6 (M - glucose + H); m/z 310.3 (M - glucose - C02 + H) and
m/z 147.1 (lysine+ H).
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Figure 2.18: Mass spectrum, in positive ion mode, of fraction 1 collected fro
of the reaction mixture between 30HKG and lysine in carbonate buffer,
pH 9. The ion at m/z 516.7 corresponds to the mass expected for the
mono addition product.
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Figure 2.19: Mass spectrum of fraction 2 collected via H P L C of the incubation
mixture of 30HKG and lysine. The ion at m/z 885.8 is attributed to the
addition of two deaminated 3 OHKG molecules to a single lysine residue.
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Figure 2.20: Mass spectrum of fraction 3 in positive ion mode. Fraction
to contain the single addition product between deaminated 3 OHKG and
lysine.

Shown infigure2.21 are structures representing the possible products obtained
by incubating 3 OHKG with lysine in carbonate buffer, pH 9:
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Figure 2.21: Possible chemicals structures identified from H P L C and mass
spectrometry of the incubation of 3 OHKG and lysine in carbonate buffer,

pH9.
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2.3.6 3 0 H K G Incubated with G S H in Carbonate Buffer, p H 9

3 OHKG was also incubated, under identical conditions to those used above,

with reduced glutathione (GSH). Incubation was allowed to proceed for 12 days befo

HPLC was performed on the reaction mixture (Fig. 2.22), possible adduct peaks were

collected, lyophilised then submitted for HPLC linked to ESI-MS due to the lack of
separation of the compounds shown below in this particular HPLC run.
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Figure 2.22: H P L C of G S H / 3 O H K G reaction mixture after 12 days of incubation in
carbonate buffer, pH 9, at 37°C. Two fractions were collected at 10.8
minutes and 11.9 to 13.4 minutes.

L C - M S was performed on the two collected fractions from H P L C of the reaction
mixture above, as described in methods section 2.2.4. Elution from the microbore
HPLC system was with a slow gradient of 4 mM aqueous ammonium acetate buffer to
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80% acetonitrile over 50 minutes at 200 uLmin ". Detection of the eluting compounds
was achieved with a 360 nm UV detector inline with ESI-MS. Shown below in figure

2.23 is the total ion current (TIC) (A) and 360 nm UV absorbance (B) profiles for t
LC-MS run of fraction 1 collected from HPLC of the incubation mixture. The region,
corresponding to the eluting peak from the microbore HPLC that absorbed at 360 nm,
had a mass spectrum generated from the total ion current (Fig. 2.24).
Analysis of the mass spectrum reveals that an adduct between deaminated
30HKG and reduced GSH is probably forming under these incubation conditions. The

molecular ion at m/z 677.3 is observed along with a fragment attributed to the mole
ion minus glucose (m/z 515.3). Also observed in this mass spectrum is unreacted
30HKG (m/z 387.2) and its aglucone fragment ion at m/z 225.3.
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Figure 2.23:

LC-MS for the collected fraction 1 of the incubation of 3 O H K G and

GSH. Represented is the total ion current (TIC) (A) and 360 nm UV
absorption profile (B). Mass spectra were generated (see figure 2.24)
from the TIC for 360 nm absorbing species at region "X" by subtracting
the background contamination, "BK" (2.23 A).
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Figure 2.24: Mass spectrum of region " X " from the total ion current of the L C - M S run
above in figure 2.23. Ions were recorded at m/z 677.3 (30HKG-GSH
adduct); m/z 515.3 (30HKG-GSH - glucose); m/z 387.2 (unreacted
30HKG) and m/z 225.3 (30HKG - glucose).

2.4

Discussion

Presented in this chapter are preliminary data to show that the kynurenine side
chain of the major human endogenous UV filter, 30HKG, is inherently unstable. By
loss of the a-amino group, the resulting a, p-unsaturated carbonyl is prone to
nucleophilic attack by amino acid residues. This mechanism may be responsible for the

increase in lenticular colouration and fluorescence that has long been observed in age
human populations. It has been shown by other researchers in our group that the
deamination process of the kynurenine side chain is slow at neutral pH, but can be
accelerated by increasing the pH31. This was the reasoning behind the incubation
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experiments with 30HKG at pH 9-10. Initial studies focussed on the compound 3benzoylacrylic acid (BAA) as an analogue of the expected intermediate when
kynurenine moieties deaminate. Incubations were performed in aqueous buffer solutions
to assess the ability of BAA to form adducts with amino acids and their protected
derivatives. Evidence for adduction was gained using the analytical techniques of high
performance liquid chromatography and mass spectrometry. Data presented in this
chapter gives an insight into the aqueous solution stability of not only the adduct
compounds formed, but also the intermediate unsaturated carbonyl compounds. BAA
could be dissolved in aqueous buffer solutions and then condensed with various amino
acid residues. BAA appears to be stable under the incubation conditions used in these
experiments. BAA was also shown to form a variety of adducts with lysine residues,
which most likely correspond to linkages through the alpha- and epsilon-amino groups
and a small amount of an adduct attributed to two additions of BAA to a single lysyl
residue. When incubated with ?-Boc-L-lysine under identical conditions a single adduct
peak was observed, attributed to BAA binding through the epsilon-amino group.
Significantly, however, is that when BAA was incubated with glutathione, with similar
molar quantities used for the lysine incubations, a single large adduct peak was
observed after 48 hours of incubation, with little or no BAA left in the incubation.
Unlike incubations with the amine containing amino acids, the sulphur-containing GSH
reaction appeared to go to completion with just one adduct observed by HPLC. This is
explained by the fact that the thiol is a better nucleophile than amine containing
moieties.
Having shown the aqueous stability and reactivity an analogous intermediate
compound, incubations were repeated with synthetic 3-hydroxykynurenine-O-p-D-
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glucoside, the most abundant UV filter found in human lenses. Incubation time was

increased to 12 days to allow for significant deamination of the starting material so

adduction could occur to either lysine or GSH. With the lysine incubation, three addu

peaks were collected from HPLC of the reaction mixture. Two of the collected fraction
had masses corresponding to the single addition of a deaminated 30HKG to lysine and
the third fraction had a mass matching that expected for two deaminated 3 OHKG

additions to lysine. This process was, therefore, similar to that observed with the B
incubations.
When incubated with GSH, three adduct peaks were again observed by HPLC,
with one peak much larger than the other two. Due to the close retention times, two
fractions were collected before and after the 3 OHKG. Fraction one was submitted for
LC-ESIMS and was found to contain unreacted 30HKG as the most abundant 360 nm
absorbing species followed by the mass expected for the adduct of deaminated 3 OHKG
and GSH at m/z 677. Fraction two was collected and submitted for LC-ESIMS but due

to the very low yields of these species, we were unable to gain an ESIMS signal on th
relatively old, and thus insensitive mass spectrometer.
In conclusion, results presented in this chapter describe the facile adduction of
nucleophilic amino acids to an analogue of the intermediate when 3hydroxykynurenine-O-P-D-glucoside moieties deaminate. This adduction process is
readily observed in aqueous buffer solution and although physiological pH was not
studied in this work, it is probable that this process would also occur, albeit at a
rate, in the environment of the human lens. This process may provide one explanation
for the observed increases in lens colouration and fluorescence as humans age.
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CHAPTER THREE
Evidence for 3-Hydroxykynurenine Glucoside Attachment to Lens
Crystallins

3.1 Introduction

Changes that occur in the ageing lens may contribute to age-related cataract. The
normal ageing lens becomes progressively more coloured and fluorescent with time

with a concomitant decrease in the solubility of the constituent proteins of the lens. T
biochemical reasons for these changes are still relatively poorly understood. This is
mainly due to the difficulty in working with heterogenous protein material that has
become aggregated or insoluble. Nevertheless, progress has been made in recent years
in quantifying some of these age-related changes in normal lenses. Significant work in
this chapter follows on from work carried out at the Science University of Tokyo by
Amane Inoue and Kenshi Satoh 'Identification of a new fluorescent compound isolated
from human lens insoluble protein fraction91.' Inoue and Satoh treated insoluble lens
protein with base to release a fluorophore from the protein material. By treating the
insoluble crystallins with alcoholic hydroxide for 48 hours, a fluorescent compound was
released that, when identified by NMR spectroscopy, was 2-amino-3hydroxyacetophenone-O-P-D-glucoside (AHAG). The Japanese researchers did not,
however, investigate the origin or the route of formation of this compound and did not
consider the possibility that it could be derived from breakdown of a precursor
tryptophan metabolite. In this work we hypothesise that the formation of AHAG derives

58

Chapter 3

Evidence for 3-Hydroxykynurenine Glucoside Attachment to Lens Crystallins

from the covalent attachment of 3-hydroxykynurenine-O-P-D-glucoside ( 3 0 H K G ) to
the lens crystallins. Other members of our research group have examined the
kynurenine side chain and discovered that the a-amino group is unstable31. This
instability can lead to the formation of a reactive a, P-unsaturated carbonyl, which
open to attack by nucleophilic amino acids. The proposed interactive mechanism for

crystallin modification by the tryptophan metabolites is shown figure 3.1. This figure

illustrates the area of specific interest of this thesis, and that is: the biochemica
consequences of UV filter modification on the structural proteins, which make up the
bulk of the lens dry weight. More specifically, this study aims to characterise some
the physical parameters normally associated with the ageing human lens, with both
human lens examples and model studies involving protein derived from the lenses of
young cattle (CLP - Bos taurus). These parameters include measurements of colour and
fluorescence, along with measurements of AHAG as an indicator of how much 3 OHKG
had bound to lenticular protein.
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Figure 3.1:

Mechanism of addition of 3 O H K G to a cysteinyl adduct and subsequent

hydrolysis by strong base to release 2-amino-3-hydroxyacetophenone
(AHAG). "X" and "Y" represent other amino acid residues in a protein
sequence.

Significantly, and fortuitously, our research group had previously synthesised a
standard of AHAG en route to the total synthesis of 3 OHKG. Having milligram
amounts of this standard allowed us to confirm the product of the hydrolysis of the

crystallin protein and to optimise the conditions necessary to quantify the amount of
A H A G released as a function of age.
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Materials and Methods

Poly-L-lysine and sequencing grade trifluoroacetic acid (TFA) were purchased
from Sigma-Aldrich (St. Louis, MO, U.S.A.); acetic acid (>99.8% purity) from BDH
(Poole, U.K.) and all other organic solvents were of HPLC grade (Ajax, Unichrom,
Auburn, N.S.W., Australia). 3-Hydroxykynurenine-O-p-D-glucoside (30HKG), 2amino-3-hydroxyacetophenone-O-P-D-glucoside (AHAG), a-N-acetyl-3hydroxykynurenine-O-P-D-glucoside (N-acetyl-30HKG) and 4-(2-amino-3hydroxyphenyl)-4-oxobutanoic acid-O-P-D-glucoside (AHBG) were synthesised in our

laboratory by the method of Manthey and co-workers90. Milli-Q™ water, purified to 1
mega ohms cm" , was used in the preparation of all solutions.

3.2.1 Human Lens Treatments

Human lenses were obtained from donor eyes used for corneal grafting with
ethical approval from the Eastern Sydney Area Health Service - research ethics
committee (Reference 90/057) and the University of Wollongong Human Ethics
Committee (Reference HE96/145). Two separate human lens experiments were
conducted on lenses of mixed age:
Experiment one involved the use of 55 whole lenses ranging in age from 14 to
85 years. Lenses were obtained from the Sydney Lions Eye Bank, Queensland Lions

Eye Bank or kindly provided by Dr Beryl Ortwerth (University of Missouri, Columbia

MO., U.S.A.). After removal, lenses were immediately placed into sterile plastic sc

capped vials and stored at -20°C until analysed. Lenses were homogenised in 0.5 mL
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8 0 % ethanol, placed on ice for 30 mins, then centrifuged at 10, 000 g for 10 mins at
4°C. The supernatant was discarded and the procedure was repeated a further three
times to ensure complete removal of the low molecular weight components, including
unbound UV filters. The protein pellets were lyophilised and approximately 30 mg
accurately weighed into screw capped glass vials. 10 mL of potassium hydroxide 5%

(w/v) in 80% (v/v) ethanol/water was added to the vial containing the protein pellet

had been crushed with a spatula and the vial wrapped in foil to exclude light, bubbl

with argon and sealed prior to incubation at 25°C for 48 hours. An aliquot of 5 mL wa
then taken from the incubation and the pH adjusted to between 5 and 7 with 3 M HC1
and lyophilised. The remaining 5 mL aliquot was taken after 144 hours and treated in
the same way. One mL of 0.05% TFA (v/v) in water was added to the crushed, dried

pellet and the salty mixture centrifuged for 10 mins at 10, 000 g. 50 uL samples of t
supernate were analysed by HPLC.
Experiment two used 39 lenses, ranging from 16 to 93 years of age. Human
lenses were obtained post mortem from donor eyes at the National Disease Research
Interchange (Philadelphia, PA) and the Sydney Lions Eye Bank.
Lens dissections were performed by Bova and co-workers . Lenses were kept, and
dissected, at -20°C. The nucleus was separated from the cortex of the lens by coring
through the visual axis with a 3 mm cork borer, approximately 0.5 mm was cut from
each end of the core and added to the remaining doughnut shaped cortex. After
dissection, lens tissues were weighed to give approximately 50 mg and 100 to 200 mg

wet weight of lens material in the nuclear and cortical regions of the lens respecti

Extraction of the lens UV filters began immediately after dissection by homogenising

the lens tissue in 100% ethanol (0.15 mL / nucleus, 0.35 mL / cortex). The homogenate

was left at -20°C for 20 mins before centrifugation at 13, 000 g for 20 mins at 4°C.
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supernatant was removed and discarded and the pellet was re-extracted a further 3 times
with 80% ethanol following the same procedures above. The protein pellet was
lyophilised and approximately 10 mg of the crushed protein pellet was accurately
weighed into separate screw capped glass vials. 3 mL of 5% potassium hydroxide in

80% ethanol was added to the vial, bubbled in argon, wrapped in foil and incubated fo
48 hours. Reaction was halted by adjusting the pH to between 5 and 7 with 3 M
hydrochloric acid. The mixture was lyophilised and resuspended in 0.25 mL of water
containing 0.05% TFA prior to centrifugation at 10, 000 g for 10 mins and 50 uL
injected for HPLC analysis.
Separate 1 mgmL" solutions of human lens protein that had been 4 x 80%
ethanol extracted and extensively dialysed were made in 6 M guanidine hydrochloride

and analysed for absorption at 360 nm and three-dimensional fluorescence, as describ
in Methods section 3.2.4.
Cataract lenses were obtained, intact, from Indian donors who had undergone
capsular extraction. These lenses were homogenised, dialysed and lyophilised. The
protein obtained from the donor lenses was reduced and carboxymethylated as per the
following method: Protein samples were dissolved in 6 M guanidine hydrochloride, 0.1
M Tris and 1 mM EDTA (5 mgmL"1). The pH of the solution was adjusted to 8.3 and a

solution of 100 mM 1,4-dithiothreitol was added to give a final concentration of 2 mM

The samples were then sealed under nitrogen and incubated at 38°C. After 1 hour, a 50
mM solution of iodoacetic acid (neutralised with sodium hydroxide) was added to give
a final concentration of 5 mM. The samples were again sealed under nitrogen and

incubated for 1 hour at 38°C in the dark. The reaction was quenched by the addition o

1% (v/v) p-mercaptoethanol. The mixture was then extensively dialysed against Milliwater during which the reduced and carboxymethylated protein precipitates out of
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solution. The precipitate was then lyophilised, resulting in a brown fluffy protein in
which it could be assured had complete removal of all non-covalently attached small
molecules92.

3.2.2 Calf Lens Protein (CLP) Preparation

Young bovine lenses of approximately 1 to 6 months of age were obtained from
the local abattoir. Lenses were homogenised in 50 mM Tris buffer containing 5 mM
EDTA, 1 mM phenylmethylsulfonyl fluoride and 0.04% sodium azide at a rate of 1.5

mL per lens. After homogenisation, the lenses were centrifuged at 4°C for 15 mins at
10, 000 g. The supernatant was decanted for exhaustive dialysis and lyophilisation

resulting in white crystalline powder devoid of salt and small molecules, consisting

almost exclusively of crystallins. This process was repeated until a stock of protei
over 50 grams was obtained, this protein was thoroughly mixed and used in all
subsequent CLP incubations throughout this thesis.

3.2.3 Incubation of CLP or Poly-L-Lysine with 30HKG

One hundred milligrams of lyophilised CLP or poly lysine was dissolved in 10
mL of 25 mM sodium carbonate / bicarbonate buffer, pH 7 or 9. 10 mg of synthetic
30HKG was added to the incubation together with 50 uL of chloroform as a
bacteriostatic agent. The tube was wrapped in foil, bubbled with argon, sealed and

incubated for up to 24 days at 37°C. Aliquots of 2 mL each were taken every 48 hours
(or at longer intervals beyond 8 days) and chromatographed through Sephadex G25
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(Pharmacia) equilibrated in distilled water. The protein fraction was combined,
lyophilised and extracted four times with 80% ethanol and, in two experiments, the

ethanol extracted protein was lyophilised, dissolved in 6 M guanidine HC1 and dialys
against 6 times 1000 volumes of water to ensure that non-covalently associated UV

filters were removed. Since the additional dialysis step did not affect the recovery

AHAG, we concluded that the multiple ethanol extraction was sufficient to remove all
low molecular weight compounds from the incubated protein.

3.2.4 Analysis of CLP or Poly-L-Lysine modified with 30HKG

One milligram of lyophilised 3 OHKG modified proteins (or polylysine) were
accurately weighed and redissolved in 1 mL of 6 M guanidine HC1 prior to
measurement of UV absorbance (Shimadzu UV-265 spectrophotometer, Kyoto, Japan)
and fluorescence (Hitachi F-4500 fluorescence spectrometer, Tokyo, Japan) in the
regions of 250 - 450 nm excitation and 300 - 600 nm emission.
Approximately 10 mg of the modified protein was accurately weighed into

screw capped glass vials for base hydrolysis to liberate AHAG. To the crushed protei
pellet was added 2.5 mL of 5% potassium hydroxide 80% ethanol and incubated for 48

hours at 25°C. The incubation was neutralised with 3 M HC1 before lyophilisation and
re-suspension in 0.6 mL of 0.05% TFA/water and 50 uL injected for HPLC analysis.
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3.2.5 Incubation of CLP with AHBG or N-Acetyl-30HKG

30 milligrams of CLP was dissolved in 3 mL of 25 mM sodium carbonate /
bicarbonate buffer, pH 9.1. 3 mg of either synthetic 4-(2-amino-3-hydroxyphenyl)-4oxobutanoic acid O-P-D-glucoside (AHBG) or a-N-acetyl-3-hydroxykynurenine-O-pD-glucoside (N-Acetyl-30HKG) was added to the incubation together with 50 uL of

chloroform as a bacteriostatic agent. The tube was wrapped in foil, bubbled with arg

sealed and incubated for up to 8 days at 37°C. Aliquots of 0.5 mL each were taken at
2, 4 and 8 days and chromatographed through Sephadex G25 equilibrated in distilled

water. The protein fraction was combined, lyophilised, extracted four times with 80%
ethanol, dialysed and lyophilised again. 1 mgmL"1 solutions of this treated protein
accurately made in 6 M guanidine hydrochloride with measurements of absorbance and

fluorescence taken as described above in Methods section 3.2.4. Along with the 0.5 m

aliquots taken above, 3 x 20 uL aliquots were also taken of the incubation mixture a
same time intervals. These aliquots were subjected to HPLC analysis using the same

conditions as those described below in section 3.2.6, to analyse for peak area of ei
AHBG or N-acetyl-30HKG to determine any loss of these compounds with incubation
time.

3.2.6 HPLC Analysis

HPLC analysis of either base hydrolysed protein samples or CLP incubation
mixtures were performed using a Varian Microsorb-MV C-18, 4.6 by 250 mm, 300 A
column with the following mobile phase conditions: 0.05% TFA for 5 mins followed by
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a linear gradient of 0 to 8 0 % acetonitrile / 0.05% T F A over 15 mins with a flow rate of
1 mLmin"1. Detection of the eluent was at 229 nm and 365 nm, achieved with a Waters
440 UV detector with an extended wavelength module attached. AHBG eluted under
these conditions at 16 mins, N-acetyl-30HKG eluted at 15 mins and AHAG eluted at 13
mins. Confirmation of the identity of AHAG, AHBG and N-acety 1-3 OHKG was
obtained by either LC-ESIMS (see below) or by comparison to an authentic standard
these compounds90. Synthetic AHAG was used to construct a standard curve for
quantification of protein-derived AHAG by HPLC. The recovery of AHAG after base
treatment was assessed by hydrolysing a synthetic sample of 3 OHKG that had been

previously conjugated to glutathione (GSH)5 and by extending the hydrolysis times u

to 144 hours for modified crystallins until no further AHAG was liberated (see Res
section 3.3.7).

3.2.7 Mass Spectrometry and LC-ESIMS

Peaks that eluted from the Microsorb HPLC column were collected and further
analysed by an in-line microbore HPLC connected to an electrospray mass
spectrometer. The equipment used was an Applied Biosystems (Foster City, CA.
U.S.A.), Model HOB solvent delivery system linked to a 785A UV detector (set at 360
nm) and a VG Quattro II triple quadrupole mass spectrometer (Altincham, Cheshire,
U.K.) using an Alltech Alltima 250 x 2.1 mm, C-18 column (Deerfield, IL. U.S.A.,

catalogue number 88371). Samples were routinely eluted using an acetonitrile gradi
in aqueous 4 mM ammonium acetate, pH 5 and a flow rate of 200 uL per minute. The
gradient was run linearly from 0 to 40% acetonitrile over 40 mins. Eluted compounds

were detected by monitoring absorbance at 360 nm and by electrospray ionisation ma
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spectrometry. Mass spectra were obtained in positive ion mode with a scan rate of 10

mass per charge (m/z) units per second and the ion source temperature was maintained
at 150°C.

3.3 Results

This study focussed on the ability of 3 OHKG to form covalent adducts with

crystallins. Both in vitro model systems utilising the total water-soluble protein o
bovine lenses (CLP) incubated with 30HKG, AHBG or N-acetyl-3-OHKG and donor
human lens tissue were investigated.

3.3.1 Modification of Calf Lens Protein with 30HKG

Our initial studies focussed on the ability of 3-hydroxykynurenine-O-p-Dglucoside (30HKG) to form covalent adducts with crystallin proteins. Following
incubation with 3 OHKG, lenticular proteins developed colouration at 360 nm and
fluorescence with excitation and emission maxima at 380 nm and 490 nm respectively,
when incubated at pH 7 (Fig. 3.2 A). Binding of the UV filter was increased

approximately 10 fold if the pH was increased to from 7 to 9 (Fig. 3.2 B), consisten
with observations on the effect of pH on the formation of the reduced compound
AHBG31 and GSH-30HKG formation in vitro56.
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Covalent modification of crystallins by 3 0 H K G and formation of

coloured and fluorescent proteins. Calf lens proteins were incubated with
30HKG for 24 days at pH 7 (A) or 8 days at pH 9 (B). UV absorbance
(•) and relative fluorescence (o) are shown. Fluorescence was measured
relative to last day (maximally fluorescent) protein samples. Slit widths
for fluorescence measurements were Ex 10 nm / Em 5 nm (A) and Ex 5
nm / Em 5 nm (B). The fluorescence intensity on day 24, pH 7 was
approximately one sixth of that for day 8, p H 9.
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It is known that the amino acid side chain of kynurenine is susceptible to

hydrolysis by strong base, producing an acetophenone derivative91. In agreement with
this we found that 30HKG, and molecules containing this moiety, i.e. GSH-30HKG
and protein-30HKG adducts, are cleaved to release 2-amino-3-hydroxyacetophenoneO-P-D-glucoside (AHAG). The extent of binding of 30HKG to CLP could, therefore,

be assessed by base hydrolysis of the modified protein followed by quantification o
AHAG released (see section 3.3.4 for AHAG standard curve). Figure 3.3 shows that

AHAG was released from the protein, suggesting that the binding of 3 OHKG to protein
was, in fact, occurring through the kynurenine side chain.
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6

Incubation Time of CLP with 3QHKG (days)

Figure 3.3:

The amount of A H A G liberated after base hydrolysis of C L P protein

incubated at pH 9 for up to 8 days. Protein was from the same incubation
used to generate figure 3.2 (B). Base hydrolysis was achieved by
incubating dialysed aliquots of the CLP / 30HKG mixture for 48 hours
in 5% KOH / 80% ethanol.
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Modification of Poly-L-Lysine with 3 0 H K G

Poly-L-lysine of approximate molecular weight 15-30 kDaltons was incubated
with 3 OHKG in carbonate / bicarbonate buffer, pH 9 under conditions used above for

the incubation of calf lens protein. Non-covalently bound 3 OHKG was separated fro
the polymer by Sephadex G25 chromatography, multiple ethanol washes and dialysis.

The incubated poly-L-lysine was analysed for absorption at 360 nm and fluorescence
which gave a maximum reading at excitation 350 nm / emission 440 nm (Fig. 3.4).
AHAG was also measured by incubating the extracted poly-lysine aliquots in 5%
potassium hydroxide (w/v) in 80% ethanol (v/v) for 48 hours at 25°C, these results
shown in figure 3.5.
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Figure 3.4:

Covalent modification of poly-L-lysine by 3 0 H K G . Poly-L-lysine was

incubated with 30HKG for 8 days at pH 9. The polymer was purified by
Sephadex G25 chromatography followed by multiple ethanol washes and
dialysis to ensure non-covalently bound 30HKG was completely
removed. Absorbance at 360 nm (•) and fluorescence at Ex 350 nm / Em
440 nm (o) was taken after the lyophilised polymer pellet was
redissolved in 6 M guanidine hydrochloride (1 mgmL").
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Figure 3.5: AHAG liberation from poly-L-lysine incubated with 3OHKG for 8 days
at pH 9 (Fig. 3.4). AHAG was obtained after base hydrolysis of poly-Llysine and quantified by RP-HPLC.

3.3.3

Reaction of A H B G or N - A c e t y l - 3 0 H K G with C L P

The aim of this work was to examine the role of deamination of U V filters in
CLP modification (Fig. 3.6). CLP was incubated with either 4-(2-amino-3hydroxyphenyl)-4-oxobutanoic acid-O-P-D-glucoside (AHBG), which lacks an a-

amino group, or N-acety 1-3 OHKG, which has a blocked a -amino group, in carbo

bicarbonate buffer, pH 9 under identical conditions to those used for incubati
30HKG. Non-covalently bound metabolites were washed clear of the CLP aliquots
Sephadex G25 chromatography, multiple ethanol washes and dialysis.
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COOH
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Figure 3.6:

N-acetyl-30HKG

Structures of A H B G and N-acetyl-30HKG. These compounds are

blocked from forming the reactive a, p-unsaturated carbonyl and
therefore, if deamination is the crucial step in reaction with nucleophiles,
should not be reactive towards crystallin protein.

The treated protein was analysed for colour absorption at 360 n m and
fluorescence. As can be seen from figure 3.7, no significant amounts of colour or
fluorescence could be detected using identical conditions as those used in figures 3.2
and 3.4. The peak area of either AHBG or N-acetyl-30HKG was also measured when
analytical HPLC was performed on aliquots of each incubation at 1, 2, 4 and 8 days
(Fig. 3.7B). This result shows that the loss of either compound over the period of this

incubation was negligible. These data indicate that the presence of an a-amino group of
the kynurenine side-chain is an important requirement for covalent modification of
protein owing to the fact that this group is able to be eliminated to form the reactive
unsaturated intermediate.
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Figure 3.7:

CLP incubations with either 3 0 H K G , A H B G or N-acetyl-30HKG.

1 mgmL"1 solutions of dialysed protein material after reaction with
AHBG or N-acetyl-30HKG in 6 M guanidine hydrochloride failed to
record any significant amounts of absorbance (360 nm) or fluorescence
(Ex 380 nm / Em 490 nm) (•) when compared to the equivalent
incubation with 30HKG (Abs • or Flu A). There was no change in the
peak area of AHBG or N-acetyl-30HKG over time up 8 days when
measured by HPLC.
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3.3.4 Standard Curve of Synthetic A H A G

2-Amino-3-hydroxyacetophenone-0-P-D-glucoside (AHAG) was synthesised in
our laboratory by Dr Michael Manthey1 and used to construct a standard

area versus mass of AHAG injected. A typical HPLC plot of AHAG is shown

3.8, with AHAG eluting under these conditions at approximately 13 mins.

milligram of AHAG was dissolved in one mL of water to produce a stock s
this was serially diluted and RP-HPLC performed.
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Figure 3.8:

RP-HPLC profile of synthetic A H A G . 2.5 ug (50 uL of 0.05

mgmL"1) was injected under the following conditions: Stationary
phase was a Varian Microsorb-MV C-18,4.6 by 250 mm, 300 A
column and the mobile phase was 0.05% TFA containing water
for 5 mins followed by a linear gradient of 0 to 80% acetonitrile
0.05% TFA over 15 mins with a flow rate of 1 mLmin"1.
Detection was set at 360 nm, AHAG eluted at 13 mins.
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Peak area was calculated from injecting 50 uL aliquots of each of the diluted

AHAG solutions and calculating peak area. A plot of these data is shown in figur

This standard curve determination was repeated at regular intervals during subse
AHAG analysis to ensure accuracy and reproducibility.
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Figure 3.9: Standard curve of peak area versus mass of A H A G injected. The equation
of the line used for subsequent mass determinations is y=168897x - 3364.
The chi squared statistical test gave a value of 1.00.

3.3.5 Optimisation of Base Hydrolysis Procedures

A H A G had been isolated previously from cataractous lenses following treatment

with base, although its origin was not investigated further. Inoue and Satoh had

that 48 hour treatment of 2 grams of the water insoluble protein fraction with 5%

potassium hydroxide in 80% ethanol at room temperature in the dark had liberated
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ug of A H A G after H P L C . Further investigation on the optimal conditions for liberation
of all the glucoside was therefore warranted.
Initial investigations centred on whether the treatment of the lenticular protein
with base to liberate AHAG was an artifact of incomplete removal of non-covalently
bound 3 OHKG, as unbound 3 OHKG trapped in the protein precipitate would yield the
same product. To ensure that the observed AHAG was not an artefact, cataract lenses
were obtained post-operatively from Indian donors who had undergone capsular

extraction, these lenses were then carboxymethylated as per Methods section 3.2.1. Thi
process of protein modification and reduction followed by extensive dialysis and

lyophilisation resulted in a brown, fluffy protein precipitate. This precipitate was t
base hydrolysed as per the method of Inoue and Satoh. It was found that AHAG was
present and its identity was confirmed with spiking experiments. This procedure
ensured that all non-covalently attached small molecules were separated from the
reduced protein, since AHAG was released after base treatment, it is indicative of
covalent attachment of a precursor to human lenticular protein.
The protein from several lenses and the GSH-30HKG adduct were also
subjected to time-course base hydrolysis to ascertain the extent of hydrolysis over
longer time periods than the 48 hours. Three human lenses were selected and extracted
with 4 times 80% ethanol to remove non-covalently bound UV filters as described in

the methods section and subjected for time-course base hydrolysis at 25°C. Aliquots of
the incubation were taken at 12, 24, 48, 96 and 144 hours and the amount of AHAG
liberated assessed by HPLC quantification. Results are shown in figure 3.10. The
percentage yield of AHAG recovered from the time-course base hydrolysis of 0.36 g of
the GSH-30HKG adduct (MW = 676 gmol"1, 0.5325 mmol) was also assessed. Six
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aliquots of the hydrolysis were taken at 0,4, 8, 12,24 and 48 hours and A H A G
quantified by H P L C , these results are shown on a secondary axis in figure 3.10.
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Figure 3.10: Time-course of base hydrolysis of human lens protein, 74 (•), 84 (•),
and 85 (•) year old lenses. The protein was extracted and subjected to
base hydrolysis for up to 144 hours to assess the extent of A H A G
liberation. Plotted on the secondary axis is the time-course of base
hydrolysis of the G S H - 3 0 H K G adduct (o) as a percentage yield of the
initial moles of G S H - 3 0 H K G .

Based on the above result, the average increase in A H A G liberated from lens
protein when incubation time was increased from 48 hours to 144 hours was
approximately 14 percent. To assess whether this was significant to the study, it was
decided that subsequent base hydrolysis incubations with human lens extracts would
have two aliquots - one at 48 hours and a second at 144 hours (see section 3.3.7). From
other preliminary work performed in the laboratory on h u m a n lens protein extracts, it
was determined that a more thorough crushing of the lyophilised, extracted protein
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pellet resulted in an increased yield of A H A G when base hydrolysed. This is the most

likely reason for the lower slope of the line for the 85 year old lens from figure

3.3.6 Confirmation of the Identity of A H A G by L C - E S I M S

Confirmation of the structure of A H A G liberated from human lens proteins was

obtained by via microbore HPLC with in-line electrospray ionisation mass spectrome
(LC-ESIMS) and by comparison with an authentic standard synthesised in our
laboratory. Base hydrolysis was performed on an 83 year old lens as described in
methods section 3.2.1. 50 uL of the supernatant was injected for RP-HPLC analysis
with UV absorbance measured at 360 nm (Fig. 3.11). The peak at 13.4 mins was
collected, lyophilised and submitted for LC-ESIMS.
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Figure 3.11: R P - H P L C of base-hydrolysed protein from an 83 year old lens. The area
of the peak corresponding to the elution of AHAG was calculated to be
83983 units or 0.52 ug of AHAG per mg of protein extract (see Fig. 3.9).
Fraction one was collected at 13.4 mins and submitted for LC-ESIMS.
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L C - E S I M S was performed on both fraction one, collected from base treatment
of human derived lens protein and synthetic AHAG. Mass spectra were generated from

the total ion current (TIC) in the region corresponding to elution of the single 3

absorbing species (Fig. 3.12). Figure 3.13 (A) shows that AHAG released from isolat

lens proteins displayed a positive ion at m/z of 314, with a fragment ion at m/z 15

consistent with the molecular mass of AHAG (313 Da) and its aglucone (151 Da). This

mass spectrum was essentially identical to that of the synthetic AHAG (Fig. 3.13 B
The lens-derived compound and synthetic AHAG also co-eluted when mixed together
and analysed by LC-ESIMS.
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Figure 3.12: L C E S I - M S for the collected fraction 1 of base hydrolysed lens protein
from and an 83 year old (Fig. 3.11). Compounds were eluted from the
microbore RP-HPLC column using a shallower acetonitrile gradient with
a different counter ion (4 mM ammonium acetate) to that used to collect
the fraction in figure 3.11. Mass spectra were generated from the total ion
current for the single 360 nm absorbing species (see Fig 3.13). AHAG
and other tryptophan metabolites absorb strongly at 360 nm.
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Figure 3.13:

Mass spectra of synthetic A H A G and lens protein derived compound.

Samples were analysed using microbore HPLC with in-line electrospray
ionisation mass spectrometry. The positive ion mass spectra are shown
for the single 360 nm-absorbing compound present (eg Fig. 3.12) and
were determined directly after elution from the HPLC column. The v
ordinates show relative signal intensity.
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3.3.7 Liberation of A H A G from W h o l e H u m a n Lens Extracts

In order to determine if human lens crystallins were also covalently modified by
3 0 H K G in vivo, 55 lenses of various ages were extracted to remove non-covalently
bound low molecular weight substances and then examined for the quantity of A H A G
released from the proteins as a function of age after 48 hours of base hydrolysis (Fig.
3.14). In the present work, an age dependent increase in A H A G was observed which
was more pronounced in lenses over 40 years of age, although considerable scatter was
evident.
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Figure 3.14: Hydrolysis of human lenticular proteintorelease A H A G . The lyophilised
protein was incubated for 48 hours in 5 % potassium hydroxide in 8 0 %
ethanol to liberate A H A G , which was quantified by H P L C . Analysis of
the contralateral lenses of the same individual are also shown (o).
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Duplicate samples of the lens extracts were hydrolysed for 144 hours to assess

the extent of AHAG liberation after 48 hours (Fig. 3.15). Increasing the incubation ti
resulted in a 15% increase, on average, in AHAG detected but did not reduce the
variability (scatter) of the data depicted in figure 3.14. Significant variations in
extent of UV filter-mediated modification of crystallins do, therefore, exist in our
population.

0.6 i
,-^
•o

-o
*u
"•
03

c 0.5

ou
o 0.4

•Ht

Q.

ou W>
Xi
Hi

O

fi
CU

0.3

on 0.2 J

2 5 0.1
<

01

0
0

10

20

30

40

50

60

70

80

90

Age (years)

Figure 3.15: Longer hydrolysis of human lenticular protein to release AHAG. 55
lenses were incubated for 144 hours in 5% potassium hydroxide in 80%
ethanol to liberate AHAG, which was quantified by HPLC. Analysis of
the contralateral lenses of the same individual are also shown (o).
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3.3.8 Liberation of AHAG from Nuclear and Cortical Human Lens Protein
Extracts

Thirty nine individual human lenses were cored to separate the nuclear and

cortical parts, as described in Methods section 3.2.1. Since it is known that hu

colouration begins in the central portions of older individuals35'82, we wanted t

determine if covalent modification by 3 OHKG had this same regional specificity.

Results from this study indicate that there is a significant difference in the a

AHAG liberated from the nucleus when compared to the cortex of the lens, particu
in older individuals (Fig. 3.16).
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Figure 3.16: AHAG liberated from nuclear and cortical human lens proteins as a
function of age. 39 lenses were sectioned into nucleus (•) and cortex (o)
as described in methods section 3.2.1 and extracted with 4 x 80%
ethanol. The lyophilised pellet was base hydrolysed for 48 hours to
liberate AHAG, which was quantified by HPLC.
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3.3.9 Fluorescence Comparison of 30HKG Modified CLP and Human
Lens Derived Protein

Three dimensional fluorescence spectra of calf lens protein that had been
modified with 3 OHKG for 16 days at pH 7 (with unbound small molecules removed,
see section 3.3.1) were obtained under the following conditions: 1 milligram of the

dialysed, modified protein was accurately weighed in duplicate into separate Eppendorf
tubes. 1 mL of 6 M guanidine hydrochloride was added to the protein and the solution
vortexed to ensure complete dissolution. Fluorescence spectra were obtained with an

excitation slit width of 10 nm and an emission slit width of 5 nm. A 1 mgmL"1 solution
of 4 x 80% ethanol extracted, dialysed and lyophilised human lens protein from a 75
year old donor was made up in 6 M guanidine hydrochloride in exactly the same way.

The excitation slit width for these solutions was narrower (5 nm), however, due to the
higher fluorescence intensity obtained from the aged lens protein. These spectra are

compared in figure 3.17. This figure indicates a close match in the fluorescence profi
between the two protein samples.
Following incubation with 3OHKG, CLP exhibited 3 major fluorescent peaks
(Excitation 380 nm; Emission 440 nm, 490 nm and 520 nm) with up to 7 other minor
peaks (Fig. 3.17A). CLP did not show any detectable non-tryptophan fluorescence (in
the scanning region shown) prior to incubation with 3 OHKG and 3 OHKG itself showed

a single fluorescent peak of excitation 357 nm / emission 500 nm. Protein isolated fro

the aged human lens showed a very similar fluorescence profile to that observed for th
CLP incubated with 3OHKG, albeit with a larger intensity (Fig. 3.17B). This result

indicates that the covalent attachment of 3OHKG is a likely explanation for the increa
in lenticular fluorescence that is observed in the ageing human lens.
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Figure 3.17: Fluorescence spectra of modified crystallins. Three dimensional
fluorescence spectra of (A), calf lens protein following incubation with
3 OHKG at pH 7 for 16 days (slit widths, Ex 10 nm / Em 5 nm) and (B),
75 year old human lens protein (slit widths, Ex 5 nm / Em 5 nm) are
shown. The concentration of protein in both samples was 1 mgmL" .
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3.3.10 Colour and Fluorescence Measurements of Nuclear and Cortical
Human Lens Protein Extracts

Based on the result in the previous section, it was decided to measure 360 nm
absorption and fluorescence of human lens cortical and nuclear protein extracts to
determine if'colour' and fluorescence were linked. 39 human lenses were separated
into nucleus and cortex according to Methods section 3.2.1. The ethanol extracted,
lyophilised protein was accurately weighed into separate Eppendorf tubes and 6 M
guanidine hydrochloride added to give a protein concentration of 1 mgmL"1. These
solutions were analysed by UV-visible spectroscopy. Absorbance of the lens proteins
was achieved by taking the tangent of the line from 600 to 500 nm and extrapolating

this line to 360 nm. By subtracting the extrapolated value from the actual 360 nm value

light scatter caused by insoluble protein could be accounted for (Fig. 3.18). This metho
was simplified from that used by Owen (1996)93 and subsequently by Gaillard et al
(2000) when working with intact lens sections. In this study protein essentially all
protein was in solution due the high concentration of guanidine hydrochloride. The

previous method assumed that the effect of light scattering could be subtracted from th

observed absorption spectrum by first fitting the scattering portion of the spectrum (e
600 to 500 nm, as used above) to the formula A = aA,n, where A is the absorbance, a is

constant, X is the wavelength and n is the order of the relationship between absorbance
and wavelength. The background absorbance is then estimated using the coefficients
determined from the fit. Other authors in this area have adopted a simplified
measurement of colour by taking the ratio of absorbance at 350 nm to that observed at
280 nm

5

or the measurement of light scattering by expressing the absorbance units at

600 nm per milligram per millilitre of soluble protein96.
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Figure 3.18: UV-Visible scan of nuclear protein from a 75 year old lens. A 1 mgmL"
solution of nuclear protein was prepared in 6 M guanidine HC1. The
solution was scanned for absorbance from 200 to 1100 nm (A). Shown in

(B) is the expanded region of 200 to 600 nm to highlight the process of
obtaining a measure of absorbance at 360 nm. 'Colour' measurement was

achieved by taking a line from 600 to 500 nm then extrapolating this li
to 360 nm as shown.
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Sectioned lenses were analysed for 360 n m absorption by the process described

above. These results are shown in figure 3.19. As can be seen from the graph, there

clear difference in absorbance between proteins isolated from the nucleus and corte
particularly in individuals greater than 40 years of age.
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Figure 3.19: Absorbance at 360 n m was measured in proteins from 39 human lenses
of various ages. Lenses were sectioned into nucleus (•) and cortex (o).
Lyophilised proteins were dissolved in 6 M guanidine hydrochloride (1
mgmL"1) and UV-visible spectroscopy performed. 'Colour' of the lens
was measured by subtracting the effect of light scattering from the
observed absorbance at 360 nm as per figure 3.18.
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Fluorescence of the lenticular proteins was also determined and the results are

shown in figures 3.20 and 3.21. Fluorescence at Excitation 380 nm / Emission 49
(Fig 3.20) and Ex 380 nm / Em 440 nm (Fig 3.21) are shown. These two peaks of

fluorescence represent the two most prominent fluorescent peaks present in huma
lenticular protein (see Fig. 3.17).
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Figure 3.20: Fluorescence of human lens proteins at Ex 380 n m / E m 490 nm. 39
human lenses were divided into nucleus (•) and cortex (o). Solutions
were the same as those in figure 3.19. Slit widths were 5 nm for
excitation and emission.
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Figure 3.21: Fluorescence of human lens protein at E x 380 n m / E m 440 nm. H u m a n
lenses were sectioned into nucleus (•) and cortex (o) (see Fig 3.19 and
3.20).

Data from figures 3.19 and 3.21 were plotted together to determine if a
correlation exists between nuclear protein absorbance at 360 nm and nuclear
fluorescence when measured at excitation 380 nm/emission 440 nm (Fig 3.22). This
figure shows that a high correlation does exist between the observed 'colour' of
and itsfluorescentcontent.
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Figure 3.22: Graph of fluorescence measurements of protein isolated from the lens
nucleus compared to absorbance measured at 360 nm (see Figs. 3.19 and
3.21). The equation of line was y = 0.0002 x + 0.0094. The chi-squared
value of the line was 0.8614. A similar relationship exists when
absorbance was plotted against fluorescence measured at Ex 380 nm/Em
490 nm (data not shown).

3.3.11 Comparison of'Colour' and Fluorescence Measurements of Nuclear
and Cortical Human Lens Protein Extracts with AHAG Content

Protein extracts were obtained from the cortex and nucleus of 39 individual
human lenses. Care was taken to ensure that non-covalently bound coloured and

fluorescent small molecules were washed clear of the protein fraction. AHAG conte

was measured (section 3.3.8), as was 360 nm absorption (as an index of 'colour') a
fluorescence (section 2.3.10).
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These data were then plotted together to determine if there was a link between

the amount of AHAG released from the protein and the colour / fluorescence observed
Three graphs below represent these correlations between AHAG released from nuclear

proteins and colour (Fig. 3.23), fluorescence at Ex 380 nm / Em 490 nm (Fig. 3.24), an
fluorescence at Ex 380 nm/Em 440 nm (Fig. 3.25).
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Figure 3.23: Graph of absorbance at 360 n m and A H A G released from nuclear
proteins. Nuclear protein was analysed for absorption at 360 nm as
described above in section 3.3.10. These values were compared to the
amount of AHAG released per milligram of the protein. The equation of
the line was y = 0.71 lx + 0.0243 and this gave a chi-squared statistical
value of R =0.7623.
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Figure 3.24: Correlation offluorescencemeasured at Ex 380 n m / E m 490 n m and
AHAG released per milligram of nuclear protein. The equation of the
line was y = 313.5x + 90.6 with R2 =0.6633.
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Figure 3.25: Correlation of fluorescence measured at Ex 380 n m / E m 440 n m and
AHAG released per milligram of nuclear protein. The equation of the
line was y = 340.lx + 90.0 with a R2 value of 0.6908.
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Discussion

Protein modification is a characteristic feature of lens ageing, in particular,

increases in non-tryptophan (or so-called 'blue') fluorescence and yellow colouration o

the lens have been reported34'35'97. We wished to assess whether this was due, in part, t
modification by covalent attachment of 3 OHKG to lens proteins.
Model incubations were set up with water-soluble CLP extracts in aqueous
buffer solution together with either 30HKG, AHBG or N-acetyl-30HKG (Fig. 3.26).
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Figure 3.26: Molecular structures of 3 0 H K G , A H B G and N-acetyl-30HKG.

The later two compounds in figure 3.26 are not able to deaminate on the
kynurenine side chain and therefore if the proposed mechanism were correct, should not
covalently bind to protein. This was shown to be the case. When incubated and
extracted under identical conditions, only the protein incubated with 3 OHKG showed
appreciable levels absorption of 360 nm and fluorescence (Results sections 3.3.1 and
3.3.3). This result indicates that formation of the reactive unsaturated carbonyl
intermediate is an important pre-requisite for covalent modification of protein.
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By elucidating a non-oxidative mechanism of covalent attachment, involving the
kynurenine side chain, all the UV filters found in the lens, which contain an intact

kynurenine side chain, become potential crystallin modifiers. This study aimed to show

this modification of the crystallin proteins with both in vivo and in vitro evidence f
30HKG covalent attachment. This evidence follows on from work carried out by Inoue
and Satoh when they discovered a way of treating highly insoluble cataractous lens
protein material with strong base. In this work they claimed to have discovered a new
UV filter, which they called AHAG91. We suspected that the AHAG was, in fact, a
result of base cleavage of 30HKG either trapped inside the precipitated protein or
30HKG that had been covalently linked to the crystallin protein (Fig. 3.1). Initial

experiments focussed on determining which of these possibilities was the likely source
of AHAG following treatment with strong base. The protein from Indian donor lenses

was pooled, dialysed and lyophilised before dissolving in 6 M guanidine hydrochloride.
This protein was reduced and carboxymethylated as per Methods section 3.2.1. The

resulting modified proteins were then extensively dialysed against Milli Q™ water with
the proteins eventually precipitating from solution. This method ensured that the
crystallin proteins had a minimal quantity of non-covalently bound small molecules
trapped within the precipitated protein. Base hydrolysis of this material resulted in
AHAG being released, indicating that the occurrence of this molecule was a result of

the covalent attachment of 3 OHKG to lenticular protein. Based on this evidence we set
about to gather donor lenses from as wide an age range as possible to measure the
AHAG content of the lens proteins as a function of age. From this work we discovered
an age and regional dependant increase in covalent modification by the most abundant
UV filter. Figures 3.14 and 3.16 show an exponential increase in the amount of AHAG

liberated from lenticular protein per gram (dry weight) of protein, as shown by the li
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of best fit. As expected there was a large amount of scatter in lens samples over the a
of 40 years. The importance of these findings is, however, that there is no significant
amounts of AHAG in protein of lenses below approximately 40 years and no lens
protein sample analysed contained higher amounts of AHAG in the cortex than the
nucleus. This indicates that covalent modification by 3OHKG begins in the nuclear
region of the lens and only after the onset of middle age.
A reasonable correlation was found between protein absorbance at 360 nm and

fluorescence in the nuclear portions of the lens with a chi-squared value of 0.86 (Fig.
3.22). A correlation was also found when the amount of AHAG liberated from the
lenticular protein was graphed against absorbance (R2 = 0.76, Fig. 3.23) and
fluorescence (R2 = 0.69, Fig. 3.25).
Importantly, CLP incubated with 3 OHKG for extended periods at pH 7 showed
similar spectral characteristics in absorbance and fluorescence than those of normal,
aged protein from the human lens although lower in intensity, as would be expected

(Fig. 3.17). This figure indicates a reasonably close match in the observed fluorescence

patterns but there are small differences. These differences are most likely due to othe
components in the aged human lens that contribute to the fluorescence. Some of these
reported contributors include kynurenine45'98,99, 3-hydroxykynurenine 83'84>100?
ascorbate48'101, pentosidine88, argpyrimidine89, MOLD and GOLD102.
The combination of reasonable correlations between the AHAG content with
observed fluorescence and absorbance measured at 360 nm and the close match in the
fluorescence profile between aged human lens protein and CLP that had been incubated
with 30HKG indicates the likely involvement of 30HKG in age-related changes that
occur to the proteins of the lens, van Heyningen thought in 197381 that the endogenous
UV filters, such as 3 OHKG, may somehow be responsible for the changes observed
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with cataract. T o test her hypothesis she isolated h u m a n lens proteins and incubated
them in sunlight with, and without, the presence of lens fluorescent compounds (LFC derivatives of, and including, kynurenine, 3-hydoxykynurenine and 3hydroxykynurenine-O-P-D-glucoside). In all her experiments, the protein exposed to
the sun in presence of LFC became yellow-brown, whereas the sun alone caused only a

faint yellowing. Amino acid analysis of these proteins indicated that the only signific
difference proteins exposed to LFC and sunlight and the control (sun only) experiments
was that tyrosine had been oxidised. Her conclusion was that LFC probably acted as
photosensitisers in that they caused oxidation of the protein. Not finding evidence for
adduction of these tryptophan metabolites to the protein, van Heyningen abandoned this
line of research.
Following the work of van Heyningen, Dillon and co-workers have looked into

the effect of UV light and LFC on the proteins of the lens with the basic hypothesis tha
the tryptophan metabolites of the lens accentuate the photo-oxidative damage
characteristic in age-related cataract87'103"106. A problem of this hypothesis is that UV

intensity decreases as light passes from the cornea and through the lens yet the effect
lens colouration and age-related cataract begin in the inner most portions of the lens.
Truscott and co-workers have also followed a research path that links the LFC
compounds to the observed effects of ageing and cataract on human lens protein. Recent
evidence points to a non-oxidative mechanism of attachment of these tryptophanderived compounds to lenticular protein (Fig. 3.1). This mechanism has been shown to
account for the second most abundant UV filter found in the lens, AHBG (Fig. 1.8)
along with a glutathione adduct of 30HKG56. Mass spectral and amino acid evidence is
45 99 , .

also emerging for these metabolites bound to crystallin protein sequences
Chapter seven of this thesis).
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A possible explanation for the large variability (scatter) observed in colouration,
fluorescence and AHAG content of lenses over middle age but very little difference in
those aged below 40 could be the difference in reduced glutathione in the centre of the
lens . GSH is well established as the primary mechanism by which covalent
modification is prevented. Research has established that concentrations must be
maintained for normal lenses function to be maintained107'111.
Recent evidence has established that a barrier to diffusion develops in older
human lenses. This barrier has the effect of markedly reducing the rate of movement of
small molecules into, and presumably out of, the centre of the lens65. Consequently,
molecules such as 30HKG are predicted to have an increased half-life in older lenses,
thereby increasing the steady-state concentration of the proposed a, p-unsaturated
carbonyl intermediate. This barrier to GSH diffusion may only affect some individuals
and to a greater or lesser extent, thus accounting for the fact that some 70+-year old
lenses had very little obvious changes measuring the parameters that we did.
In conclusion, evidence is provided for a biochemical link to the observed

increases in lenticular colouration and fluorescence as a result of covalent modification
by the most abundant UV filter, 3-hydroxykynurenine-O-p-D-glucoside.
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CHAPTER FOUR
Effect of Kynurenine on Calf Lens Protein

4.1 Introduction

A common feature of the ageing lens and, in particular, age related cataract is

the progressive increase in insoluble protein, especially in the centre of the lens8'112. In
normal, aged lenses, this protein is insoluble in water but soluble in concentrated
solutions of guanidine hydrochloride or urea. In the cataractous lens, much of the
protein in the centre of the lens is not soluble in even these high concentration
deaggregating solutions59'113. These facts indicate that the high molecular weight
complexes forming in normal aged lens are non-covalent in nature - high concentrations
of urea are able to break up and solubilise these complexes but in cataract the
complexes are covalently cross linked, thus insoluble due to their large molecular size.
The large size of these aggregates may be the primary biochemical basis behind the
pathophysiological effects of cataract: patients experience increases in glare, decreased

visual acuity and, finally, blindness. One of the reasons that the biochemistry of catarac
is relatively poorly understood is that the insoluble protein from the lenses of cataract
patients is just that - insoluble . The complexes are heterogenous in that they contain
possibly 20 different protein subunits, some are structurally related like the beta and
gamma crystallins and some are very different, for example the alpha family of
crystallins. The protein sub-units are also generally truncated to a greater or lesser
degree50'114. The insolubility of these complexes makes finding what differentiates these
proteins from those in normal lenses very difficult. A key question, however, is what
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initiates the protein aggregation in normal aged lenses? It is possible that the events that
cause the initial aggregation may also be involved in forming the covalent cross links
associated with cataract. As stated in the introduction to this thesis, the most likely
explanation for the non-covalent aggregation of crystallins with age is the build up of
post-translational modifications on these exceptionally long-lived proteins. The lens
contains a protein concentration unmatched anywhere else in the human body of
approximately 300 mgmL" . To have a protein concentration so high and yet still be
soluble, such that light in the visible part of the spectrum can pass unimpeded, requires
that these proteins must have a highly ordered packing array with many short-range
non-covalent interactions between adjacent protein molecules (Fig. 4.1).

+ Protein Modifier -X

Figure 4.1:

Representation of the effect of protein modification (shown as - X ) on

interactions between neighbouring protein strands. It is thought that
modification of the protein can create localised changes in the surface
charge, causing adjacent polypeptides to be attracted to each other, thus
forming non-covalent high molecular weight complexes.
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The postulate states that the build up of post-translational modifications disrupts
these short-range interactions by progressively changing the surface charge of the
globular protein and, thus, causing attractions between neighbouring parts of protein
where there were once repulsions .
We have recently elucidated a novel protein modification mechanism by
kynurenine45 and 30HKG57 in the lens. Other workers in our laboratory have also

shown the first chemical evidence that the kynurenine side chain is inherently unstabl
at neutral pH resulting in deamination and the formation of an a, (3-unsaturated

carbonyl that is susceptible to nucleophilic attack. In the following chapters we aime

provide a range of physical data to illustrate the effect of this covalent modificatio
model system using crystallins from the calf lens and three human UV filters, namely
kynurenine, 3-hydroxykynurenine (see Chapter 5) and 3-hydroxykynurenine-O-P-Dglucoside (Chapter 6). This series of incubations with CLP was done with the most
abundant human UV filters, namely 30HKG, Kyn and 30HK. 30HKG has an in vivo
concentration range of approximately 400 nmolg"1 to 100 nmolg" (wet weight)
depending on age. Kyn (~ 20 nmolg"1 wet weight of protein) and 3-OHK (~ 10 nmolg"1
wet weight)28 are therefore present in the lens but at least 10 times less concentrated
the lens than the glucosylated moiety. We have chosen a model incubation system that
employed significantly higher concentrations of UV filter compounds (1 and 10 mM of

each UV filter, respectively) than that found normally in the lens in order to quantif

potential post-translational modifications after five days of incubation that one woul

normally expect to occur over the lifetime of an individual. To further accentuate thi
modification, some incubations were performed at pH 9.1 (compared to the normal
physiological pH 7.2). This high pH had previously been shown to increase the rate of
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deamination of the kynurenine side chain31 thus allowing more reactive a,p-unsaturated
intermediate to bind to the lenticular protein.

4.2 Materials and Methods

Kynurenine (Kyn), 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB) and glutathione
(GSH) were purchased from Sigma-Aldrich (St. Louis, MO, USA). All organic solvents
and acids were HPLC grade (Ajax, Auburn, NSW, Australia). Milli-Q™ water (purified
to 18.2 MQ/cm ) was used in the preparation of all solutions. Fresh calf lenses (< 6
months old) were obtained from Parish Meats, Yallah, NSW, Australia and prepared as
per section 3.2.2 of this thesis. Amino acids (N-a-t-Boc-L-histidine, N-a-t-Boc-L-

lysine or cysteine) Sodium hydrosulfite and Kyn sulfate salt were all obtained from
Sigma (St. Louis, MO, USA). Hydrochloric acid (6N) sequencing grade was from
Pierce (Rockford, Illinois, USA). Pre-cast 12% SDS-PAGE cassettes were purchased
from Gradipore (North Ryde, NSW, Australia, Cat. No. NG21-012). All other
chemicals were of analytical quality.

4.2.1 Calf Lens Protein Incubations with Kynurenine at pH 7 and 9

300 mg each of CLP was weighed into separate 20 mL glass screw capped vials
from a stock of lyophilised protein. The vials were placed under a gentle stream of

argon to remove oxygen while buffer solutions were prepared. Phosphate buffer (0.04
M, pH 7.2 or pH 9.1) was freshly prepared from 0.2 M stock solutions of sodium
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phosphate monobasic and sodium phosphate dibasic. The phosphate buffer was

extensively sparged with helium, filtered through a 0.45 urn filter and 6.1 mL added
(1) 1 mM Kyn incubations (1.27 mg, MW = 208.22 gmol"1, 6.1 umol)
or
(2) 10 mM Kyn incubations (12.7 mg, 61 umol)
in screw capped glass vials and warmed slightly in a water bath to dissolve the

kynurenine. From these stock solutions, 3 mL was pipetted directly into the glass vi
containing the weighed protein to give a protein concentration of 100 mgmL"1 and a
kynurenine concentration of 1 mM or 10 mM respectively. The pH was checked and

adjusted to pH 7.2 or 9.1 with 1 or 2 drops of concentrated sodium hydroxide solutio
and 50 uL chloroform added as a bacteriostatic agent. Argon was bubbled through the

incubation mixture for 10 minutes at a slow rate and the tube was sealed, wrapped in
foil to exclude light and incubated in a 37°C water bath for five days with 400uL
aliquots (40mg of protein) being removed every 24 hours, including day 0, under a

gentle stream of argon gas. Protein only controls were prepared at pH 7.2 and 9.1 an
incubated under identical conditions (Table 4.1).
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Incubation

Kynurenine

Number

Concentration

Tubel

ImM

7.2

Tube 2

10 m M

7.2

Tube 3

ImM

9.1*

Tube 4

10 m M

9.1*

Tube 5

OmM

7.2

Tube 6

OmM

9.1*

pH

Table 4.1:

Six incubations were set up with a C L P concentration of 100 m g m L "

with varying concentrations of kynurenine and varying pHs. Incubation
was maintained at 37°C in the dark. 40 mg aliquots of the protein
incubation mixture were taken every 24 hours for five days and analysed
for various physical parameters as described below.

* Care was taken to not increase p H above 9.1 when adjusting the pH with concentrated sodi
hydroxide solution, as protein precipitation was found to occur.
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C L P incubations with l O m M K y n and varying concentrations of

glutathione at pH 7.2

Five protein incubations were set up as above except only 10 mM kynurenine at

pH 7.2 was used plus one protein only control. Glutathione was prepared by dissolvi
the required mass in helium sparged phosphate buffer at a concentration of
9.23 mgmL" . Kynurenine solution was prepared by dissolving the required mass in
degassed buffer at a concentration of 3.36 mgmL"1. 1 mL of the kynurenine solution

was pipetted into separate glass screw capped vials containing 150 mg of lyophilise

CLP. The required volume of glutathione solution was pipetted into each tube to giv
final concentration of OmM (0 uL), 0.5mM (25 uL), 2mM (100 uL) and lOmM (500

\iL) respectively. Degassed buffer was used to make up the volume of the incubation
1.5 mL. The tubes where then wrapped in foil to exclude light, bubbled gently with

argon, 50 uL of chloroform added, sealed and incubated at 37°C for five days with 20
uL (20 mg of protein) aliquots taken every 24 hours under a gentle stream of argon
(Table 4.2).
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Incubation

Kynurenine

Glutathione

Number

Concentration

Concentration

Tubel

10 m M

OmM

Tube 2

10 m M

0.5 m M

Tube 3

10 m M

2mM

Tube 4

10 m M

10 m M

Tube 5

OmM

OmM

Five incubations were set up containing C L P at 100 mgmL" 1 at p H 7.2

and kynurenine concentration (except protein only control) with varying
concentrations of glutathione to test its effect on rate of protein
modification by kynurenine.

The glutathione content of each tube was analysed by the DTNB assay after the

final aliquot of the incubation had been taken on day five with reference to a s

curve of L-cysteine in the concentration range of 0 to 1 mM, according to the fo
method: A standard 10 mM solution of DTNB in methanol (MW = 396.3, 3.963 gL"1)

was freshly prepared in a glass vial. A fresh stock of 50 mM L-cysteine (MW =121.
6.06 gL"1) was prepared in 1.0 M Tris buffer pH 9, 20 uL of this stock solution
diluted with 980 uL of Tris buffer to make a concentration of cysteine equal to

This solution was then serially diluted by half each time, with Tris buffer, unt

concentration of 0.00781 mM cysteine had been reached. In a 0.5 mL quartz cuvett
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0.3 m L of each dilution was mixed with 0.1 m L of water. Absorbance at 412 n m was
noted before 10 uL of the stock DTNB solution was added to the cuvette, mixed and

difference in absorbance was taken after 30 seconds. These values of L-cysteine ve
absorbance at 412 nm are plotted in figure 4.2.
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Figure 4.2:

Standard curve of L-cysteine concentration versus difference in

absorbance at 412 nm before and after addition of DTNB. The equation
of the line is y = 12.87x - 0.0368 with a chi-squared value = 0.9996.

4.2.3 Oxygen Content of CLP Incubations After Bubbling with Argon

A calf lens protein only control experiment was setup under similar conditions

to those used in Section 4.2.1 of this thesis. We wished to ascertain the rate of o
removal from bubbling argon gas through the incubation mixture. The oxygen probe
(Model MI-730, Microelectrodes Inc, Bedford, NH, U.S.A.) was two-point calibrated

against 3 mL of air saturated distilled water at 24 °C and with the same water afte
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addition of 50 m g of sodium hydrosulfite as the zero point calibrant. 300 m g of C L P

was solubilized in 3 mL of freshly prepared 0.04M phosphate buffer, pH 7.2, argon wa
bubbled through the incubation mixture at the rate of 2 bubbles per second. The
concentration of oxygen in the incubation mixture was measured over 10 mins.

4.2.4 Size Exclusion Chromatography Analysis of CLP Incubations

Gel filtration was performed using the following system: a pre-packed
Pharmacia Biotech HiPrep 16/60 Sephacryl S-300 High Resolution column was linked
to a Bio-Rad Biologic medium pressure chromatography system fitted with an AV7-3

automatic sample injection valve and a 1.0 mL loop. Detection of the eluting protein

was achieved with the optics unit supplied with the Bio-Logic system fitted with the
analytical flow cell, a mercury lamp and a 360 nm UV filter as well as an additional
Bio-Rad EM-1 Econo UV Monitor with 280nm filter and sensitivity set to 0.1.
Running buffer for the elution of the crystallins from the S-300 column was
prepared according to the following recipe: EDTA (0.3722 gL" , 1 mM), NaCl
(5.26 gL"1, 0.09 M), NaN3 (200 mgL"1), 98 mL 0.2 M Na2HP04 and 102 mL 0.2 M
NaH2P04 with Milli-Q de-ionised water to make the volume to 1 litre. The buffer was

stirred until all salts were dissolved, filtered through a 0.45 uM filter and degass
using helium sparging for 10 minutes at a moderate flow of helium (1 minute per 100

mL of buffer). Samples for gel filtration were prepared by diluting each 50 uL aliquo

of the incubation mixture with 950 uL of de-ionised water and loading 400 uL (2 mg o
protein) into the sample loop. Samples were eluted from the S-300 column by running
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isocratically at 0.7 mLmin" 1 . All protein and kynurenine eluted from the column in four
hours. A typical elution profile is shown in figure 4.4.

4.2.5 Protein Precipitate Measurements

A measure of protein precipitation was obtained by placing 150 uL of the
thoroughly mixed incubation mixture into pre-weighed Eppendorf tubes. Samples were
centrifuged for 30 mins, 4°C at 14 000 rpm (10 000 g). The supernatant was removed
reproducibly into separate pre-weighed Eppendorf tubes for Bio-Rad protein assay. The
protein pellet was washed three times with 150 uL 90% ethanol with the resuspended

pellet being left for 30 mins at -18°C between each washing, followed by centrifugatio

for 30 mins, 4°C at 14 000 rpm. After the third wash and removal of the supernate, the
pellet was lyophilised and the pellet mass was recorded.
The Bio-Rad protein assay was performed on the supernate from the protein
precipitate measurement by taking 1 mL of the stock Bio-Rad protein assay solution
(catalogue number 500-0006) and diluting with 4 mL of de-ionised water. On a 96 well
microtitre plate, a standard curve was prepared using a 1 mgmL"1 solution of type 5
fraction BSA in duplicate.
Solutions of the treated protein supernate were prepared by taking 10 uL of the
supernate solution and diluting with 990 uL of water and thoroughly vortexed to give
protein concentration of approximately 1 mgmL"1. A concentration profile was

constructed along each row of the microtitre plate similar to that used for the standa
curve in order for the protein concentration of the diluted supernate solution to be

accurately assessed. Increasing volumes from 1 to 15 uL of the supernate solution were

ill

Chapter 4

Effect of Kynurenine on CalfLens Protein Incubations

added to an inversely proportional volume of water such that all volumes equalled 15
uL. To these protein solutions was added 235 uL of the diluted Bio-Rad protein assay
reagent. The microtitre plate was read using a plate reader set at 630nm. A standard
curve using BSA absorbance was plotted and protein concentrations of the supernates
thus calculated by averaging 3 microtitre plate wells with readings in the 0.1 to 1.0
absorbance range (630 nm). The average protein concentration was multiplied by

volume of the supernatant aliquot to give protein mass associated with the supernatant
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Figure 4.3:

A typical standard curve of B S A absorbance versus protein mass when

measured using the Bio-Rad protein dye-binding assay. Results were
averaged from two rows of duplicate protein concentrations and were
repeated each time for a new series of CLP incubations. Typical equation
of the line was y = 0.1154x + 0.0005 with a R2 = 0.9801
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Colour and Fluorescence M e a s u r e m e n t s of the Incubated Protein

Colour (A360nm) and fluorescence of the incubated proteins was measured taking
50 uL of the thoroughly mixed incubation solution(supernatant and precipitate) and

dissolving in 2 mL of 8 M urea. The solution was placed in pre-boiled dialysis tubing
and dialysed against 3 x 200 mL of 8 M urea then 1 x 200 mL each of 6 M, 4 M, 2 M
urea, followed by 10 x 200 mL Milli-Q de-ionised water. Each dialysis step was
allowed at least 4 hours to equilibrate before the introduction of fresh buffer. The
protein was then lyophilised and 1 mg accurately weighed into separate Eppendorf
tubes and 1 mL of 6 M guanidine added to each tube and vortexed. A UV-visible scan

of the solution was obtained by placing the protein solution in a 1cm quartz cuvette
scanning from 800 nm to 190 nm using a Shimadzu UV-PC2401 (Shimadzu
Corporation, Japan). A measure of 'colour' was obtained by taking a line from 600 to
500 nm and extrapolating to 360 nm, this value was subtracted from the actual value
obtained at 360 nm (see figure 3.18). Colour measurement in this way ensures that
samples are normalised for light scatter. Fluorescence spectra of the same protein
solutions were obtained using a Hitachi F-4500 fluorescence spectrometer (Tokyo,

Japan) in three-dimensional scan mode with slit widths set at 5 nm (excitation) and 5
nm (emission).

4.2.7 SDS-PAGE of the CLP Incubation Mixtures

SDS-PAGE was performed on selected aliquots of the incubation using pre-cast
12% Gradipore SDS-PAGE cassettes by taking 10 uL of the treated protein incubation
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mixture and diluting with 90 u L of water. From this solution, 10 u L was taken and
added, in separate Eppendorf tubes, to 30 uL of SDS-PAGE glycine sample preparation
buffer consisting of:
4 mL of 10% (w/v) sodium dodecyl sulfate (SDS)
2 mL glycerol
1 mL 0.1% (w/v) bromophenol blue
2.5 mL 0.5 M tris-HCl, pH 6.8
0.3 mL P-mercaptoethanol
Deionised water was used to make up the final volume of the buffer to 10 mL.
These tubes were placed in boiling water for 3 mins before cooling and loading 10 uL
into separate wells of the pre-cast gel. Gels were run using the Bio-Rad® Protean II
SDS-PAGE apparatus at 200 Volts for 60 mins. Gels were removed from the plastic
casing and stained by preparing fresh, filtered Comassie Blue R-250 in a solution of
40% methanol, 10% acetic acid and 50% water overnight. Gels were de-stained using
the same solution without the Comassie Blue.

4.3 Results

This study utilised the total water-soluble protein from bovine lenses (CLP). As
described in the methods section 3.2.2, CLP was obtained after exhaustive dialysis of
the supernate of the of the centrifuged lens homogenate, which, after lyophilisation,
resulted in white powder devoid of salt and other small molecules, consisting almost

exclusively of crystallin protein. This protein was incubated in phosphate buffer at c
to the maximum concentration able to be redissolved in solution (100 mgmL"1) with,
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and without, the h u m a n U Vfiltercompound, kynurenine. In one case glutathione was
also added. Kynurenine is found in relatively low concentrations of approximately 20
nmolg"1 lens tissue, depending on age28. Kynurenine is relatively insoluble in aqueous
solution with a maximum concentration at room temperature of approximately 10 mM.
The protein solutions were analysed with respect to protein aggregation; protein

precipitation; protein cross-linking; protein fluorescence and UV absorption at 360 nm
Experiments were conducted to assess the effect of modification by this metabolite in
this model system.

4.3.1 Oxygen Concentration of the CLP Incubations

These incubations of protein derived from the calf lens with and without human
derived UV filter compounds were undertaken in an attempt to mimic conditions

thought to exist in normal human lenses, i.e. high protein concentration but with a low
oxygen content. We wished to analyse the physical effects of non-oxidative binding of
the UV filter compounds to lenticular protein. To ensure that oxygen was excluded from

the incubations, argon was slowly bubbled through the buffered protein solutions prior

to sealing the glass vials and incubating for up to five days. Shown in Figure 4.4 is a
graph of oxygen concentration versus the time of argon bubbling through the
incubation. As shown in this graph, the level of oxygen reaches undetectable levels (<
0.001 mg/L oxygen) after 9 mins.
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Figure 4.4:

C L P was dissolved in 0.04 M phosphate buffer (pH 7.2). This solution

was bubbled with argon for 10 mins to ascertain the extent of oxygen
removal prior to incubating the protein for up to five days. This
experiment was repeated three times, with a representative profile shown.

4.3.2 Gel Filtration Analysis of the Incubated Protein

The effect of incubating CLP with UV filter compounds was analysed with respect
to protein aggregation. Subsequent separation of the CLP incubation mixture into
separate crystallin classes was achieved by size exclusion chromatography. This

technique does not denature proteins into their constituent subunits; rather, separati

achieved based on aggregate size. Figure 4.5 illustrates a typical separation of CLP a
incubation with kynurenine into four main classes:

(1)

The most highly aggregated (yet still water-soluble) protein peak designated

the high molecular weight fraction (HMW). This peak elutes first from the
Pharmacia S-300 column, at approximately 50 mins.
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Alpha crystallin is the next major family of crystallin subunits to elute from

the column between 60 and 80 mins. The a-crystallins form large aggregates
of-800 kDa.
(3) The beta crystallin family has two constituent peaks, an octomer of
heterogeneous subunits designated beta high (pH) and a mixture of trimers
and dimers designated beta low (pL). Beta crystallins elute between 80 and
130 mins.
(4) The monomeric gamma crystallins (y and yS) elute from the S-300 column at
approximately 130 to 170 mins. yS was partially separated from y but the
two were combined for analysis.

The last peak to elute from the size exclusion column is the unbound UV filter
compounds, which come off at approximately 200 to 240 minutes depending on the
structure.
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Figure 4.5:

Typical size exclusion chromatography profile showing day 0 of
incubating C L P with kynurenine. Peaks were detected by monitoring
absorbance at 280 nm. Crystallin families were analysed for peak area by
taking perpendicular lines to the baseline at the points of inflexion
between adjacent peaks.

4.3.3 Analysis of CLP Incubated with Kynurenine

By examining the gel filtration profiles of the six incubation mixtures at two pH
and kynurenine concentrations, it is clear that kynurenine plays a role in inducing
aggregation of proteins. Peak area data was determined from the profiles by taking
perpendicular lines to the baseline at the point of inflection between adjacent peaks and
calculating relative peak area for each of four crystallin fractions: high molecular weight
( H M W ) , a, p and y crystallin for each day of the incubation. Protein-only control
experiments were set up each time alongside each series of incubations involving the
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tryptophan metabolites. Peak area data from the protein-only controls, i.e. in the absen
of kynurenine, were averaged over five separate incubations. This peak area average
was then used to standardise the peak area data for all of the subsequent protein
incubations such that data could be compared between incubations involving
kynurenine and glutathione (Results section 4.3.6), 3-hydroxykynurenine (Chapter 5)
and 3-hydroxykynurenine-O-P-D-glucoside (Chapter 6). Detailed analysis and
discussion of these comparisons are made in section 6.4 of this thesis.
Figure 4.6 shows typical gel filtration profiles of calf lens protein incubated for
five days, in the dark, under low oxygen conditions at 37°C. Figures 4.6 A, B and C

indicate typical gel filtration profiles for the protein only control at pH 7.2 for day
and 5, respectively. Also shown is the 10 mM kynurenine incubations, pH 7.2, for 1 day
(Fig. 4.6 D), 3 days (Fig. 4.6 E) and 5 days (Fig. 4.6 F). Analysis of the peak area

indicates that there is a clear trend: the formation of high molecular weight aggregates

as judged by a larger peak area of the fraction eluting in the void volume. This process
seemed to be accentuated in the presence of kynurenine.
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Comparison of protein-only control (pH 7.2): day 1 (A), day 3 (B)
and day 5 (C) with respect to 10 m M kynurenine C L P incubation
(pH 7.2): day 1 (D), day 3 (E) and day 5 (F). The 10 m M
kynurenine incubations show more protein associated with the
H M W fraction with respect to the protein-only control at the same

time.

Figure 4.7 (A) shows the relative peak areas of the four crystallin regions after

five days of incubation at 37°C, pH 7.2 and figure 4.7 (B) at pH 9.1. Data represents t

average result for five separate incubations in the case of the protein-only control an
three separate incubations for 1 and 10 m M kynurenine. Standard deviations are
summarised for each crystallin fraction at p H 7.2 protein only control incubations in
table 4.3.

120

Chapter 4

Effect of Kynurenine on Calf Lens Protein Incubations

A
pH7.2

100%
16.2

15.3

13.7

38.7

36.7

19.5

03

<

43.2

03
9i

50.3

a.

i

P

•2E

TT
9.7

3

46.6

42.0

15.8

a

30.9
15.9

0%o

1

-i

D a y 5 - Protein Only

HMW

1

Day 5 - I m M

Day 5-10 m M

D a y 0-Protein Only

B

100% -\
14.9

12.0

12.1

35.8

33.4

18.3

pH9.1

03

t

37.2

<
03

0%

7.5

10.4

£

51.5

"52"

'•Ht

03

1

48.3

44.8

37.4

15.4
14.7

0 % -I

P

r

Day 5 - Protein Only Day 5-1 m M

Figure 4.7:

Day 5-10 m M

Day 0 - Protein

Aggregation of C L P : C L P was incubated with 1 m M kynurenine (column

2) and 10 mM kynurenine (column 3) at pH 7.2 (A) and 9.1 (B) and
compared to the protein only controls after 5 days (column 1) and 0 days
(column 4) of incubation at 37°C. Size exclusion chromatography was
performed on aliquots of the whole incubation mixture. Relative peak
area was calculated for four crystallin fractions, these are represented:
H M W (|), alpha (1), beta (!) and g a m m a (1).
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Incubation

H M W Average

Alpha Average

Time (days)

±S.D.

±S.D.

0

15.9±0.13

15.81 ±1.07

50.30 ±1.82

19.45 ±0.75

1

20.10 ±1.29

12.80 ±2.54

48.89 ±1.91

18.75 ±0.56

2

23.26 ±3.05

11.74 ±3.24

46.85 ±2.81

18.25 ±0.66

3

27.58 ± 4.49

10.68 ±3.88

44.22 ±1.23

17.72 ±0.63

4

29.14 ±5.06

10.07 ±4.20

43.52 ±1.22

16.77 ±0.98

5

30.87 ±4.69

9.691 ±3.91

42.35 ± 0.64

16.17 ±0.83

Average S.D.

3.12

3.14

1.61

0.74

Table 4.3:

Beta Average G a m m a Average
±S.D.

±S.D.

Average peak area, as a percentage of the total peak area, for five

separate protein only controls at pH 7.2 ± standard deviation (S.D) for
each time point, with the last row containing the average S.D. for each
crystallin fraction. The average total S.D. for the control experiments
2.15

It is clear that higher concentrations of kynurenine leads to a higher p

of the crystallin fractions being associated in the HMW fraction. When c

control incubations, CLP that had been incubated with 10 mM kynurenine s
approximate increases in the HMW fraction of approximately 50% (pH 7.2)

(pH 9.1) after five days of incubation at 37°C (Fig. 4.7). When averaged
separate experiments, these data had a calculated error of less than 4%
to the control experiments.
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4.3.4 Protein Precipitation M e a s u r e m e n t s

Precipitated protein was measured in the incubation mixture in two ways: by

mass of pellet and by analysis of the protein remaining in solution by Bio-Rad protein

assay. Aliquots of the 37°C incubations were taken every day for five days. Analysis of
this data indicates that some protein became insoluble in the control experiments.

Incubation of the CLP with kynurenine again accentuated this precipitation. Figure 4.8
A indicates that 10 mM kynurenine incubated with CLP at pH 7.2 induces protein

precipitation when compared to the protein only control and the lower concentration of
kynurenine. This equated to an average increase of approximately 25% when compared
to the control experiments.
Figure 4.8 B shows similar data for the incubations at pH 9.1. These data are
similar to the pH 7.2 data except lower in magnitude (10 mM kynurenine incubations

showed an average increase in precipitated protein of approximately 13%), possibly due

to some of the crystallin proteins having an isoelectric point closer to pH 9.1 than 7
thereby making the protein mixture more soluble at pH 9.1.
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Figure 4.8:

Protein precipitation measurements for incubations at p H 7.2 (A) and 9.1

(B). Precipitation was measured by two methods: mass of the ethanol
washed, lyophilised pellet (lower line) and Bio-Rad protein dye-binding
assay of the supernate (higher line). Shown on each graph are the protein
only control (o), 1 mM Kyn (•) and 10 mM Kyn (•) incubations with the
results averaged from three separate experiments. The error was
calculated to be less than 3% between experiments.
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4.3.5 Colour a n d Fluorescence of the Incubated Protein

Samples of the treated protein were extensively dialysed then lyophilised and redissolved in 6 M guanidine hydrochloride at 1 mgmL"1. These solutions were analysed
for absorption at 360 nm, as described in Results section 3.3.10 and fluorescence
intensity at Excitation 380 nm/Emission 440 nm. Typical spectra are shown in figure

4.9 A and 4.9 B. Results were averaged from three separate incubation mixtures and are
graphically represented in figure 4.10 A (pH 7.2) and 4.9 B (pH 9.1).
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Figure 4.9:

Colour andfluorescenceof CLP incubated with kynurenine. 1 mgmL"

solutions of the dialysed and lyophilised protein were made in 6 M
guanidine hydrochloride. Representive profiles of CLP incubated with
kynurenine are shown for absorption (A at pH 9.1 for 5 days) and
fluorescence (B at pH 7.2 for 5 days).
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Figure 4.10: Colour andfluorescencemeasurements of C L P incubated with
kynurenine for 5 days. Absorption at 360 nm (A) and fluorescence at Ex
380 nm/Em 440 nm (B) were measured for CLP incubated with
kynurenine after extensive dialysis. 1 mgmL"1 solutions of lyophilised
protein were made up in 6 M guanidine hydrochloride. Shown on each
graph are measurements for: 1 mM Kyn, pH 7.2 (a); 10 mM Kyn, pH 7.2
(•); 1 mM Kyn, pH 9.1 (o); 10 mM Kyn, pH 9.1 (•). Standard deviations
were calculated for each time point and averaged for each series from
three separate experiments.
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4.3.6 SDS-PAGE of C L P Incubated with Kynurenine

SDS-PAGE was performed on selected aliquots of CLP incubated in the
presence and absence of kynurenine, to ascertain if there were any observable changes

in the crystallin profile. Due to the denaturing nature of this technique, the non-cova
complexes of the HMW, alpha and beta crystallin fractions are not observed (as with
size-exclusion chromatography). Instead, individual crystallin subunits are seen as
bands on SDS-PAGE that correspond to the molecular weight of each subunit. Changes
in the profile of an SDS-PAGE would only be observed if covalent cross-linking
between individual subunits is occurring. In the case of incubations with kynurenine,
this was not apparent (Fig. 4.11). There does, however, appear to be a polypeptide
cleavage product appearing in the incubations containing kynurenine (labelled as LMW
in figure 4.11) of approximately 19 kDa.
SDS-PAGE was also performed on the HMW fraction collected from gel
filtration of the CLP mixture after five days of incubation at pH 7.2 with 10 mM
kynurenine (Fig. 4.12). This figure shows that the HMW fraction consists primarily of
two large bands that correspond to aA, aB and/or yT crystallin (20 kDa) and PB2 and
pB3 (23-25 kDa). Interestingly, only a very minor band is observed for pBl (28 kDa)
and generalised smearing below the 20 kDa band indicated that some of the cleaved
polypeptides had been incorporated into the HMW complex.
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Lane N u m b e r 1

107,000
76,000

-

52,000

-

Figure 4.11: S D S - P A G E of C L P incubations with kynurenine at p H 7.2. Thoroughly
mixed aliquots (supernatant and precipitate) of the reaction mixture were
taken every day forfivedays.
Lane 1 - standards as marked.
Lane 2 - day 1, 1 m M K y n incubation.
Lane 3 - day 3, 1 m M K y n incubation.
Lane 4 - day 5, 1 m M K y n incubation.
Lane 5 - C L P only control, incubated for 5 days.
Lane 6 - day 1,10 m M K y n incubation.
Lane 7 - day 3, 10 m M K y n incubation.
Lane 8 - day 5, 10 m M K y n incubation.
Gels were generally overloaded in order to see minor bands of higher
molecular weight.

129

Chapter 4

Effect ofKynurenine on CalfLens Protein Incubations

Lane Number 1 2
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H

76,000 ~
52,000 ~

36,800 ~
pBl
PB3
(3B2

27,200 -

aA, aB,yT
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Figure 4.12: S D S - P A G E of the H M W fraction, collected from gelfiltrationof an
aliquot of day 5 of the CLP incubation with 10 mM kynurenine at pH 7.2.
The HMW fraction was collected, lyophilised then reconstituted in water
such that the protein concentration was approximately the same as that
used to generate figure 4.10. Major bands of the HMW fraction correspond
to those expected for PB3/PB2 and ot/y-crystallins, respectively.

4.3.7 CLP Incubations with Kynurenine - Effect of Glutathione

Glutathione ( G S H ) is believed to be the primary antioxidant in the lens. Its
synthesis, regeneration and subsequent transport throughout the lens is an area of

55
increasing research interest in relation to pre-disposing factors for cataract
form

Recent structural elucidation of an adduct between GSH and the most abundant UV
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filter, 3-hydroxykynurenine-O-P-D-glucoside, has further highlighted the importance of
maintaining viable concentrations of this antioxidant throughout the lens tissue56. The
presence of this compound suggests that GSH in the lens can compete with protein for
the reactive a, p-unsaturated carbonyl intermediate. With this in mind, a series of 10
mM kynurenine incubations were set up with varying concentrations of GSH. The aim

of this work was to ascertain if GSH played a role in preventing protein aggregation an
precipitation.

4.3.7.1 Gel Filtration Analysis of CLP Incubated with Kynurenine and GSH

Control experiments were established to test wether GSH was important for
preventing protein aggregation. The protein-only control exhibited similar aggregation

characteristics as those described in section 4.3.2., in that more protein was associat
with the HMW fraction as incubation time increased. Similarly, this effect was
exacerbated by the addition of 10 mM kynurenine. A comparison of five separate CLP
incubations by size exclusion chromatography with varying concentrations of GSH

indicates that GSH is important in preventing protein aggregation. Analysis of the high
molecular weight peak area (Fig. 4.13) indicates that even small amounts of GSH
protect CLP from kynurenine-induced aggregation. Interestingly, high concentrations of
GSH afforded no better protection than incubations with the low concentration (0.5

mM)ofGSH.
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Figure 4.13: High Molecular Weight (HMW) peak area (as a percentage of the total
peak area of CLP) following incubation over five days with 10 mM
kynurenine and varying concentrations of glutathione. Five incubations
with CLP and kynurenine were established to assess the effect of GSH on
protein aggregation:

0.5 mM GSH, 10 mM Kyn (|)

2 mM GSH, 10 mM Kyn (1)
10 mM GSH, 10 mM Kyn (|)

0 m M GSH, 0 m M Kyn (1)
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4.3.7.2 Protein Precipitation Analysis

CLP that had been incubated with kynurenine and varying concentrations of
GSH was analysed with respect to protein precipitation by the two methods described
previously (Methods section 4.2.5): protein pellet mass and Bio-Rad protein assay,
results are shown in figure 4.14. 2 mM GSH appears to offer the greatest protection
from protein precipitation, with a difference between CLP incubated with kynurenine,
but without GSH, of approximately 50% increase in precipitation on day 5 of the
incubation. Again, a high concentration of GSH afforded little better protection than
CLP incubated alone without GSH or kynurenine.
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Figure 4.14: Protein precipitation data for C L P incubated with kynurenine and varying
concentrations of GSH. 150 uL (15 mg) aliquots of the CLP incubations
were taken every day for 5 days and precipitation measured by two
methods: pellet mass after ethanol washing (lower lines) and Bio-Rad
protein assay (higher lines). Five separate CLP incubations are shown on
the graph:

0 mM GSH, 10 mM Kyn (•);
0.5 mM GSH, 10 mM Kyn (•);

2 mM GSH, 10 mM Kyn (•);
10 mM GSH, 10 mM Kyn (o) and

0 mM GSH, 0 mM Kyn (o).
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4.3.7.3 Colour and Fluorescence

Absorbance at 360 nm and fluorescence measurements were obtained from 1
mgmL"1 solutions of CLP in 6 M guanidine hydrochloride (Fig. 4.15). The results

indicate that GSH is important in inhibiting covalent attachment of the UV filter to l
protein, with no measurable amounts of 'colour' or fluorescence obtained from
solutions of CLP incubated with the highest concentration of GSH and only minor
modification, which is at the limits of detectability, from CLP incubations with the
lower concentrations of GSH.
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0 m M GSH
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Figure 4.15: Absorbance at 360 n m (A) andfluorescenceat Ex 380 nm/Em 440 n m
(B) of CLP incubated with 10 m M kynurenine and varying
concentrations of GSH. Indicated on each graph are:
0 rnM G S H (•); 0.5 m M G S H (•) and 2 m M G S H (A). Neither the
control (0 m M GSH, 0 m M Kyn) or 10 m M GSH, 10 m M Kyn (•)
samples exhibited measurable amounts of colour or fluorescence.
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4.3.7.4 G S H Remaining at the E n d of Five Days of Incubation

Reduced G S H was measured by D T N B colourimetric assay by reference to a

standard curve of L-cysteine (Methods section 4.2.2). 100 uL aliquots of the incubati
mixture where taken after the fifth day and centrifuged at 10 000 g for 10 mins. The
supernates were analysed for GSH content after appropriate dilution, the results are

shown in figure 4.16. The results indicate that there is some loss of GSH. The causes

the loss of GSH could be due to the preferential binding of deaminated a,P-unsaturat
Kyn to GSH (Kyn-GSH adduction), the addition of GSH to free cysteine residues of the
CLP and/or trace levels of oxygen in the incubation solutions.
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Figure 4.16: D T N B assay for reduced G S H content of C L P mixtures after five days of
incubation. Absorbances obtained at 412 nm are the average values from
three separate DTNB assays on each diluted incubation mixture. Shown
for each of the incubations is the GSH concentration prior to (left column
of each series) and immediately after (right column) five days of
incubation with 10 mM Kyn and 100 mgmL"1 CLP at 37°C.
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Discussion

Understanding the key biochemical events, which cause the physiological
effects of ageing and cataract, is a fundamental requirement toward any proposed
intervention strategy. As mentioned in the introduction to this chapter, the path to
discovering these biochemical events has been very difficult due to the heterogenous

nature of the insoluble protein aggregates. In the model system presented in this chapter,
protein that had been isolated from young bovine lenses was incubated with, and
without, the human UV filter kynurenine. Incubating protein isolated from bovine lens
tissue offers many advantages: the protein is freely available in large quantities; the

protein has a high degree of similarity to that of the human lens; it can be redissolved i
solution at relatively high concentration (-100 mgmL"1) and the protein had not
previously been in contact with kynurenine-type moieties as the bovine lens lacks this
metabolic pathway.
The protein isolated from the bovine lens was utilised to examine the effects of
incubation with kynurenine on crystallin protein aggregation and precipitation.
Incubation of the protein in the absence of kynurenine over five days resulted in
increases in both protein aggregation and precipitation. Previous studies have examined
this tendency of the crystallin proteins to form high molecular weight complexes in both
the human115 and bovine lens116'117. In particular, these studies point to the heterogeneity
of the high molecular weight fraction and the role of the a- and p-crystallins in the
formation of protein aggregates >300,000 Daltons. In the ageing bovine and noncataractous human lens, these complexes appear to be non-covalent in nature. SDSPAGE dissociated the complexes into free a-, P- and y-crystallin subunits. A similar
result was observed in section 4.3.6 of this thesis when SDS-PAGE was performed on

138

Chapter 4

Effect of Kynurenine on Calf Lens Protein Incubations

the H M W fraction collected from gelfiltrationthe bovine crystallins that had been
incubated for five days. The HMW fraction contained two large bands and a third minor
band of approximately 20 kDa, 24 kDa and 28 kDa, respectively. The first two bands
correlate with bovine a/y-crystallin and pB2/pB3-crystallin, whereas the minor third
band most probably contains PBl-crystallin.
Protein aggregation was measured in this model system by size exclusion

chromatography. This work established that the crystallin proteins isolated from bovine
lenses have a tendency to form HMW complexes spontaneously in solution as
incubation time increases. Analysis of the gel filtration profiles for the protein only
controls indicated that these complexes become more abundant as measured by the
larger peak area. Incubating the protein with kynurenine exacerbated these effects. CLP
that had been incubated with 10 mM kynurenine showed an average 50% (pH 7)
increase in the relative peak area of the HMW fraction compared to control experiments
incubated at the same pH. Protein incubated at pH 9 showed the percentage difference
between the 10 mM kynurenine incubation and the control experiments was lower (30%
increase in HMW fraction).
In all vertebrate lenses a-crystallin comprises up to 40% of the total lens protein,
usually consisting of a 3:1 ratio of aA and aB subunits to form a heterogeneous
multimeric complex with a molecular weight distribution ranging from 300 000 to over
1 million118. a-Crystallin has also been shown to possess chaperone-like properties thus
being capable of binding to unfolded or denatured proteins to suppress non-specific
aggregation. Analytical gel filtration chromatography is a simple way to study the
molecular weight distribution of the incubated bovine lens proteins and to compare the
effect of the kynurenine moiety. This study demonstrated that there are complex
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aggregates of various crystallins that may be due to the chaperone-like activity of acrystallin as it scavenges protein in the process of denaturation119"121 as demonstrated by
the loss of the a-crystallin fraction and a corresponding gain in the HMW fraction.
Protein precipitation was measured by the two methods described above in
section 4.2.5. These data appear to correlate quite well with the protein aggregation
data, in that the higher concentration of kynurenine and the lower pH causes more
protein to precipitate from solution as incubation time increases. These values equate to
an average increase of 25% (pH 7) and 13% (pH 9) of precipitated protein when
compared to the protein only controls. One would expect greater modification of the
crystallin protein at the higher pH. The lower than expected difference between the 10
mM kynurenine incubation at pH 9 and the control could possibly be due to crystallins
aggregating less at pH 9 because this pH is further from the isoelectric points of the
crystallins and therefore has enhanced charge-charge repulsion.
Data in this chapter provide support for the hypothesis that kynurenine moieties
can bind covalently to the structural proteins of the lens. This evidence comes from
increases in 360 nm absorption and fluorescence in this model system. The rate of
modification could be affected by altering the pH of the incubation mixture. By
increasing the pH from 7 to 9, an approximate 10-fold increase in protein modification,
by kynurenine, was observed by the methods described above (see Fig. 4.9 and Hood et
al51). This reflects the fact that deamination of the kynurenine side chain to form the
reactive a, P-unsaturated carbonyl is occurring at a faster rate .
Ageing of the lens is associated with increases in 'colour' and fluorescence, this
process involves changes to the proteins. In addition, protein of the lens becomes
progressively more aggregated and insoluble. These data provide a possible mimic for
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the physiological effects of ageing in the lens by demonstrating a model system in
which protein incubated with a human UV filter compound showed measurable

increases in absorbance at 360 nm and non-tryptophan fluorescence as well as increases
in protein aggregation and precipitation.
Due to the denaturing ability of SDS-PAGE, non-covalent complexes are broken
up into individual crystallin subunits that are seen as bands on the gel. Cataract is

characterised by the formation of large, covalently cross-linked aggregates that are no
denatured by the conditions used for gel electrophoresis. Consequently, SDS-PAGE of

lenticular protein, isolated from nuclear cataract patients, shows a large proportion o

the protein unable to penetrate the polyacrylamide gel due its large molecular size. Th
incubations involving kynurenine did not display any discernable difference when
compared to the protein only control when analysed by SDS-PAGE. This indicates that
kynurenine does not covalently cross-link polypeptide chains under these conditions.
CLP protein was also incubated with 10 mM kynurenine in the presence of

varying amounts of glutathione to ascertain the effect of this antioxidant compound on

the rate of protein modification. Incubations were set up under identical conditions to
those used previously except with the addition of GSH such that a concentration of
between 0 and 10 mM GSH was achieved. Results indicate that GSH can play a role in
preventing protein modification: concentrations of GSH above 2 mM prevented the
CLP from developing any measurable amounts of 360 nm absorption or fluorescence
over the period of this incubation (Fig. 4.15). GSH was also important in preventing
kynurenine-induced protein aggregation (Fig. 4.13) and precipitation (Fig. 4.14).

Surprisingly, it was not the highest concentration of GSH (10 mM) that offered the mos
protection when measuring these parameters, rather the 2 mM GSH incubation. The
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reasons for this are not clear but m a y be due to destabilisation of the protein
conformation by the presence of glutathione mixed disulfide122,123 or just that the
protein was at or near the saturation point in solution and the addition of excess GSH
caused more protein precipitation.
The amount of GSH remaining in solution after 5 days of incubation was also
measured by the DTNB assay. Results indicated that there was a small loss of the
reduced GSH over the period of this incubation. The loss of GSH equated to
approximately 50% in the incubations containing a low initial GSH concentration (0.5
and 2 mM, respectively) and approximately 10% from the high concentration GSH (10
mM). This result was encouraging as it suggests that the incubations of CLP were, in
fact, under low oxygen conditions. If this were not the case then lower values of
reduced GSH would be anticipated after five days84'85.
The centre of normal, non-cataractous lenses is thought to be a region of low
oxygen tension . While this has yet to be confirmed by direct measurement of oxygen
content (due to the hardness of the tissue) indirect evidence is available. Measurement
of O2 by oxygen probe in the chicken lens show lower oxygen concentration in the
nuclear region (8% oxygen) compared to the cortex (20% oxygen) of the lens .

Biochemical measurements of crystallins from normal lenses indicate that there is little
evidence for oxidation of tryptophan, methionine or tyrosine residues in the crystallin
proteins of aged, healthy lenses and there also seems to be only small amounts of
disulphide cross linking involving cysteine residues. Despite the low oxygen tension,
however, modification of the crystallins over time does occur as evidenced by increases
in colour and fluorescence as we age33'35, as well as more and more protein being
associated with high molecular weight complexes particularly in the nucleus of the

142

Chapter 4

Effect of Kynurenine on Calf Lens Protein Incubations

lens ' . Data from this thesis, and other members of the A C R F research group, show
that kynurenine does not require oxidation in order to covalently modify crystallin
protein55 and this is consistent with the mechanism of deamination.
In conclusion, a model system involving incubation of protein under conditions

similar to that found in the human lens is presented. By incubating crystallins with on
of the UV filters found in the human lens and measuring parameters that are associated
with the normal ageing process, it was discovered that kynurenine may, indeed, play a
role in the physiological effects of the ageing human lens.
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CHAPTER FIVE
Effect of 3-Hydroxykynurenine on Calf Lens Protein

5.1 Introduction

3-Hydroxykynurenine (30HK) is an o-aminophenol suggesting that its reactions
with proteins would be more complex than that of Kyn or 3 OHKG, which do not have a
potentially reactive phenolic group. The difficulty in working with this compound is

that 30HK is readily autoxidised in even miniscule amounts of oxygen, a process that is
accelerated when the pH rises above 6 . Deamination of the kynurenine side chain is a
slow non-oxidative process which occurs to an appreciable extent over a period of days
at pH 731. By comparison under oxidative conditions, 30HK is converted to a reactive
quinonimine in a matter of minutes to hours . Both processes will occur under
conditions where 30HK, oxygen and protein are present. The readiness of 30HK to
form reactive quinonimine in the presence of oxygen leaves it susceptible to

nucleophilic attack on the ring via Michael addition (Fig. 5.1). Reaction in this way h
been shown to be the case for the formation of xanthommattin, a 30HK dimer that is
readily degraded to a quinone product, DHQCA under slightly basic conditions. The
quinonimine product may also be susceptible to nucleophilic attack by protein amino
1?^ 1 Oft \11 128 •

groups. Although these reactions are readily observed in vitro ' and in vivo ' in

other biological tissues, it is unclear whether this process may occur in the lens. The

availability of oxygen, particularly in the centre, and the presence of antioxidants suc
as ascorbate and glutathione may dictate whether initial autoxidation of 30HK occurs.
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In this chapter reaction of C L P and 3 0 H K was investigated under conditions of low
oxygen tension in order to try to model the situation in the normal lens.
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Figure 5.1:

Proposed autoxidative mechanism of 3 0 H K , and formation of the
83N

products xanthommattin and D H Q C A (from Vazquez et al. ).
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Materials a n d M e t h o d s

3-Hydroxykynurenine (30HK) was purchased from Sigma-Aldrich (St. Louis,
MO, USA). All organic solvents and acids were HPLC grade (Ajax, Auburn, NSW,

Australia). Milli-Q™ water (purified to 18.2 MQ/cm2) was used in the preparation of

solutions. Fresh calf lenses (< 6 months old) were obtained from Parish Meats, Yall
NSW, Australia and prepared as per section 3.2.2 of this thesis. Pre-cast 12% SDSPAGE cassettes were purchased from Gradipore (North Ryde, NSW, Australia, Cat. No.
NG21-021). All other chemicals were of analytical quality.

5.2.1 Calf Lens Protein Incubations with 30HK at pH 7 and 9

The method of incubating protein isolated from young bovine lenses (CLP) was

established in the previous chapter (see section 4.2.1) and was used with the foll
modification:
To obtain a concentration of the UV filter in each incubation at 1 and 10 mM,
respectively, the mass of 30HK was adjusted accordingly.
(1) 1 mM 30HK incubations (1.36 mg, MW - 224.22 gmol'1, 6.1 umol)
or
(2) 10 mM 30HK incubations (13.6 mg, 61 umol)

Aliquots (0.4 mL, 40 mg of protein) were taken every day (including time zero) and

analysed for: protein aggregation (Methods section 4.2.3); protein precipitation (s
4.2.4); colour and fluorescence (section 4.2.5) and SDS-PAGE (section 4.2.7).
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C L P Incubations with 3-Hydroxykynurenine

CLP was incubated with two different concentrations (1 and 10 mM) of 30HK
in phosphate buffer at either pH 7.2 or 9.1, along with protein only controls. As
mentioned in the introduction to this chapter, 30HK is a difficult compound to work

with due the relative ease of autoxidation reactions undertaken by this o-aminophenol,
especially at higher pH values. It was anticipated, before beginning this series of

incubations, that the chemistry of binding to the lenticular proteins would be somewhat
different than the non-oxidative binding of kynurenine. All precautions were taken to
minimise oxygen content of the incubations, as described in Methods section 4.2.1,
however, this series of incubations was not intended to be a 'zero oxygen' analysis,

rather, a 'minimal oxygen' incubation of lenticular protein in the presence of UV filte
similar to that thought to be found in the human lens.

5.3.1 Gel Filtration Analysis of the Incubated Protein

Size exclusion chromatography (SEC) was used to analyse each 24-hour aliquot
from the five day incubation of CLP with 30HK and the protein only controls by
monitoring at 280 nm. Four regions corresponding to HMW, alpha, beta and gamma

crystallin were subsequently analysed with respect to peak area as a percentage of the
total peak area. What became apparent early in the incubations involving high
concentrations of 30HK, was the large amounts of protein precipitation, and thus
progressively smaller total peak areas of the SEC profile. This was exaggerated in the
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high p H , high 3 0 H K incubation where virtually all protein had precipitated after day 1.
Shown below in figure 5.3 is the HMW peak area data for pH 7.2 (A) and 9.1 (B),
results show large amounts of protein aggregation when compared to the kynurenine
incubations (Fig. 4.6). Analysis of the data also indicates that these soluble high
molecular weight complexes are also larger in size shown by earlier elution (of up to
mins) from the size-exclusion column than for the corresponding kynurenine
incubations (Fig.5.2).

£0.8

Time (hours)

Figure 5.2:

Comparison of size-exclusion chromatography profiles for C L P that had

been incubated with either 1 mM 30HK (—) or 1 mM Kyn (-) for five
days at pH 7.2. HMW aggregates from the incubation involving 30HK
are both larger in size and more abundant than those for the
corresponding Kyn incubation.
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Figure 5.3:

Relative peak area of the H M Wfractionas a function of incubation time.

CLP was incubated at pH 7.2 (A) and 9.1 (B) with no 30HK (|), 1 mM
30HK (|) and 10 mM 30HK (D for up to 5 days in a low oxygen
atmosphere, in the dark at 37°C. Aliquots were analysed by size
exclusion chromatography. N.B. Results for days 2 through 5 of the 10
mM 30HK incubation at pH 9.1 are not shown due to gel formation
within the incubation, hence difficulty in obtaining an accurate aliquot.
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5.3.2 Protein Precipitation

These incubations were also subjected to protein precipitation analysis by the
two methods described previously: pellet mass after centrifugation followed by ethanol
washing and Bio-Rad protein assay of the supernate. Figure 5.4 shows large amounts of

protein precipitation for the high concentration of 30HK at both pH 7.2 (A) and 9.1 (B)
There also appears to be a comparatively large precipitation in the 1 mM 30HK
incubation at pH 9.1, when compared to the kynurenine incubation (Fig. 4.7). One cause

of this amount of precipitation is covalent cross-linking between crystallin subunits (
section 5.3.4) due to autoxidation of 30HK under these high pH conditions, even
though oxygen levels are low (Fig. 4.4).
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Figure 5.4:

Protein precipitation measurements for incubations at p H 7.2 (A) and 9.1

(B). Precipitation was measured by two methods: mass of the ethanol
washed, lyophilised pellet (•) and Bio-Rad protein dye-binding assay of
the supernate (o). Shown on each graph are the protein only control (•),
1 mM 30HK (•) and 10 mM 30HK (•) incubations.
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5.3.3 Colour and Fluorescence

Absorbance at 360 nm and three-dimensional fluorescence measurements were

taken of extensively dialysed aliquots of the incubation mixtures. These results we
graphed and are shown in figure 5.6. Unlike kynurenine incubations, which have a
fluorescence maxima at excitation 380 nm / emission 440 nm, 30HK incubations have
a fluorescence maxima of Ex 380 nm / Em 530 nm (Fig 5.5). Again the greatest amount
of protein modification was observed in the high pH, high concentration of 30HK,

which was proportionally larger than that observed for the kynurenine incubations p
milligram of protein after 5 days of incubation. Absorbance at 360 nm was measured

be 0.235 in the case of 30HK versus 0.165 for the average kynurenine absorbance pe
milligram when CLP was incubated with 10 mM solutions of UV filter at pH 9.1.

300

400

500

600

Emission Wavelength (nm)

Figure 5.5:

Fluorescence profile of C L P incubated with 1 m M 3 0 H K for 5 days at

pH 7.2. 1 mgmL"1 solutions of the dialysed protein were made in 6M
guanidine hydrochloride.
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Figure 5.6:

Colour (A) and fluorescence (B) of CLP incubated with 3 0 H K for up to

5 days. Solutions of the extensively dialysed, lyophilised protein aliquot
were made in 6 M guanidine hydrochloride (1 mgmL"1). Shown on each
graph are: 1 mM 30HK, pH 7.2 (•); 10 mM 30HK, pH 7.2 (•); 1 mM
30HK, pH 9.1 (o) and 10 mM 30HK, pH 9.1 (•) CLP incubations.
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5.3.4 SDS-PAGE

Selected aliquots of the incubation mixture were also subjected to SDS-PAGE to

ascertain if covalent cross-linking of the crystallin protein was occurring. In the case
30HK, there appears to be quite large amounts of cross-linked HMW weight protein, as

evidenced by the large amount of protein failing to penetrate the polyacrylamide matrix.
A smeared band of protein is also observed at approximately 52 kDa that increases with
incubation time and 30HK concentration suggesting formation of a dimeric species.
Concurrent with the increased formation of higher molecular weight species, there is a
decrease in intensity of all other bands. This is especially notable in the high
concentration of 30HK at day 5 of incubation at pH 7.2, whereby the band
corresponding the a and y crystallin subunits at 20 kDa has all but disappeared (Fig.
5.7).
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Lane Number 1 2345 678

107,000 ~
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Figure 5.7: SDS-PAGE of CLP with 30HK incubations at pH 7.2. Lane 1 standards as marked. Lane 2 - day 1, 3 - day 3, 4 - day 5 1 mM 3QHK
incubations. Lane 5 - CLP only control, day 5. Lane 6 - day 5,
7 - day 3, 8 - day 1 10 mM 3QHK incubations.
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5.4 Discussion

When incubated under identical conditions to those used for the previous
chapter, CLP appeared to by modified to a greater extent by 3-hydroxykynurenine, as
opposed to kynurenine. This is evidenced by greater increases in all five of the
parameters measured in this chapter, as compared to the protein only control

experiments. This difference in the rate of protein modification may be explained by the
increased rate at which 30HK deaminates compared to either Kyn or 30HKG129. The
presence of the phenolic functionality in the case of 30HK may also account for the
difference in reaction rate. Some of the known physical properties of this reactive
compound in vitro are that it is unstable in aqueous buffer solutions with a pH greater
than 683; it readily undergoes autoxidation reactions to produce reactive intermediate
compounds, such as DHQCA and xanthommattin (Fig. 5.1); and it is capable of forming
amino acid cross-links130. Incubation of 30HK under aerobic conditions is also known
to generate hydrogen peroxide (H202), phenoxyl radicals (Xan") and hydoxyl radicals
(HO*) as shown by electron paramagnetic resonance spectroscopy (EPR) ' . It is still
unknown what significance of these in vitro reactions with 30HK have in the lens. The
presence of other free-radical scavengers such as ascorbic acid and glutathione may
dictate whether these reactions can occur. The evidence is quite clear, however, for

major oxidative assault of the crystallin proteins (and other structures within the lens
the case of cataract patients. This evidence comes from locating oxidation products of
methionine69 and other hydroxylated amino acid products, indicative of H202 and HO*
being produced within the lens .
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In this chapter data were provided to show that the major effects of incubating

this reactive compound with lenticular protein are the generation of both larger prote
aggregates, (earlier elution from the size-exclusion column) and a greater amount of
these aggregates (larger peak area of the HMW fraction). These aggregates were shown
to be, in part, covalent in nature, SDS-PAGE showed large amounts of insoluble protein

at the top of the gel (molecular weight »100, 000 Da), as well as a concurrent loss of
crystallin protein fractions normally associated in the 20 - 40K Da molecular weight
range. These observations were most prominent for protein incubations with 10 mM
30HK (Fig. 5.4, pH 7). Proportionally larger increases were also observed in protein
precipitation, absorption at 360 nm and fluorescence (Ex 380 nm/Em 530 nm)
measurements over the period of the incubation compared to the equivalent kynurenine
incubations. Analysis of these parameters with respect to incubations involving
kynurenine (chapter 4) and 3-hydroxykynurenine-O-P-D-glucoside (chapter 6) are
discussed more fully in the next chapter (see Discussion section 6.4).
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CHAPTER SIX
Effect of3-Hydroxykynurenine-0-P-D-glucoside on Calf Lens Protein

6.1 Introduction

3-Hydroxykynurenine-O-P-D-glucoside (30HKG) is a tryptophan metabolite
found only in the lenses of humans and other higher order primates (Fig. 6.1). This
metabolic pathway involving glycosylation is unusual in the animal kingdom and is
perhaps an evolutionary consequence due to the reactive nature of its immediate
precursor, 3-hydroxykynurenine. The final of this series of incubations with CLP was
done with the most abundant human UV filter, 3 OHKG, which has an in vivo
concentration range of approximately 400 nmolg"1 to 100 nmolg" (wet weight)
depending on age. Several factors have led to the hypothesis that binding of 30HKG to
protein is a major factor in the increases in lenticular colouration and fluorescence
age:
• 3 OHKG has the same kynurenine side chain that has been shown to
spontaneously deaminate at neutral pH to form a reactive a,p-unsaturated
carbonyl moiety31. When compared to kynurenine (~ 20 nmolg"1 wet weight of
protein) and 3-hydroxykynurenine (~ 10 nmolg" wet weight) , 30HKG is at
least 10 times more concentrated in the lens, making it more likely to bind to
crystallin. This assumes that 30HKG has a similar rate of deamination and that
the decomposition product is equally reactive with protein.
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From chapter 3 of this thesis, A H A G can be released from lens crystallin protein

as a function of age, from near zero levels in the young lens to levels
approaching 1 umolg-1 (dry weight of nuclear lens protein) in some older lenses
(see Results section 3.3.10 of this thesis).
• The extinction coefficient of free 30HKG is 4340 M^cm"1 but when conjugated
to GSH, the extinction coefficient rises to 6759 M^cm"1, leading to speculation
that when bound to protein, 3 OHKG may have a similar or higher extinction
coefficient56.
• CLP incubated with 3 OHKG has very similar spectral (absorbance and
fluorescence) characteristics to crystallin, isolated from the aged human lens.
What has not been established, however, is whether 3 OHKG plays a role in the other
parameters examined in this chapter, i.e. protein aggregation and precipitation.

6.2 Materials and Methods

3-Hydroxykynurenine-O-P-D-glucoside (30HKG) was synthesised in laboratory
by the method of Manthey and co-workers90. All organic solvents and acids were HPLC
grade (Ajax, Auburn, NSW, Australia). Milli-Q™ water (purified to 18.2 MQ/cm2) was

used in the preparation of all solutions. Fresh calf lenses (< 6 months old) were obt
from Parish Meats, Yallah, NSW, Australia and prepared as per section 3.2.2 of this
thesis. Pre-cast 12% SDS-PAGE cassettes were purchased from Gradipore (North Ryde,
NSW, Australia, Cat. No. NG21-012). All other chemicals were of analytical quality.
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6.2.1 Calf Lens Protein Incubations with 30HKG at pH 7 and 9

The method of incubating protein isolated from young bovine lenses (CLP) was

established in chapter four of this thesis (see section 4.2.1) and was used with the
following modification:
To obtain the concentration of the UV filter in each incubation at 1 and 10 mM,
respectively, the mass of 30HKG was adjusted as follows:
(1) 1 mM 30HK incubations (2.36 mg, MW = 386.36 gmol"1, 6.1 umol)
or
(2) 10 mM 3OHK incubations (23.6 mg, 61 umol)

Aliquots (0.4 mL, 40 mg of protein) were taken every day (including time zero) and

analysed for: protein aggregation (Methods section 4.2.3); protein precipitation (sec
4.2.4); colour and fluorescence (section 4.2.5) and SDS-PAGE (section 4.2.7).

6.3 Results

Data collected from previous chapters of this thesis and from other members of

the research group would suggest that reactions involving 3 OHKG should be similar t
those involving kynurenine, i.e. covalent modification through the a, p-unsaturated

carbonyl intermediate, without the complication of the autoxidative reactions sugges

from the previous chapter. CLP incubations were set up under identical conditions to
those used for kynurenine and 3-hydroxykynurenine and analysed for protein
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aggregation, precipitation and cross-linking, along with measurement of 360 n m
absorption and non-tryptophan fluorescence. Data were analysed with respect to the

protein only controls at pH 7.2 and 9.1. These data were then analysed in relation to t
previous two chapters and these comparisons appear in the Discussion section of this
chapter.

COOH

Figure 6.1:

Structure of 3-hydroxykynurenine-O-P-D-glucoside ( 3 0 H K G ) . Lenses of

humans and other higher order primates contain this compound in
relatively large quantities28. This fact has led researchers to believe that
its primary role may be to prevent light with wavelengths below 400 nm
from reaching, and damaging, the sensitive retina .

161

Chapter 6

Effect of3-Hydroxykynurenine-0-P-D-glucoside on Calf Lens Protein Incubations

6.3.1 Gel Filtration Analysis

CLP was incubated with 30HKG under identical conditions to those for
kynurenine and 30HK, as described in methods section 4.2.1. 50 uL aliquots were
taken every day for up to 5 days, diluted with water up to 1 mL and 0.4 mL (2 mg of
protein) subjected to size exclusion chromatography with detection of the eluting

protein peaks achieved with UV absorbance set at 280 nm. Peak areas for the four majo
crystallin families: HMW, alpha, beta and gamma were calculated, shown in figure 6.2
is the HMW data for pH 7.2 (A) and 9.1 (B) for the six incubations over five days.

Results indicate that 3 OHKG has a similar effect on protein aggregation as kynurenin

(Fig. 4.6), with the higher concentration of the UV filter and higher pH causing more
crystallin to be associated with the HMW fraction. These HMW aggregates were similar

in both molecular size (in terms of elution times from the size exclusion column) and
amount (peak heights) when compared to the equivalent incubations involving
kynurenine.
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Figure 6.2:

H M W peak area data for CLP incubated with 3 0 H K G at p H 7.2 (A) and

9.1 (B). CLP was incubated for up to 5 days without 3 OHKG (|), with 1
mM 30HKG (I) and with 10 mM 30HKG (0. HMW peak area was
calculated as a percentage of the total crystallin peak area.
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6.3.2 Protein Precipitation

CLP incubated with 3 OHKG was also measured for protein precipitation by the
two methods described in chapter 4 of this thesis. Aliquots of the incubation mixture

were taken every day for five days, centrifuged and the supernate removed reproducibly

from the pelleted protein into pre-weighed Eppendorf tubes. The pellet was washed with
80%) ethanol several times then lyophilised and weighed. The supernate protein
concentration was measured by the Bio-Rad protein assay. These results are shown in
figure 6.3, with pH 7.2 data seen in (A) and pH 9.1 data in (B).

164

Chapter 6

Effect of3-Hydroxykynurenine-0-fi-D-glucoside on Calf Lens Protein Incubations

Incubation T i m e (days)

Incubation T i m e (days)

Figure 6.3:

C L P was incubated with 3 0 H K G at p H 7.2 (A) and 9.1 (B) for up to 5

days. Precipitated protein was measured by the mass of the ethanol
washed pellet after centrifugation and by measuring protein
concentration of the supernate. Shown in each graph are the protein only
controls (•), protein incubated with 1 mM 30HKG (•) and 10 mM
30HKG (•).
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6.3.3 Colour and Fluorescence

CLP incubated with 3 OHKG for different time periods was extensively dialysed
then lyophilised. Treated proteins were made up in 6 M guanidine hydrochloride to
mgmL"1 and the absorbance at 360 nm was measured, after taking into account the

effect of light scatter. Fluorescence in the non-tryptophan region was obtained wi
excitation of 380 nm and an emission of 490 nm based on the appearance of the 3D
fluorescence spectra of 30HKG-treated samples (Fig 6.4). Absorbance at 360 nm is
shown in figure 6.5 (A) and fluorescence maxima (B) for CLP treated with 30HKG for

up to five days. Results show similar effects to the kynurenine incubations but la
magnitude, probably due to the larger extinction co-efficient of 3 OHKG.
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Figure 6.4: Fluorescence profile of CLP incubated with 1 mM 30HKG for 5 days at
pH 7.2. 1 mgmL"1 solutions of the dialysed protein were made in 6M
guanidine hydrochloride.
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Figure 6.5: The effect of incubation of CLP with 30HKG for up to 5 days.
Absorbance at 360 nm (A) and fluorescence at Ex 380 nm/Em 490 nm
(B) were measured. 1 mgmL"1 solutions of protein in 6 M guanidine

hydrochloride were analysed. Shown on each graph are the followin
incubation mixtures: 1 mM 30HKG, pH 7.2 (•); 10 mM 30HKG, pH
7.2 (•); 1 mM 30HKG, pH 9.1 (o) and 10 mM 30HKG, pH 9.1 (•).
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SDS-PAGE

SDS-PAGE was performed on selected aliquots of the total incubation mixture
at pH 7.2 to ascertain if 30HKG was causing covalent cross-linking between the
crystallin subunits. Using identical conditions to those used for the previous
incubations, CLP incubated with 1 mM and 10 mM 30HKG for up to 5 days at pH 7.2
was compared to CLP incubated for 5 days without 3 OHKG. As can be seen from
figure 6.6, there appears to be no significant cross-linking of CLP incubated with

30HKG.
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SDS-PAGE of CLP incubated with 3 0 H K G for up to 5 days at pH 7.2.

Lane 1 - standards as marked. Lanes 2,3 and 4 - day 1, 3 and 5
respectively of the 1 mM 3 OHKG incubations. Lane 5 - CLP only

control day 5. Lanes 6, 7 and 8 - day 1, 3 and 5 respectively of the 10
mM 3 OHKG incubations.
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6.4 Discussion

CLP was incubated in Chapters 4, 5 and 6 with the primate UV filter compounds
kynurenine (with and without glutathione), 3-hydroxykynurenine and 3hydroxykynurenine-O-p-D-glucoside to assess the effect of these human UV filters on
lenticular protein. This model system was used to test five key parameters normally
associated with ageing in the human lens:
• Aggregation (increased protein associated with the high molecular weight fraction.
• Precipitation (increased precipitated protein and loss of soluble protein).
• Colouration (increased absorption at 360 nm).
• Fluorescence (generalised increase in non-tryptophan fluorescence).
• Cross-linking (crystallin protein cross-linking by SDS-PAGE, although this is
associated with cataract rather than ageing).

The model system was created in order to test the hypothesis that the human UV

filters may be involved in, or largely responsible for, these ageing effects. Shown belo

in figures 6.7 to 6.10 are a series of graphs depicting the comparison analysis of all f
incubations using the five parameters listed above. For the purpose of simplification
these graphs only show the results at the biologically relevant pH 7.2, after five days
incubation.
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Figure 6.7: Comparison of nine incubations with CLP and various UV filter
in the graph are relative peak areas for the HMW fraction, pH 7.2, day 5
of incubation:
1 = Protein only control average
2 = ImM kyn

3-10mMkyn
4 = 10 mM kyn, 2 mM GSH
5=10mMkyn, lOmMGSH
6 = 1 mM 30HK
7=10mM3OHK
8 = 1 mM 30HKG
9 = 10 mM 30HKG
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Protein Precipitation

"e3 100
•Ht

O

H

80

^
^—y
©^

t/1

60

CS

£ii
•HI

40 i

CS
•

^

Cu
«u
-*
Ci

20

u

0

OH

1

2

3

4

5

6

7

8

9

Incubation N u m b e r

Figure 6.8: Comparison of protein precipitation from CLP incubated with various
human derived U Vfiltersat p H 7.2. Represented in the graph are the
precipitated protein data, measured by pellet mass.
1 = Protein only control average
2 = I m M kyn

3=10mMkyn
4=10mMkyn,2mMGSH
5 = 10 m M kyn, 10 m M GSH
6 = 1 m M 30HK
7=10mM3OHK
8 = 1 m M 30HKG
9=10mM3OHKG
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Figure 6.9: Comparison of absorbance measurements at 360 nm of 1 mgmL"
solutions of extensively dialysed C L P after 5 days of incubation with
various U Vfiltersat p H 7.2. Absorbance at 360 n m was measured after
subtracting the effect of light scatter.
1 = Protein only control average
2 = I m M kyn

3=10mMkyn
4=10mMkyn,2mMGSH
5=10mMkyn, lOmMGSH
6 = 1 m M 30HK
7=10mM3OHK
8 = 1 m M 30HKG
9=10mM3OHKG
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Figure 6.10: Comparison of maximum fluorescence intensity in the non-tryptophan
region. Solutions of dialysed C L P were made up in 6 M guanidine
hydrochloride at 1 mgmL" 1 after 5 days of incubation at p H 7.2. Threedimensionalfluorescenceprofiles were obtained for each series of
incubations to ascertain the peakfluorescenceintensity; these peaks were
measured relative to each other in a series. Each profile was obtained
with excitation and emission slit widths of 5 n m and 5 nm, respectively.
Peak fluorescence intensity were obtained at E x 380 nm/ E m 440 n m for
K y n incubations; E x 380 n m / E m 530 n m for 3 0 H K incubations and Ex
380 n m / E m 490 n m for 3 0 H K G incubations.
1 = Protein only control average

3 = 10mMkyn

4= lOmMkyn, 2 m M G S H

5=10mMkyn, lOmMGSH
7=10mM3OHK

2 = I m M kyn

6=lmM30HK

8 = 1 m M 30HKG

9=10mM3OHKG
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The graphs shown in figures 6.7 to 6.10 depict a comparison analysis for nine
series of incubations involving three human UV filters, namely kynurenine, 3hydroxykynurenine and 3-hydroxykynurenine-O-P-D-glucoside. An experiment was

also conducted with one of the UV filters (Kyn) and two concentrations of glutathione

The data depicted in each of these graphs were generated by comparison to protein onl
control experiments, which were conducted under identical conditions but without the
addition of UV filter compounds. Data from the control experiments were averaged
across all series of incubations. Average standard deviation was calculated for each

point in each of the four parameters tested above. Reproducibility was a crucial fact

these experiments, if comparisons were to be made across the four parameters measured

in these series of incubations. The calculated standard deviation values for the cont
experiments testify to this reproducibility, with a maximum S.D. in any of the
parameters found to be less than 3%. Data were then compared by normalising each
series of incubations (Kyn, Kyn + GSH, 30HK and 3 OHKG) to these control average
results, these are the data depicted in figures 6.7 to 6.10.
Some general statements can be made on the basis of these results. Kyn and

3 OHKG appear to generate similar degrees of protein aggregation and precipitation, a
well as similar levels of 360 nm absorbance and non-tryptophan fluorescence compared
to the protein only controls. Incubating CLP with 30HK, however, showed

considerable increases in all four of the above-mentioned parameters, indicative of t

fact that 30HK deaminates more readily than Kyn or 3 OHKG but it is likely that these
reactions probably involved some oxidation. As mentioned previously, attempts were
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made to exclude oxygen by performing incubations in sealed vials under argon but it is
very difficult to exclude all oxygen.
SDS-PAGE was performed on CLP incubations with all three human UV filters
at pH 7.2. Only the incubations with the o-aminophenol compound, 3-OHK, showed

any appreciable protein cross-linking, as evidenced by the large amounts of protein that
failed to run into the gel (Fig. 5.7). An increase in highly aggregated protein seen at
top of the gel was associated with a decrease in band intensity for the crystallin
subunits, normally observed in the 20-40 kDa mass range and an increase. This result is

indicative of crystallin subunit cross-linking and precipitation, a phenomenon associate
with human cataract formation.
From the results presented in these chapters, it is clear that the UV filters may
play some role in affecting the parameters ascribed with the normal ageing lens. By

binding to the proteins that make up the bulk of the lens dry weight, over time they can

cause increases in colour and fluorescence, an effect that has long been observed in the
ageing human lens35'132. Throughout this thesis we have used increases in 360 nm
absorption as an index of increasing 'colour', however, increases in the 360 nm

absorption in these cases is associated with a generalised longer wavelength absorption.

This results in a broad absorption of the wavelengths of light that we normally associat
with the blue and green colours (see Section 1.1.1- The artist's view with cataract).
Data in these chapters may also provide possible explanations for the normal
ageing phenomenon of increased levels of water-insoluble, aggregated protein116'133'134.
There are several possible reasons for this: Disruption of the short-range repulsive
interactions of the crystallins, thereby causing non-covalent aggregation . Binding of
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the UV filter to a-crystallin may also inhibit this protein from performing its chaperone
function i.e. stabilising partially unfolded protein, thus preventing precipitation99.
In conclusion, a model for lenticular ageing is presented in which the soluble
protein from the young bovine lenses is incubated under a low oxygen atmosphere with
human UV filters to assess the effect of this incubation on the parameters associated
with the ageing human lens: protein aggregation, precipitation, colouration and
fluorescence.
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CHAPTER SEVEN
Preliminary Mass Spectroscopic Evidence for the Covalent Binding of
30HKG to Crystallin Protein

7.1 Introduction

In previous chapters evidence has been given for the covalent attachment of
kynurenine moieties to crystallin protein based on the knowledge that the alpha-amino
group of the kynurenine side chain is spontaneously unstable in aqueous solutions at
neutral pH. This instability leads to the formation of reactive a, P-unsaturated

carbonyls, which are susceptible to nucleophilic attack by glutathione, if it is present,
with protein amino acids if it is not. Binding of 3 OHKG and other kynurenine UV
filters to the crystallin proteins appears to be a likely explanation for the observed
increases in lenticular colouration and fluorescence as we humans age. Recent evidence
also implicates kynurenine as a possible inhibitor of the chaperone function of aBcrystallin99, since a major site of covalent modification by kynurenine was the putative
peptide-binding region at histidine-83 (a site crucial for its role as a chaperone). The
loss of chaperone ability of a-crystallin may also explain the age-related increase in
water insoluble protein. It should be noted that a-crystallin is essentially absent from
the soluble lens protein after age 4040. In this chapter, direct evidence for protein
modification by UV filters was obtained via tryptic digestion of crystallin protein that
had been incubated with 30HKG at pH 7 for 5 weeks. Mass spectroscopic techniques
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were used to elucidate the structures of the tryptic fragments that contained conjugated

30HKG.

7.2 Materials and Methods

3-Hydroxykynurenine-O-p-D-glucoside was synthesised in our laboratory by the
method of Manthey and co-workers90. Calf lens protein was obtained by the method

outlined in section 3.2.2 of this thesis. Donor human lenses were obtain post-morte
from the Sydney Lions Eye Bank and were prepared according to Methods section
3.2.1, without modification.
Trypsin (E.C. 3.4.21.4) which had most salt removed was purchased from
Sigma-Aldrich (St. Louis, MO, U.S.A - catalogue number T-8642) and used as
supplied. All organic solvents were of HPLC grade and purchased from Ajax-Unichrom

(Auburn, N.S.W., Australia). Milli-Q™ water, purified to 18 mega ohms cm"2, was used
in the preparation of all solutions. All other chemicals used in this chapter were
analytical quality and used without further purification.

7.2.1 Crystallin Preparation

Calf lens protein (CLP) was separated into the major classes of crystallins,

namely a, P and y by size exclusion chromatography as follows: 300 mg of lyophilise

CLP was solubilised in 3 mL of elution buffer (0.05 M Tris HC1, 0.02% sodium azide,
pH 6.8), and centrifuged at 10 000 g at 4°C for 15 mins. The supernatant was loaded
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onto a 1200 x 25 m m column, packed with Pharmacia S-300 gel, and eluted at a
constant flow rate of 20 mLhr"], similar to the method of Slingsby and Bateman
(1990)

(Fig. 7.1). Fractions from peaks corresponding to the a-, p \ and y-crystailin

families were pooled and concentrated with a Diaflo ultrafiltration apparatus (Amicon)
using a Y M 1 0 , 10 000 D a cutoff membrane. The concentrated protein solution

was

extensively dialysed and then lyophilised in readiness for the incubation procedi
lures
below.
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Figure 7.1:

L o w pressure size exclusion chromatographic separation of total calf lens
protein (Pharmacia S-300 gel media, 0.05 M Tris H C 1 buffer, p H 6.8,
flowrate 20 mLhr" 1 ). Fractions corresponding to a-, p- (P high + p low)
and y- (yS and y) crystallin were pooled and lyophilised in preparation for
the incubation with 3 O H K G .
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Crystallin Incubations with 3 0 H K G at p H 7.4

50 mg each of a-, P- and y-crystallin were added to separate pre-weighed glass
screw-capped vials. To these vials was added 10 mL of 100 mM phosphate buffer, pH
7.4 that had been sparged with helium, and 5 mg of 30HKG. The vials were then
bubbled with argon for 10 mins and 100 uL of chloroform added as a bacteriostatic
agent. The tubes were sealed, wrapped in foil and incubated at 37°C. 5 mL aliquots
the incubation mixture were taken at 3 and 5 weeks. These aliquots were
chromatographed on Sephadex G-25 (Pharmacia) equilibrated in Milli-Q water to
remove unbound UV filters. The protein fraction was pooled and lyophilised.

7.2.3 Tryptic Digestion of Crystallins Incubated with 3 Q H K G

Approximately 5 m g of each crystallin fraction that had previously been
incubated with 3 OHKG, was weighed into separate Eppendorf tubes. To each tube was
added 100 uL of Milli-Q water and the tube vortexed before placing the tubes into
boiling water for 1 min to denature the protein. To each tube was added 0.3 mL of
tryptic buffer, which consisted of 200 mM ammonium bicarbonate and 1.5 mM calcium

chloride. A solution of trypsin was made (freshly each time) by taking 0.6 mg of the
solid and dissolving it in 0.6 mL of the tryptic buffer. This trypsin solution was

each crystallin solution at a rate of 100 JIL per tube, such that the concentration

trypsin to crystallin protein was 1:50. Another 1:50 addition of trypsin was made a
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90 mins of incubation at 37°C and the mixture allowed to incubate for a further 4.5
hours. Digestion was halted by freezing the mixture.

7.2.4 HPLC Separation of the Tryptic Fragments

Separation of the tryptic fragments from the alpha-cry stallin incubation was
achieved by two stages of HPLC purification using two Varian Microsorb-MV C-18,
4.6 x 250 mm, 300 A columns. Stage one of the purification had the following mobile
phase conditions: aqueous 0.05% TFA for 5 mins then a linear gradient of 0-80%

acetonitrile / 0.05% TFA over 40 mins with a flow rate of 1 mLmin"1. Detection of the
eluent was at 229 nm and 365 nm, achieved with a Waters 440 UV detector with an
extended wavelength module attached. Coloured (360 nm absorbing) peaks were

collected from the eluent and lyophilised before the second stage of purification u
second Varian Microsorb-MV C-18, 4.6 x 250 mm, 300 A column equilibrated in
aqueous 4 mM ammonium acetate buffer. Elution of the coloured peptides was
performed via a linear gradient of 0-48% acetonitrile (4 mM ammonium acetate) over

40 mins at a flow rate of 1 mLmin"1. Coloured peaks were collected from the eluent of
the HPLC column before examination by ESI-TOFMS.
Separation of coloured tryptic peptides for beta- and gamma-crystallin
incubations was achieved with one stage of HPLC purification using a Varian
Microsorb-MV C-18, 4.6 x 250 mm, 300 A column equilibrated in aqueous 4 mM

ammonium acetate buffer. Elution of the coloured peptides was via a linear gradient
0-48% acetonitrile (4 mM ammonium acetate) over 40 mins at a flow rate of 1 mLmin" .
Peaks were collected, corresponding to 360 nm absorption and fluorescence at
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excitation 380 nm/emission 490 nm. The collected fractions were examined by
electrospray MS using a QToF-2 (Micromass). Analysis of the collected fractions was
performed without the need for lyophilisation.

7.2.5 Mass Spectroscopy

Collected peptides from the tryptic digest of 30HKG-modified crystallins were
analysed on a Micromass Q-ToF-2 hybrid quadrupole / time-of-flight mass
spectrometer (ESI-TOFMS). Peaks collected from the analytical HPLC separation were

continuously injected at a flow rate of 5 uLmin"1 to acquire initial spectra over the

m/z 300 to m/z 2000. A cone voltage of 28 V was used. Peaks observed in these spectra

were cross-referenced with a database of predicted masses for 30HKG-modified tryptic
peptides of bovine crystallin. Positive matches were further analysed using tandem
MS/MS experiments in order to confirm the identity of the 30HKG-modified peptide.

7.3 Results

CLP was separated into the major crystallin families by size exclusion

chromatography, as described in Methods section 7.2.1. The separated and lyophilised

protein fractions (a, p and y-crystallin) were incubated with 3-hydoxykynurenine-O-P

D-glucoside at pH 7 under similar conditions to those used for the previous chapters
this thesis. These protein suspensions were sampled at 3 and 5 weeks. These samples
were then digested with trypsin and analysed by HPLC.
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7.3.1 HPLC of a-Crystallin Digests

a-Crystallin was digested with trypsin as described in Methods section 7.2.3.
Trypsin cleaves protein chains by specific scission on the C-terminal side of either

lysine or arginine residues. This specific cleavage allows for HPLC separation based o
the hydrophobicity (often peptide size) of the tryptic fragments. Two stages of HPLC
purification were employed in order to separate 360 nm absorbing tryptic fragments
from the remaining unmodified peptides. Stage one of the purification employed a
linear gradient of 0-80% acetonitrile over 40 mins buffered with the volatile counter

TFA (Fig. 7.2). Six fractions of approximately 0.5 to 1 mL each were collected from th
eluent of the HPLC that corresponded to regions of the chromatogram that had
absorption at 360 nm. These peaks were then reanalysed by HPLC with a slower linear

gradient of acetonitrile and a different buffer (4 mM ammonium acetate), an example of
this is given in figure 7.3.
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Figure 7.2:

First stage H P L C separation of tryptic peptides from the incubation of
bovine a-crystallin with 3 0 H K G for 3 weeks at pH 7.4. Eluting tryptic
peptides were monitored by 229 nm (A) and 360 nm (B) U V absorption.
Six 360 nm-absorbing fractions were collected, as indicated by the labels
shown.
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Figure 7.3:

Second stage H P L C purification of 360 nm-absorbing tryptic peptides

from fraction f-5 collected above (Fig. 7.2). Four fractions were collec
from the eluent as per the labels above. These fractions were then
analysed by ESI-TOFMS (see below).
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7.3.2 M a s s Spectrometry of 3 0 H K G - M o d i f i e d a-Crystallin Tryptic
Peptides

Tryptic peptides ionised by electrospray ionisation are particularly amenable to
tandem mass spectrometric sequencing. This technique produces informative
fragmentation patterns of the peptides into complementary b- and y- ion series. An
example of this fragmentation pathway is given in figure 7.4.
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Figure 7.4:
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A n example of the fragmentation of a small tryptic peptide into b- and y-

series ions during MSMS. Fragmentation of the peptide usually occurs at
the peptide bond thus enabling determination of the peptide sequence by
mass subtraction. Note that the b- and y- series ions are complementary.
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ESI-TOFMS was employed to screen collected tryptic peptides. The mass and

charge state of the resultant product ions were then matched to a database of predic
peptides from tryptic digestion of a A and aB- bovine crystallin (Appendix 1). The
charge state of the ions, i.e. +1, +2 or +3 could also be deduced by measuring the

difference (atomic mass units, amu) between isotopic peaks. For 1+ ions, this differe

was 1 amu.; for 2+ ions the difference was 0.5 amu and for 3+ ions, this difference w

0.33 amu. Ions that had a corresponding match to the peptide sequence with the addit
of a single deaminated 30HKG molecule, were further analysed by ESI-TOFMSMS.

Peptide sequence ions were then matched to those predicted, via the use of Bio-Linx®

software confirming their structure. Shown below in figures 7.5 and 7.6 are the ESITOFMS and ESI-TOFMSMS, respectively, for 30HKG-modified T-17 of bovine oAcrystallin (Table 7.1).
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Figure 7.5:

ESI-TOFMS of fraction f-52, collected from two stages of H P L C
purification of tryptic peptides after incubating a-crystallin with 3 O H K G
for 3 weeks at p H 7.4. Labelled above are product ions and their
proposed identity after matching the obtained m/z values to a database of
predicted masses. The ion with m/z 999.1 was matched to this database as
being the T17 tryptic fragment (3+ charge state) of bovine a A crystallin
that had been modified by a single 3 O H K G . This ion was selected and
further analysed by E S I - T O F M S M S (Fig. 7.6).
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Figure 7.6: ESI-TOFMSMS of the product ion with m/z 999.1, from figure 7.5
above. Ions indicated with either b- or y- are matched to those predicted
in table 7.1.
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Bovine a A - Tryptic Fragment T-17 with Cysteine Modified by 3 0 H K G
Ion Type
114.1
b
211.1
298.2
412.2
511.3*
626.3*
Residue #
bl
b2
b3
b4
b5
b6

to Crystallin

754.4*

Residue #

Leu
y26

Pro
y25

Ser
y24

Asn
y23

Val
y22

Asp
y21

b7
Gin
y20

y"

-

2882.1

2785

2697.9

2583.8

2484.7

2369.6

b

841.4*

912.4*

1025.5*

1112.6*

1583.7

1670.7

1784.9

Residue #

b9
Ala
yl8

blO
Leu
yl7

bll
Ser
yl6

bl2
30HKG-cys

Residue #

b8
Ser
yl9

yl5

bl3
Ser
yl4

bl4
Leu
yi3

y"

2241.5

2154.4

2083.3

1970.2

1883.1

1410.7*

1323.7*

b

1872

1943.1

2058.2

2115.2

2246.4

2359.6

2460.7

Residue #
Residue #

bl5
Ser
yl2

bl6
Ala
yll

bl7
Asp
ylO

bl8
Gly
y9

bl9
Met
y8

b20
Leu
y7

b21
Thr
y6

y"

1210.6*

1123.5*

1052.5*

937.5*

880.5*

749.4*

636.3*

b

2607.9

2694.9

2752

2849.1

-

Residue #
Residue #

b22
Phe
y5

b23
Ser
y4

b24
Gly
y3

b25
Pro
y2

b26
Lys
yi

y"

535.3*

388.2*

301.2*

244.2*

147.1

A.A

Ion Type

A.A

Ion Type

A.A

Ion Type

A.A

Table 7.1:

Predicted masses for the a A T-17 tryptic peptide that had been modified

with 3 OHKG. Shown above are the expected masses after MSMS
analysis. Ions indicated with an asterisk were observed in figure 7.6.

7.3.3 Analysis of p-Crystallin Digests

p-Crystallin was incubated with 3 O H K G under conditions identical to those
used above. The chromatographed and lyophilised protein fraction was then digested
with trypsin and analysed by a single stage of HPLC using 4 mM ammonium acetate

and a slow linear gradient of acetonitrile. Tryptic peaks that showed fluorescence a
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excitation 380 nm/emission 490 nm (Fig. 7.7 A) and absorption at 360
nm were
collected from the HPLC (Fig. 7.7 B).
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Figure 7.7:

HPLC separation of tryptic peptides from the incubation of bovine p-

crystallin with 3OHKG for 5 weeks at pH 7.4. Peaks were collected as
shown.

The collected tryptic peptide fractions from 30HKG-modified bovine pcrystallin incubated with 30HKG were analysed in the first instance by
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(Fig. 7.8) in the same way as that used for the a-crystallin digests (Results section

7.3.2). Peptide ions that showed matches to those predicted from Appendix 1 as b
modified by the single addition of 30HKG were further analysed by ESI-TOFMSMS
(Fig. 7.9).
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365.3-[T12-13pA3J
2+
496.2-[T16pBl]
381.1
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Figure 7.8: ESI-TOFMS of fraction f-12 (Fig 7.7). For simplicity, only one stage
HPLC separation was employed for the separation of 30HKG-modified
peptides. As a result, however, more unmodified peptides were found in
the ESI-TOFMS that were identified by matching the obtained masses to
those predicted from Appendix 1. Shown above are the predicted
peptides from this matching process. The ion with m/z 1045.9 was triplycharged and selected for ESI-TOFMSMS because it corresponded to the
mass expected for 30HKG-modified T-2 of bovine PB2.
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Figure 7.9:

E S I - T O F M S M S of m/z 1045.9 from figure 7.8. M S M S of this ion

showed ions consistent with those predicted for the tryptic fragment T-2
from bovine PB2 crystallin modified by the single addition of
deaminated 3OHKG at the cysteine residue. Ions indicated with either bor y- are matched to those predicted in table 7.2.
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Bovine Beta B 2 - Tryptic Fragment T-2 with Cysteine Modified by 3 0 H K G
Ion Type
114.1
b
227.2*
340.3*
487.3*
616.4*
744.4*
bl
b2
Residue #
b6
b3
b4
b5

to Crystallin

873.5*

y24

He
y23

lie
y22

Phe
y21

Glu
y20

Gin
yl9

b7
Glu
yl8

-

3021.3

2908.1

2795

2647.8

2518.7

2390.5

b

987.5*

1134.6*

1262.6*

1319.7

1456.7

1543.8

1680.8

Residue #
Residue #

b8
Asn
yl7

b9
Phe
yl6

blO
Gin
yl5

bll
Gly
yl4

bl2
His
yl3

bl3
Ser
yl2

bl4
His
yll

y"

2261.4

2147.3

2000.1

1872

1815

1676.7

1589.7

b

1811

1924.1

2038.2

2095.3

2192.4

2663.9

2761

Residue #

bl6
Leu
y9

bl7
Asn
y8

bl8
Gly

b20

yv

bl9
Pro
y6

30HKG-cys

Residue #

bl5
Glu
ylO

y5

b21
Pro
y4

y"

1452.6*

1323.6*

1210.5*

1096.5*

1039.5*

942.4*

471.3*

b

b2875.1

b2988.2

-

Residue #
Residue #

22
Asn
y3

23
Leu
y2

24
Lys
yi

y"

374.2*

260.2*

147.1

A.A

He

Residue #

y"
Ion Type

A.A

Ion Type

A.A

Ion Type

A.A

Table 7.2:

Predicted masses for the p B 2 T-2 tryptic peptide modified by 3 0 H K G .

Shown above are the expected masses after MSMS analysis. Ions
indicated with an asterisk were observed in figure 7.9.

7.3.4 Analysis of y-Crystallin Digests

The y-crystallins were also isolated, incubated and digested under identical
conditions to those used for a- and p-crystallin. HPLC was performed on the tryptic

mixture of peptides using the same conditions as those used for p-crystallin (Fig. 7

195

Chapter 7 Preliminary Mass Spectroscopic Evidence for the Covalent Binding of30HKG

to Crystallin

100
Fluorescence
(Ex 380 nm/Em 490 nm)

•f 80
X

•a ^o
Si
OH

a

40

es

^ • ^ ^ ^ v * ^ , ^ ^
0
0

5

10

15

20

25

30

35

40

45

50

55

60

Run Time (mins)

100
B
360 nm

J3
80
.Sf
'S 60

es
o>
PH
tu

13

40

f4

p»

es

I

20
0

i

0

5

i

—

10

i

15

i

20

i

25

i

30

— i

35

1

40

1

45

1

50

r

55

60

Run Time (mins)

Figure 7.10:

H P L C of the tryptic digest of y-crystallin that had been incubated with

30HKG for 5 weeks. Eluting peptides were monitored by fluorescence
(Excitation 380 nm/Emission 490 nm) (A) and absorption at 360 nm (B).
Fractions were collected from the eluent as per the labels shown.
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7.3.5 Tryptic Digests of Human Lens Crystallins

Preliminary studies on human lens protein homogenates with the goal of
identifying peptide sequences that were modified by 3 OHKG were also performed. Due
to the fact that mass spectral analysis were attempted on the older, less sensitive,
Quattro II mass spectrometer (as used in Chapter 2), protein adducts could not be

detected. However, it is worth noting that the digestion of the protein obtained from
human lenses was very reproducible (Fig. 7.11). Human lenses were homogenised and
extracted four times in 80% ethanol to remove unbound low molecular weight

compounds from the protein. The lyophilised protein pellet was resuspended in tryptic

digestion buffer and the samples placed in boiling water for 1 minute to denature the

crystallins129. Two aliquots of trypsin were added to these protein solutions at a rat

1:50 (w/w) each; at time zero and again after 90 mins of incubation. The incubation a

37°C was allowed to proceed for a further 4.5 hours before freezing the peptide mixtu
HPLC was performed on each of the tryptic peptide solutions as described in Methods
section 7.2.4 by running a slow acetonitrile gradient with 0.05% TFA as the counter-

ion. Shown in figure 7.11 are the HPLC profile overlays (detection by UV absorption a
229 nm) of four elderly human lens protein tryptic digests. As can be seen from this

figure, these digests appear to be very reproducible. Further attempts to elucidate s
of modification by the UV filters are currently underway in our laboratory following
similar methods as those described here.

197

Chapter 7 Preliminary Mass Spectroscopic Evidence for the Covalent Binding of30HKG to Crys
Protein

Detection at 229 n m

200

80 years
77 years
66 years
69 years

0

10

20

30

40

Time (mins)

Figure 7.11: H P L C comparison of the tryptic digest of h u m a n lens proteins from
donor lenses over 65 years of age. A s can be seen from the profiles
above, the peptide profile of h u m a n lens protein is quite reproducible.
D u e to the complexity of the H P L C profile (from the large number of
possible trypticfragments),second stage H P L C purification of 360 n m
absorbing peptides is a requirement prior to mass spectral analysis. The
lack of access to the n e w (hence more sensitive) E S I - T O F M S hindered
further investigation in this part of the project.
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Discussion

The aim of this section of work was to elucidate crystallin sequences that had
been modified by the most abundant UV filter found in the human lens, 30HKG, and to

confirm that the binding is covalent in nature. Only partial analysis of the tryptic d
was possible as I was markedly restricted in terms of my access to the mass spectral

equipment required. Initial work focused on incubating the separate crystallin familie
of bovine crystallin with 30HKG for up to 5 weeks at pH 7.4 at 37°C. The advantages
of using the bovine crystallins for this type of incubation are that there is a large
of sequence homology with the human crystallin proteins, and the bovine species lacks
the metabolic pathway for the production of the human tryptophan-derived UV filters
and therefore the protein had not been previously in contact with these compounds.
By incubating the separate crystallin families for up to 5 weeks, it was hoped
that sufficient protein modification had occurred for this to be evident by mass
spectroscopy. This aim was achieved by finding two tryptic peptides from bovine
crystallin that were modified at cysteine residues: tryptic fragment 17 (T-17) from
bovine aA and T-2 from bovine PB2.
Because of the tryptophan-derived UV filters spontaneously deaminate to form
a, p-unsaturated carbonyl compounds, it was speculated in our laboratory that these
reactive intermediates may go on to form adducts with nucleophilic amino acids such as
lysine, histidine and cysteine via Michael-type additions31'56. It had been shown
previously that an analogous lipid peroxidation product, 4-hydroxy-2-enal (HNE) has

reacted with these nucleophilic amino acids in vitro138'140. Recent evidence suggests th
the cysteine residue of bovine aA crystallin (Cysl31) is an initial and major site for
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modification by kynurenine98. This result was confirmed by identifying this same
residue as modified by 3 OHKG and may also explain why only cysteine-modified

tryptic fragments were identified in this chapter. The lack of reactivity of the s-amin

group of lysine may the result of a pKa of this group of 10.5, compared to a value of 6
for the histidine imidazole group and 8.3 for the cysteine thiol group. At neutral pH,
imidazole ring nitrogen of histidine is more likely to attack the a, P -unsaturated
carbonyl of the kynurenine side-chain than the protonated e-amino group of lysine.
Cysteine has a higher pKa value than that for histidine and thus would not be expected
to be as reactive as histidine at neutral pH, however the thiol group is a better
nucleophile1. In the HPLC separation of both the a- and P-crystallin incubations with
30HKG (Figs. 7.2 and 7.7), the most abundant 360 nm absorbing peak was identified as
a modified cysteine-containing residue. Smaller peaks from these chromatograms may
contain adducts of histidine and to a lesser extent lysine.
In theory, incubating the crystallin families separately simplified the

identification of the crystallin tryptic fragments and thus we were able to process mor
samples in the limited time available with the new Micromass Q-ToF-2 hybrid
quadrupole / time-of-flight mass spectrometer (ESI-TOFMS). This new mass
spectrometer offers ion sensitivity orders of magnitude better than the machine it

replaced (VG Quattro II triple quadrupole mass spectrometer), we were thus able to find

and elucidate the structures of these modified peptides in much less time. Samples only
needed one HPLC purification step and the collected fractions from the eluent did not

need concentration, such was the sensitivity of this instrument. Again, due to the limi
opportunities to use the new machine, modified peptides from the y-crystallin
incubation were unable to be identified at this time.
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Much of the practical work associated with this project involved optimising the
approaches subsequently used in this chapter to elucidate modification in human lens
protein. Ultimately, the conditions necessary for reproducible tryptic digestion of

elderly human lens protein were obtained (Results section 7.3.5). This pattern of tryp

digestion indicates that the processes involved in the normal ageing of the human lens
are also common. This result is encouraging as it gives a clear target for the HPLC

purification and subsequent mass spectral analysis of 360 nm absorbing and fluorescent
(Ex 380 nm/Em 490 nm) peptides from the human lens. Work is currently underway in

our laboratory to repeat the findings from this chapter with the newer, more sensitive
ToF instrument.
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Conclusion
The lens allows light to be focussed and transmitted onto the retina. The

transparency of the lens to light in the visible region and its flexibility to focus thi
are crucial in maintaining vision. Transparency and the refractive index of the lens
depend on the short-range interactions and concentrations of the water-soluble protein

that constitute it141. It is a widely held view that the physical manifestations of agein

the lens are attributed to post-translational modification of the crystallin protein. Ov
time these modifications alter the integrity of the protein and may disturb the normal
interactions between neighbouring protein molecules. Individual units aggregate and
eventually cease to remain soluble. Many researchers have speculated as to which
particular types of post-translational modification are more important in causing the
physical manifestations of ageing and cataract formation: The protein in the lens
becomes progressively more yellow, the effect of this filter being that the colours

transmitted to the retina are diminished, especially the blue-green colours. In addition
the lens proteins become more fluorescent and the crystallin protein, which makes up
most of the dry weight of the lens, slowly becomes insoluble.
This thesis has postulated that at least part of the responsibility for physical
changes observed with the ageing human lens lies with a group of low molecular weight
fluorescent compounds derived from the metabolism of tryptophan, termed UV filter
compounds. These compounds absorb most of the UV light transmitted by the cornea
between 295 and 400 nm. It has been speculated that the function of these compounds
within the lens may be to protect the lens and the retina from harmful UV radiation and
to increase visual acuity.
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In this study tryptophan metabolites were examined for their ability to

covalently modify crystallin protein of the lens. One objective was to find evidence fo

this modification in lens proteins. Secondary objectives of this study were to discover
what physical effects these modifications had on parameters normally associated with
the ageing lens, namely increases in protein 'colouration', fluorescence, aggregation
precipitation.
An important finding from research undertaken in our laboratory was that
metabolites of tryptophan that contain the kynurenine side-chain, can spontaneously
deaminate to form an a, p-unsaturated carbonyl compounds. The mechanism of
deamination opened up an important field of research in our laboratory, molecules that
had been thought to be beneficial in maintaining integrity of the visual pathway were
now, themselves, shown to contribute to the post-translational modification of the

crystallin protein. In line with this finding, chapter two of this thesis showed studie
conducted with an analogue of this reactive intermediate in aqueous buffered solutions
can further react to form adducts with various nucleophilic amino acids. Evidence was
given that not only shows that the intermediate is stable in aqueous buffered solution
but that adducts can be formed with thiol and e-amino groups of cysteine and lysine,

respectively, in high yield. Further research into the chemistry of the kynurenine sid
chain revealed the importance of the a-amino group when analogues of this compound
that had the a-amino group either blocked or removed altogether (a-N-acetyl-3hydroxykynurenine-O-p-D-glucoside (N-acetyl-30HKG) and 4-(2-amino-3hydroxyphenyl)-4-oxobutanoic acid-O-P-D-glucoside (AHBG), respectively) failed to
show any appreciable level of modification of calf lens protein when compared to the
equivalent incubation with 30HKG.
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Having established the feasibility of forming kynurenine-derived adducts with
crystallin residues, we then established a test to quantify the amount of 3hydroxykynurenine-O-p-D-glucoside (3OHKG - the most abundant kynurenine-derived
UV filter) bound to protein from human lenses. By treating protein material with
alcoholic hydroxide for up to 144 hours, a fluorescent compound was released that was
identified as the cleavage product of 30HKG (2-amino-3-hydroxyacetophenone-0-P-Dglucoside, AHAG). AHAG was quantified from the protein extracts of over 100

individual human lenses spanning over eight decades of life. Quantification showed tha
there were negligible quantities of the bound fluorophore prior to approximately 40
years of age, whereas after an exponential increase could be observed. The amount of
3 OHKG bound to the crystallin protein also showed a good correlation to the observed
360 nm absorption and non-tryptophan fluorescence of the human lens protein. Further
quantification and correlation studies showed that the covalent attachment of 3 OHKG

was concentrated in the nucleus of the lens, especially those past the fourth decade of
life. This important finding is one of the first major links between the physical and
biochemical effects of the ageing human lens, i.e. the physical changes to the lens
(fluorescence, colouration and opacification) are known to begin in the lens nucleus,
now biochemical evidence is given for a major post-translational modification also
localised to the nucleus.
Having established that the major UV filter compound, 30HKG, could bind to
the human crystallins, we now set about to determine what effect this binding had on
crystallin proteins in model incubation studies. The UV filter compounds were

incubated with crystallin protein isolated from young bovine lenses for up to five days
with the aim of examining the parameters associated with the ageing lens. The
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crystallins obtained from the bovine lens have a close sequence homology to that of the
analogous human lens proteins but the bovine species lack the UV filter metabolic
pathway, hence the protein had not previously been in contact with these small
molecules. The incubated protein material exhibited similar physical characteristics
protein from aged human lenses, namely, increases were observed in 360 nm

absorption, non-tryptophan fluorescence, protein aggregation and protein precipitatio
as incubation time and UV filter concentration were increased. The inclusion of
glutathione, an anti-oxidant compound normally found in healthy human lens
homogenates, delayed crystallin modification as measured by these parameters.
Finally, mass spectral evidence was provided for crystallin sequences that had
been modified by the most abundant UV filter, 3 OHKG. By incubating separate

crystallin families with 3 OHKG for up to five weeks followed by digestion with trypsin
we found that cysteine residues from bovine aA and pB2 crystallin sequences were
sites of covalent modification by this UV filter compound. Since 3 OHKG (and the other
kynurenine-derived UV filters) are continually synthesised in the human lens over the

lifetime of the individual, these findings may provide a biochemical link to the phys
parameters associated with the ageing lens and cataract formation.
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APPENDIX
Bovine Crystallin Database Information

Bovine crystallin sequences were downloaded from SwissProt
(www.expasy.org), an internationally recognised resource for primary protein amino

acid sequence information. Cysteine residues are highlighted in red, histidine residue
are highlighted blue and lysine residues are highlighted green for each sequence thus
indicating possible sites of modification by the kynurenine-derived UV filter
compounds.

Alpha A Crystallin
173 Amino Acids, Theoretical Molecular Weight 19790 Da.
MDIAIQHPWF KRTLGPFYPS RLFDQFFGEG LFEYDLLPFL SSTISPYYRQ
SLFRTVLDSGISEVRSDRDK FVIFLDVKHF SPEDLTVKVQ EDFVEIHGKH
NERQDDHGYI SREFHRRYRL PSNVDQSALS CSLSADGMLT FSGPKIPSGV
DAGHSERAIP VSREEKPSSA PSS

Alpha B Crystallin
175 Amino Acids, Theoretical Molecular Weight 20037 Da
MDIAIHHPWI RRPFFPFHSP SRLFDQFFGE HLLESDLFPA STSLSPFYLR
PPSFLRAPSWIDTGLSEMRL EKDRFSVNLD VKHFSPEELK VKVLGDVIEV
HGKHEERQDE HGFISREFHRKYRIPADVDP LAITSSLSSD GVLTVNGPRK
QASGPERTIPITREEKPAVT AAPKK
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Beta B l Crystallin

252 Amino Acids, Theoretical Molecular Weight 28012 Da.
SQPAAKASAT AAVNPGPDGK GKAGPPPGPA PGSGPAPAPA PAPAQPAPAA
KAELPPGSYK LVVFEQENFQ GRRVEFSGEC LNLGDRGFER VRSIIVTSGP
WVAFEQSNFR GEMFVLEKGE YPRWDTWSSS YRSDRLMSFR PIKMDAQEHK
LCLFEGANFK GNTMEIQEDD VPSLWVYGFC DRVGSVRVSS GTWVGYQYPG
YRGYQYLLEP GDFRHWNEWG AFQPQMQAVR RLRDRQWHRE
GCFPVLAAEP PK

Beta B2 Crystallin

204 Amino Acids, Theoretical Molecular Weight 23167 Da.
ASDHQTQAGK PQPLNPKHIFEQENFQGHS HELNGPCPNL KETGVEKAGS
VLVQAGPWVG YEQANCKGEQ FVFEKGEYPR WDSWTSSRRT DSLSSLRPIK
VDSQEHKITL YENPNFTGKK MEVIDDDVPS FHAHGYQEKV SSVRVQSGTW
VGYQYPGYRG LQYLLEKGDY KDSGDFGAPQ PQVQSVRRIR DMQWHQRGAF
HPSS

Beta B3 Crystallin

210 Amino Acids, Theoretical Molecular Weight 24197 Da.
AEQHSTPEQA AAGKSHGGLG GSYKVIVYEM ENFQGKRCEL TAECPNLTES
LLEKVGSIQV ESGPWLAFER RAFRGEQYVL EKGDYPRWDA WSNSHHSDSL
LSLRPLHIDG PDHKLHLFEN PAFGGRKMEIVDDDVPSLWA HGFQDRVASV
RAINGTWVGY EFPGYRGRQY VFERGEYRHW NEWDANQPQL QSVRRIRDQK
WHKRGVFLSS
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Beta A l Crystallin

215 Amino Acids, Theoretical Molecular Weight 25131 Da
METQTVQQEL ESLPTTKMAQ TNPMPGSVGP WKITIYDQEN FQGKRMEFTS
SCPNVSERNF DNVRSLKVEC GAWVGYEHTS FCGQQFVLER GEYPRWDAWS
GSNAYHIERL MSFRPICSAN HKESKITIFE KENFIGRQWEICDDYPSLQA
MGWPNNEVGS MKIQCGAWVC YQYPGYRGYQ YILECDHHGG
DYKHWREWGS HAQTSQIQSI RRIQQ

Beta A2 Crystallin

196 Amino Acids, Theoretical Molecular Weight 22099 Da
SSAPAQGPAP ASLTLWDEED FQGRRCRLLS DCANIGERGG LRRVRSVKVE
NGAWVAFEYP DFQGQQFDLE KGDYPRWSAW SGSAGHHSDQ LLSFRPVLCA
NHSDSRVTLF EGENFQGCKF ELNDDYPSLP SMGWASKDVG SLKVSSGAWV
AYQYPGYRGY QYVLERDHHS GEFRNYSEFG TQAHTGQLQS IRRVQH

Beta A4 Crystallin

209 Amino Acids, Theoretical Molecular Weight 23729 Da
SGMFSGSISE TSGMSLQCTK SAGHWKIWW DEEGFQGRRH EFTAECPSVL
ELGFETVRSL KVLSGAWVGF EHAGFQGQQY VLERGEYPS W DAWSGNTSYP
AERLTSFRPV ACANHRDSRL TIFEQENFLG RKGELSDDYP SLQAMGWDGN
EVGSFHVHSG AWVCSQFPGY RGFQYVLECD HHSGDYKHFR EWGSHAQTFQ
VQSIRRIQQ
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Gamma S Crystallin
177 Amino Acids, Theoretical Molecular Weight 20796 Da
SKAGTKITFF EDKNFQGRHY DSDCDCADFH MYLSRCNSIR VEGGTWAVYE
RPNFAGYMYI LPRGEYPEYQ HWMGLNDRLS SCRAVHLSSG GQYKLQIFEK
GDFNGQMHET TEDCPSIMEQ FHMREVHSCK VLEGAWIFYE LPNYRGRQYL
LDKKEYRKPV DWGAASPAVQ SFRRIVE

Gamma A Crystallin
174 Amino Acids, Theoretical Molecular Weight 21003 Da
GKITFYEDRG FQGHCYQCSS NNCLQQPYFS RCNSIRVDVH SWFVYQRPDY
RGHQYMLQRG NYPQYGQWMG FDDSIRSCRLIPQHTGTFRM RIYERDDFRG
QMSEITDDCP SLQDRFHLTE VNSVRVLEGS WVIYEMPSYR GRQYLLRPGE
YRRYLDWGAM NAKVGSLRRV MDFY

Gamma B Crystallin
174 Amino Acids, Theoretical Molecular Weight 20965 Da
GKITFYEDRG FQGHCYECSS DCPNLQPYFS RCNSIRVDSG CWMLYERPNY
QGHQYFLRRG DYPDYQQWMG FNDSIRSCRL IPQHTGTFRM RIYERDDFRG
QMSEITDDCP SLQDRFHLTE VHSLNVLEGS WVLYEMPSYR GRQYLLRPGE
YRRYLDWGAM NAKVGSLRRV MDFY
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Gamma D Crystallin
173 Amino Acids, Theoretical Molecular Weight 20735 Da
GKITFYEDRG FQGRHYECSS DHSNLQPYLG RCNSVRVDSG CWMIYEQPNY
LGPQYFLRRG DYPDYQQWMG LNDSVRSCRLIPHAGSHRLR LYEREDYRGQ
MIEITEDCSS LQDRFHFNEI HSLNVLEGSW VLYELPNYRG RQYLLRPGEY
RRYHDWGAMN AKVGSLRRVIDIY

Gamma E Crystallin
173 Amino Acids, Theoretical Molecular Weight 20743 Da
GKITFYEDRG FQGRCYQCSS DCPNLQPYFS RCNSIRVDSG CWMLYERPNY
QGHQYFLRRG DYPDYQQWMG FNDSIRSCCLISDTSSHRLR LYEREDQKGL
IAELSEDCPC IQDRFRLSEV RSLHVLEGCW VLYEMPNYRG RQYLLRPQEY
RRYQDWGAVD AKAGSLRRVV DLY

Gamma F Crystallin
173 Amino Acids, Theoretical Molecular Weight 20955 Da
GKITFYEDRG FQGRHYECSS DHSNLQPYFS RCNSIRVDSG CWMLYEQPNF
QGPQYFLRRG DYPDYQQWMG LNDSIRSCRLIPHTGSHRLRIYEREDYRGQ
MVEITEDCSS LHDRFHFSEIHSFNVLEGWW VLYEMTNYRG RQYLLRPGDY
RRYHDWGATN ARVGSLRRAV DFY

210

Gamma Z Crystallin
330 Amino Acids, Theoretical Molecular Weight 35403 Da.
MATGQKLMRAIRVFEFGGPE VLKLQSDVAV PIPKDHQVLI KVQACGVNPV
DTYIRSGTHNIKPLLPYTPG FDVAGIIEAV GESVSAFKKG DRVFTTRTIS
GGYAEYALAA DHTVYTLPEK LDFKQGAAIGIPYFTAYRAL LYSAPVKPGE
SVLVHGASGG VGIAACQIAR AYGLKVLGTA STEEGQKIVL ENGAHKVFNH
KEANYIDKIK KSVGEKGVDV IIEMLANVNL SNDLNLLSHG GRVIWGSRG
TIEINPRDTM TKESSIKGVT LFSSTKEEFQ QFAAALQAGM EIGWLRPVIG
PQYLLEKATQ AHENIIHSSG ATGKMLLLD
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